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 When I reflect on the last five years and the decisions that led me to pursue this 
Ph.D. in the first place, I cannot with the benefits of hindsight say that I would absolutely 
travel the same path.  That said, I cannot say for sure that I would do things differently, 
either.  Regardless, this process has been an incredible learning experience.  I learned a 
lot about myself; I learned a lot about friendships and relationships; I somehow managed 
to learn things about my wonderful family that I hadn’t in the 24 years prior to coming to 
Atlanta.  I even learned a bit about scientific research along the way.  
 I want to gratefully acknowledge anyone and everyone who assisted me in this 
journey, no matter how small the contribution.  I cannot even begin to enumerate all the 
names, but my sincerest thanks are extended to every individual who in some way helped 
propel me to the completion of this degree. 
 First and foremost, I need to thank my thesis advisor, Dr. Robert E. Guldberg.  I 
came to Georgia Tech with every intention of working for Bob, and told him as much 
when I arrived on campus in the fall of 2008.  Thankfully, he saw enough potential in me 
to take me on despite the fact that I had not really even thought about a cell since high 
school freshman biology.  He then stuck with me through that first year when on any 
number of days he could have taken a look at the obnoxious neck-beard I insisted on 
growing, silently shook his head, and decided that this just wasn’t going to work out.  
The growth I have experienced as a researcher since first joining the lab is due in no 
small part to Bob.  He was a calm, thoughtful mentor who provided a constant steadying 
force while I did my best to navigate the ups and downs of doctoral research; on more 
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than one occasion, he probably believed in me and my work more than I did myself.  His 
ability to give insightful, critical analysis without crossing the boundary to personal 
criticism was a key to keeping my project moving forward on more than one occasion.  
Now, as my time in the lab draws to a close, Bob has been incredibly supportive and 
proactive in trying to help me with career development, even as I struggle to figure out 
what exactly I want that next step to be.  Finally, there has never been a question as to 
whether Bob cares about my personal well-being, not just my productivity as a student, 
and for that I am truly grateful.   
 I also wish to thank each of my committee members for their essential roles in 
this project.  Dr. Taylor gave valuable input on the project, especially aspects related to 
vascular growth, and reinforced the importance of precise word choice for explaining my 
rationale and results.  Dr Bellamkonda was an important collaborator on the bone and 
nerve model, and made sure I always kept the big picture questions in mind.  Dr. 
Temenoff challenged me to always be clear about the specific scientific question I was 
trying to address.  Dr. Gilbert provided unique perspective and useful input from an 
orthopaedic clinician who also values and participates in basic science research.  All of 
these individuals were generous with their time and expertise despite their incredibly 
demanding schedules.   Through their insightful comments and probing questions, both 
this project and my abilities as a researcher were able to achieve potential they otherwise 
would not have.    
 In some form or fashion, all of the educators I’ve encountered throughout my life 
contributed to this degree.  For a professional group that never really receives their 
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deserved credit, I offer my deepest gratitude here.  Especially in (the incredibly unlikely) 
case any of them stumble across this document one day. 
 This work certainly would not have been possible without the contributions, past 
and present, of my fellow Guldberg lab members.  No one truly enjoys days spent in the 
OR suite, but they do have a funny way of building bonds and instilling a collaborative 
spirit with the group in a way few other things can.  Also, ORS conferences will likely be 
some of the best “work” trips I ever take, due in large part to my tremendous labmates.  
Hazel Stevens and Angela Lin deserve special recognition for everything they do for the 
lab.  If either is ever in need of a reminder of just how important they are to the group, I 
will be more than happy to send heaps of praise their way.  Hazel does a tremendous job 
keeping the lab running smoothly, was instrumental in the latter aspects of my project, 
and her wit is one-of-a-kind.  Conversations with her were one of the little joys of day-to-
day lab work.  I still hold out hope that her claim to not enjoy Queen or The Rolling 
Stones is some sort of cruel jape.  Angela is one of the world experts on micro-CT and 
provided immeasurable technical help at numerous points in my project.  I have a 
suspicion that she may not have been my biggest fan in the early days, but I now count 
her amongst my closest friends.  Fry parties, lobster boils, Candlerwood/Cabbagewood 
races, and Bourbon Street are among the many Angela related memories I will cherish.  
She is also the reason I will always remember that “winter is coming” and “the enemy’s 
gate is down.”  Vivian Johnson deserves thanks for always managing to squeeze me into 
Bob’s schedule on short notice and never seeming remotely annoyed by my requests.  I 
need to thank Ken Dupont and Yash Kolambkar for all the help they provided when they 
were on the way out the door and I was just arriving, as much of their work paved the 
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way for my own.  I have no doubt there were numerous times when they were annoyed 
with my nagging questions, but were always generous with their time and advice, and 
remain so to this day.   Joel Boerckel was perhaps the labmate most essential to my 
project, providing enormous help for 3 solid years, and I enjoyed the reciprocal assistant 
roles we each took in the other’s work.  Joel possesses a great mind for research, and was 
always eager to make conversation on anything from science to bicycles to life in 
general.  Nick Willett has been a tremendous asset to the lab and picked up where Joel 
left off by providing significant contribution to the latter parts of this project.  Nick was 
incredibly generous with his time and very supportive of me as a researcher and an 
individual, for which I am incredibly grateful.  Also, if ever in the need of travel 
companions for a two week jaunt through central Europe, he and his bride-to-be, Amber 
Hudson, are top notch.  Chris Dosier … where does one even begin?  Chris is 
undoubtedly one of the smartest people I know and also one of the most unique.  His 
ability to deliver sound scientific input in the most non-PC way possible is likely 
unmatched (as is his ability to apply Top Gun quotes to any real life situation – sorry, 
Dave).  His sense of humor also ensured that every day at work was different from the 
last.  Jason Wang has been with me all 5 years in the lab, and provided good company for 
many of the long hours in the CT room.  Jessica O’Neal Green and Mela Johnson Carroll 
were great labmates in my early years, and even better kickball teammates.  Alice Li has 
been a terrific co-investigator in the composite injury research group, and I have all the 
confidence in the world in her as the torch bearer of that group going forward.  Tanu 
Thote and Lauren Priddy have been excellent additions to the lab and were solid back 
row officemates who made sure that I removed my headphones and engaged my 
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neighbors in conversation at least a couple times each day (until I moved to the office and 
resumed my hermit ways).  Laxmi Krishnan, David Reece, and Marian Hettiaratchi have 
always been willing to help with surgeries, and contributed thought-provoking questions 
and useful input on my research.  Tamim Diab, Liqin Xie, Taran Lundgren, Shamus 
(SHAMUS!!) Moran, Yazdan Raji, and Chelsea Fechter also deserve thanks for the 
assistance they provided in various aspects of this project.  The future of the lab also 
appears to be in very capable hands with Brennan Torstrick, Albert Cheng, and Giuliana 
Salazar-Noratto.  Again, my absolute sincerest thanks to all of my fellow Guldbergers for 
making this Ph.D. possible.  I wish every one of you absolutely nothing but the best in all 
of your future endeavors, which undoubtedly will be enormously successful.   
 One final labmate acknowledgement is in order, but will fall woefully short on 
these pages.  I cannot even begin to express how truly amazing and special Ashley Allen 
is, or adequately thank her for her consistently positive disposition, devoted friendship, 
the love and support she provided me, and all of the countless ways she bettered my 
world, so I won’t embarrass either one of us in attempting to do so.   
 My wing 2D/lair colleagues deserve many thanks as well for contributing useful 
scientific discussion, encouraging useful non-scientific discussion, commiserating when 
experiments had utterly failed, and in general, just promoting a terrific work 
environment.  I also owe an incredible amount of gratitude to Dr. Laura O’Farrell, Kim 
Benjamin, and the PRL staff.  Dr. O’Farrell provided essential input at several points of 
my project and training in many areas vital to its completion.  The PRL staff is such an 
important part of the IBB in facilitating the in vivo work done and making our jobs as 
researchers infinitely easier.  I want to also thank the IBB staff, including Aqua Asberry, 
 ix 
Floyd Wood, James Godard, Alyceson Andrews, Karen Cannon, Allen Echols, and Meg 
McDevitt, all of whom provided great help to me at one point or another.   
 Two research collaborators deserve specific recognition for their technical 
contributions to this thesis – Isaac Clements and Natalia Landázuri.  Isaac was essential 
for the experimental execution of all things neuro, and without Natalia’s expertise, 
adaptation of the ischemia surgery technique would have been much more difficult and 
time consuming.    
Lest I give the impression that my time at Georgia Tech was all work and no play, 
I also developed some phenomenal friendships that will continue to endure long after my 
time here is done.  Dave Dumbauld and Kelly Erby Dumbauld are exceptional people and 
hands down two of the greatest friends I will ever know.  In many ways, I was practically 
their full-grown child – they fed me, planned my weekend activities, took me to visit 
grandparents, and ultimately, ushered me through some of the darkest days I’ve known.  
This all despite the fact that on more than one occasion I was invited over for social 
football watching, only to sit in the back of the room watching a different game with 
headphones on [insert guilty face here].  So many of my favorite Atlanta memories are 
Dumbauld-related, and I look forward to all Larryville ones yet to come.  Vince Fiore and 
Alison Douglas filled in admirably following Dave and Kelly’s departure from 8
th
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Argonne.  Vince and I have been fast friends since I came to his rescue on the BBUGS 
rafting trip our first month in Atlanta.  Vince’s dedication to his research is truly 
admirable, his passion for living-it-up infectious, and his support of me unwavering.  
Alison is quick to offer libations, eager to extend invitations, and always a willing 
listener; she has been a terrific influence on Vince, and a great friend to me.  Jeremy Lim 
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is an incredibly dedicated friend, whom I could count on for anything from grabbing a 
beer, to hashing out personal issues, performing a cappela Beastie Boys karaoke, or just 
playing catch in the park.  A constant companion at sporting events, even the biggest 
gaffe during our friendship (miles of unnecessary walking on and around the Auburn 
University campus) produced a memorable moment – the round mound of rebound, Sir 
Charles!  Ted Lee is a truly unique individual who possesses a terrific mind for science, a 
remarkable knack for befriending nearly anyone and everyone, and a modus operandi of 
letting the good times roll (bottles in the club).  Were motivating happy hour excursions 
at all analogous to Voltron assembly, Ted would undoubtedly be the head.  Although 
unbeknownst to me, I nearly sabotaged my friendship with the wonderful Kate Wilson 
before it even began.  Thankfully, when afforded a second chance, I found a great friend 
in the teleworker extraordinaire/board game aficionado who truly excels at pointed 
discussion of “feelings” and the art of giving hugs.  Not to be forgotten is the Murray Hill 
crew of Scott Robinson and Rich Carpenedo (and all affiliated parties).  Rich, long lost to 
the Great White North, taught me about cycling in Atlanta and about drinking in Atlanta 
… and then how to successfully pair the two.  Scrob is an unrivaled story teller, who 
introduced me to the glories of Patak cured meats, tank tops, and the refined pairing of 
scotch, steak, and bad sci-fi movies.  Sean Coyer and Shetal Shah brought The Blue Frog 
into my life (uh, thanks for that, I guess), and I was incredibly honored to be present for 
their nuptials, an event so impressive and entertaining that it will forever temper my 
expectations when attending future weddings.  Ed Phelps and Devon Headen are all 
around good dudes, and continuously humble me in research and cycling capabilities, 
respectively.  Tim Petrie befriended me early on, and brought me into the BBUGS 
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intramural sports fold, where I developed friendships with Andrés Bratt-Leal, JP Rabbah, 
Jay Sy, Matt Magnusson, Nathan Hotaling, Randy Ankeny, Chris Edens, and Eric Ping.  
Other folks who contributed to good times in Atlanta include Chris Lee, Katie Pitz, Song 
Seto, Jonathan Suever, Jen Lei, Ian Campbell, Cindy Bower, Julia Henkels, and Mel Li.   
 I need to also thank my non-Atlanta friends for the roles they have played in 
getting me to this point.  Specifically, The Roo – Neil, DB, Tim, Ferrel, Matt, Ross, RJ, 
Dan, and Jeff – for being the greatest, funniest, most unique group of friends I could ask 
for.  Several of them have been my closest friends for over half of my 29 years, and I 
consider them brothers in every sense of the word.  There was many a day that the Roo 
thread boosted my spirits when research was trying its best to keep me down.  It’s been 
an absolute pleasure to have them all along on this ride.  My close friend Zack Rabold 
deserves thanks for all the support, encouragement, and advice he has provided for many 
years.  Though our friendship took a tortuous path at times, the two of us share 
innumerable fond memories, and Zack has long believed in my ability to achieve great 
things (in short, he might say “I been knowin’”). 
 My family deserves more thanks than I could ever convey here.  Absolutely none 
of this would have been possible without my incredible parents: Earlene Uhrig and Rod 
Uhrig.  They are two of the strongest people I will ever meet and are walking, talking 
examples of persevering through adversity.  They have taught me so, so much, and 
continue to do so on a weekly basis.  The value of hard work; to always give my best 
effort; to believe in myself; to passionately live my life and pursue my dreams; to be 
steadfast in my convictions; to be curious but practice patience; to treat people with 
integrity and respect; to be kind and compassionate; and perhaps above all else, to remain 
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loyal, honest, and keep my word.  My Grandma Stuart also deserves special thanks for 
the immeasurable impact she has had on my life.  She is far and away one of the most 
inspirational and loving people I will ever know.  I consider her one of the greatest 
blessings I will ever receive.  My aunts, uncles, cousins, etc. provided continuous love 
and support throughout this endeavor, and served up constant reminders to continuously 
refine my ability to talk about research with people from outside of the field.  These 
individuals molded me into the man I am today.  I strive to do my best every single day to 
make them all proud.   
 Finally, endless thanks go to my brother, Brian, for being my absolute best friend 
in this world and unequivocally the greatest sibling anyone could ever hope for.  We have 
partnered on an incredible journey that began 29 years ago when sharing a womb, with 
many a moment of pure, unbridled happiness, but certainly our fair share of trials and 
tribulations.  Through broken noses and broken bones, broken spirits and broken hearts, 
we’ve endured together.  I know that no matter what the circumstance, when all the chips 
are down, there is, at minimum, one person in this world who will always, always be in 
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 Severe extremity trauma often involves significant damage to multiple tissue 
types, including bones, skeletal muscles, peripheral nerves, and blood vessels.  Such 
injuries present unique challenges for reconstruction, and improving structural and 
functional outcomes of intervention remains a pressing, unmet clinical need.  While 
tissue engineering/regenerative medicine (TE/RM) therapeutics offer promising potential 
to overcome the status quo limitations of surgical reconstruction, very few products have 
transitioned to clinical practice.  Improving treatment options will likely require 
advancing our understanding of the biological interactions occurring in the repair of 
damaged tissues.   
 Bone tissue is known to be innervated and highly vascularized, and both tissue 
types are involved in normal bone physiology.  However, the degree to which these tissue 
relationships influence the repair of large, multi-tissue defects remains unknown.  
Accordingly, the goal of this thesis was to investigate tissue regeneration in two novel 
composite injury models.  First, we characterized interactions in a composite bone and 
nerve injury model where a segmental bone defect was combined with a peripheral nerve 
gap.  Our results indicated that although tissue regeneration was not impaired, the 
composite injury group experienced a marked functional deficit in the operated limb 
compared to single-tissue injury.  Second, we developed a model of composite bone and 
vascular extremity trauma by combining a critically-sized segmental bone defect with 
surgically-induced hind limb ischemia to evaluate the effects on BMP-2-mediated bone 
repair.  Interestingly, our results demonstrated a stimulatory effect of the recovery 
 xxii 
response to ischemia on bone regeneration.  Finally, we investigated early vascular 
growth and gene expression as potential mechanisms coupling the response to ischemia 
with bone defect repair.  Although the response to ischemia promoted robust vascular 
growth in the thigh, it did not directly augment vascularization at the site of bone 
regeneration.  In addition, the stimulatory effects of ischemia on bone regeneration could 
not be explained by gene expression alone based on the genes and time points 
investigated.   
 Taken together, this thesis presents pioneering work on a new thrust of TE/RM 
research – tissue regeneration in models of composite injury.  This work has provided 
new insights on the complexity of composite tissue repair, specifically in regard to the 
relationship between vascular tissue growth and bone healing.  Going forward, successful 
leverage of models of composite tissue injuries will provide valuable test beds for 
screening new technologies, advance the understanding of tissue repair biology, and 
ultimately, may produce new therapeutic interventions for limb salvage and 








 Severe extremity trauma resulting in significant injury to multiple tissues, 
including bone, skeletal muscle, nerve, and vasculature, presents a multitude of clinical 
challenges that often cannot be managed with conventional reconstruction techniques. 
Furthermore, due to the complex nature of these injuries, a lack of consensus exists for 
surgical intervention strategies (Yazar et al., 2004; DeFranco and Lawton, 2006; Nauth et 
al., 2011).  Multi-stage treatment is routinely required in these cases, and patients are 
often encumbered with diminished long-term function even if limb salvage and 
reconstruction are successful (Bosse et al., 2002; MacKenzie et al., 2005).   
 Autologous tissue grafting remains the clinical gold standard for many tissue 
defect reconstruction procedures, including those for large bone defects, peripheral nerve 
gaps, and blood vessel repair.  In nearly all cases, these procedures face limitations due to 
the volume of tissue available for grafting and the associated morbidity at the donor site.  
The field of tissue engineering and regenerative medicine (TE/RM) has emerged with 
potential strategies to overcome the unmet clinical needs of reconstruction, but to date, 
few products are commercially available.  Considerable investigation is ongoing in tissue 
engineering and regenerative medicine therapeutics to improve reconstruction outcomes; 
however, the vast majority of musculoskeletal trauma models employed for testing 
therapeutics consist of single-tissue defects.  Such models have an undeniable place as 
TE/RM research tools, but possess only limited utility for investigating therapeutic 
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strategies for the repair of large, multi-tissue defects.  Furthermore, they offer little 
potential for insight into endogenous interactions between healing tissues. 
 Bone tissue is known to be innervated and highly vascularized, and both tissue 
types are involved in physiological bone processes.  Neuronal regulatory pathways have 
been implicated in fracture healing and also in homeostatic metabolism.  Additionally, 
bone repair is known to be tightly coupled to angiogenesis, and local blood supply is 
essential to maintain viable bone tissue.  However, the degree to which these tissue 
relationships influence the repair of large, multi-tissue defects remains unknown.  
Accordingly, the overall objective of this project was to develop two novel composite 
injury models of limb trauma and investigate the effects of composite injury on tissue 
regeneration.  This was done in support of the long-term goal of improved engineering of 
TE/RM therapeutics by advancing our understanding of interactions in composite tissue 
repair.  The central hypothesis of this work was that composite tissue trauma results in 
perturbed healing responses with effects on tissue regeneration and functional restoration.  
We approached this objective through the following specific aims:  
Specific Aim I 
Develop a composite limb injury model of severe bone and peripheral nerve trauma 
and assess the effects of concomitant injury on bone and nerve regeneration. 
 Extremity trauma resulting in extensive skeletal damage often involves injury to 
surrounding tissues including peripheral nerves.  Our working hypothesis was that 
composite injury affects bone regeneration and limb function compared to bone injury 
alone.  To test this hypothesis, we developed a rat model of composite lower limb bone 
and nerve injury featuring quantitative functional outcome measures.  The composite 
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injury model consisted of an 8 mm mid-femoral bone defect and a 14 mm sciatic nerve 
gap, both of which have been demonstrated to be critically-sized, and single-injury 
groups were used for comparison.  We characterized the healing response in the 
composite injury model to biomaterials-based therapeutics previously demonstrated to 
show promise in well-established, single-tissue injury models.  Quantitative outcome 
measures were used to assess both bone regeneration and peripheral nerve regeneration, 
as well as overall limb function.  Secondarily, we studied morphology and mechanical 
properties of ipsilateral and contralateral femora to test the hypothesis that the nerve 
injury induces an adaptive response in intact femora.  The results of this aim are 
discussed in Chapter 3. 
Specific Aim II 
Evaluate the effects of hind limb ischemia on rhBMP-2-mediated segmental bone 
defect repair in a composite injury model of severe lower limb bone and vascular 
trauma. 
 Bone repair is known to be tightly coupled to angiogenesis, and concomitant 
vascular insults present clinical complications for fracture and bone defect healing.  
Based on reported clinical and experimental observations on the importance of vascular 
networks in bone repair, we hypothesized that concomitant hind limb ischemia impairs 
bone regeneration compared to bone injury alone.  To test this hypothesis, we developed 
a rat model of composite lower limb bone and vascular trauma to discern how hind limb 
ischemia affects the BMP-2-mediated segmental bone defect repair process.  The 
composite injury model consisted of a critically-sized 8 mm mid-femoral bone defect in 
combination with surgical excision of the femoral artery and vein.  Bone repair was 
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investigated at both bridging and non-bridging doses of rhBMP-2.  Traditional 
radiography, micro-CT, and histology techniques were used to evaluate bone healing, and 
mechanical testing was used to assess functional restoration.  Quantitative, anatomical 
evaluation of vascular tissue networks was performed using contrast-enhanced micro-CT 
angiography.  The outcomes of this aim are discussed in Chapter 4. 
Specific Aim III 
Determine the effects of hind limb ischemia on early vascular growth and gene 
expression in rhBMP-2-mediated segmental bone defect repair. 
 Early vascular network growth and biological signaling cascades are critical in the 
process of bone repair.  Our working hypothesis was that the injury response to hind limb 
ischemia produces changes in early vascular tissue growth and/or gene expression 
compared to bone injury alone.  Such changes might help to explain the enhanced bone 
regeneration response observed in Aim II.  Histology provided qualitative assessment of 
early bone regeneration and vascular growth.  Changes in blood flow were assessed using 
laser Doppler perfusion imaging and contrast-enhanced micro-CT angiography was used 
for quantitative evaluation of vascular morphology.  Comparison of gene expression was 
performed in both the defect region and adductor muscle tissue using quantitative real-
time reverse transcription polymerase chain reaction (qRT-PCR).  The outcomes of this 
aim are discussed in Chapter 5. 
Significance 
 Extremity trauma remains the predominant combat casualty for U.S. armed forces 
members in ongoing military conflicts, a continuation of historical trends.  Explosive 
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munitions are the primary mechanism for these injuries (Owens et al., 2007; Owens et 
al., 2008), resulting in penetrating blast wounds with large zones of injury that 
encompass multiple tissue types, and, notably, a high incidence of bone and soft tissue 
trauma (Owens et al., 2007).  High-energy trauma incidents, such as motor vehicle 
collisions, produce an additional civilian patient population.  Although passenger survival 
in these incidents has increased with improved engineering of safety features, severe 
extremity trauma remains common (Burgess et al., 1995; Richter et al., 2005).  
 A variety of potential therapeutic strategies to circumvent the status quo 
reconstruction limitations are under investigation throughout the field of tissue 
engineering and regenerative medicine.  However, current animal models of 
musculoskeletal trauma used in evaluating emerging technologies typically consist of 
critically-sized, single-tissue defects.  Such models are vital research tools, but possess 
only limited utility for investigating therapeutic strategies for multi-tissue repair and offer 
little potential for insight into endogenous interactions in healing tissues.  Developing 
effective TE/RM therapies and successful translation to clinical practice will first require 
establishing rigorous, well-characterized pre-clinical models with quantitative outcome 
measures of functional restoration to use as test beds for evaluating emerging 
technologies.  Accordingly, there exists a need for challenging animal models of 
composite tissue injury.   
 The work described herein is significant because it presents the pioneering 
research on a platform of small animal test-bed models of composite limb injury which 
will provide a foundation for benchmarking new technologies.  Additionally, it has 
advanced our understanding of endogenous interactions that occur during repair of bone 
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& nerve or bone & vascular injuries.  Specifically, this work has suggested additional 
complexity to the coupling of bone repair with vascular growth/remodeling.  Ultimately, 
elucidating such interactions is a critical step toward better management of extremity 
trauma patients in the present, and will open the door for future development of novel 
therapeutics designed to leverage combinatorial or synergistic tissue repair and 




Bone Structure and Development 
 Bone is unique in many ways, not the least of which is that it is both a tissue and 
an organ.  Bones provide a multitude of physiological functions that include protection of 
internal organs, providing a support structure that allows for locomotion, serving as a 
homeostatic mineral repository, and housing the activities of hematopoiesis.  At an 
anatomical level, bones are often classified as long bones, short bones, or flat bones.  
Long bones, such as the femur, are the most relevant to this thesis, and are often divided 
into three anatomical sections base on their geometry and the type of bone structure 
present: diaphysis, methaphysis, and epiphysis.  The diaphysis is the tube-shaped shaft of 
long bones composed primarily of cortical (compact) bone.  The epiphysis is located at 
the ends of long bones, and the metaphysis is located between the diaphysis and 
epiphysis.  The growth plate (physis) provides a physical boundary between the 
metaphysis and epiphysis.  Both the metaphysis and epiphysis are composed primarily of 
trabecular (cancellous) bone with a thin shell of cortical bone.  At a structural level, 
cortical and trabecular bone have distinct differences.  Cortical bone is densely organized 
with very little macroscopic spaces (less than 10% porosity), whereas trabecular bone is 
organized as a network of interconnecting plates and rods with considerable macroscopic 
voids (30-90% porosity).  These structural dissimilarities allow for specialized 
homeostatic and mechanical functions (Miller et al., 2007). 
 Regardless of the structure presented, bone tissue has the same compositional 
constituents: bone matrix and bone cells.  Bone matrix is the primary component of bone 
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tissue and is comprised of inorganic mineral (60-70% of the tissue) and organic matrix 
material (20-25% of the tissue).  The inorganic mineral is primarily in the form of 
hydroxyapatite, a calcium phosphate apatite with molecular composition 
Ca10(PO4)6(OH)2.  The organic matrix component is predominantly Type I collagen 
(~90%), with noncollagenous proteins (such as osteopontin, osteocalcin, bone 
sialoprotein, etc.) and proteoglycans making up the remainder.  Bone matrix also contains 
a small amount of embedded growth factors inclusive of, but not limited to, members of 
the BMP, TGF-β, IGF, and FGF families.  Three primary cell types make up the cellular 
constituent of bone tissue: osteblasts, osteoclasts, and osteocytes.  Osteoblasts are bone 
forming cells responsible for laying down new matrix, whereas osteoclasts are bone 
resorbing cells.  Osteoblast and osteoclast activity is reciprocally coupled in the 
regulatory process of bone remodeling.  Osteocytes are the most common cell type in 
bone tissue, and are derived from terminally differentiated osteoblasts that became 
embedded in the bone matrix.  Osteocytes reside in the lacunae of bone tissue and each 
possess numerous cell processes that extend outward in the canaliculi where they connect 
with neighboring osteocytes at gap junctions.  The primary function of osteocytes is 
thought to be intercellular signaling for homeostatic bone maintenance and adaptation 
(Miller et al., 2007). 
 Developmental skeletogenesis occurs through two distinct physiological pathways 
termed endochondral and intramembranous ossification.  Endochondral bone formation is 
the primary developmental pathway for long bones and consists of a cartilaginous 
skeletal anlage that is subsequently remodeled and replaced by bone in a process coupled 
to angiogenic blood vessel invasion (Gerber et al., 1999).  Intramembranous bone 
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formation is the common developmental process for flat bones of the skeleton.  In 
contrast to endochondral ossification, intramembranous bone formation does not proceed 
through a cartilage intermediate, instead resulting from the direct differentiation of 
mesenchymal progenitor cell condensations to osteoblasts. 
 Irrespective of the developmental pathway, the resulting bone tissue is primary 
woven bone.  This initial tissue has no clear collagen or mineral organization, and is 
subsequently removed and replaced by highly organized llamelar (secondary) bone in the 
bone remodeling process.  Woven bone is formed more rapidly, and is less mineralized 
than its lamellar counterpart, likely to allow for easier remodeling.  While lamellar bone 
is formed more slowly, the organizational structure provides the necessary mechanical 
properties for functional bone tissue. (Miller et al., 2007) 
Bone Healing and Regeneration 
 Bone repair is a unique postnatal healing response whereby bone tissue is 
regenerated in the absence of scar tissue formation.  The exact mechanisms of bone 
regeneration involve a complex spatial and temporal coordination of multiple cellular and 
molecular contributors in physiological processes that, in part, recapitulate embryonic 
skeletogenesis (Ferguson et al., 1999).  As in development, bone healing involves a 
combination of both endochondral and intramembranous ossification pathways.  In 
general, bone healing proceeds through the three overlapping hallmark stages of wound 
healing: inflammation, repair, and remodeling.   
 The inflammation stage encompasses the initial injury, hematoma formation, 
inflammatory cell invasion and inflammatory cytokine signaling (Gerstenfeld et al., 
2003).  The importance of inflammation in initiating bone repair has been recently 
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reviewed (Mountziaris and Mikos, 2008; Kolar et al., 2010),  with formation of the 
hematoma having been shown to be a critical step in the healing process (Grundnes and 
Reikeras, 1993; Kolar et al., 2010), as it possesses both osteogenic (Mizuno et al., 1990) 
and angiogenic (Street et al., 2000) potential.  The invading inflammatory cell types are 
inclusive of polymorphonuclear cells, platelets, macrophages, and lymphocytes that 
coordinate and secrete a variety of cytokines and growth factors necessary for the proper 
cascade of morphogenetic events.  Amongst these secreted factors, tumor necrosis factor-
α (TNF-α) has demonstrated a particularly important role (Gerstenfeld et al., 2001; 
Gerstenfeld et al., 2003).  Other factors involved are inclusive of interleukins-1 and -6 
(IL-1 and IL-6), receptor activator of nuclear factor kappa-B ligand (RANKL), 
macrophage colony stimulating factor (M-CSF), multiple chemokines including 
monocyte chemotactic protein-1 (MCP-1/CCL-2),  transforming growth factor-β (TGF- 
β), several bone morphogenetic proteins (BMPs), platelet derived growth factor (PDGF), 
vascular endothelial growth factor (VEGF), and fibroblast growth factor-2 (FGF-
2/bFGF).  Together, the secreted factors facilitate on the ongoing mediation of 
inflammation and initiate the recruitment of osteoprogenitors and uncommitted 
mesenchymal stem cells that will actively participate in bone repair (Gerstenfeld et al., 
2003; Schindeler et al., 2008; Pape et al., 2010). 
 The distinct processes involved in the reparative stage of bone healing are largely 
dictated by the degree of stability at the site of injury (Le et al., 2001).  In rare instances 
of anatomical restoration with rigid fixation producing negligible interfragmentary strain, 
primary bone healing can occur as the cortex attempts to directly re-establish itself 
(Einhorn, 1998).   More classically, bone repair proceeds through what is known as 
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secondary bone healing, consisting of sequential sub-stages of soft and hard callus 
formation (Einhorn, 1998; Gerstenfeld et al., 2003).  The early hallmarks of this repair 
process include intramembranous ossification at the periosteal surface, as well as 
chondrocyte synthesis of the cartilaginous soft callus.  The function of the soft callus is to 
provide the requisite initial mechanical stability for fracture repair, but it will also 
ultimately serve as a scaffold for the bony callus to follow.  Upon completion of the soft 
callus, chondrocytes undergo hypertrophy and the calcification of the callus takes place 
(Einhorn, 1998; Schindeler et al., 2008).  This mechanically stable, calcified callus then 
becomes a target for vascular ingrowth in a coordinated process that involves matrix 
metalloproteinase (MMP)-driven extracellular matrix remodeling and angiogenic vessel 
growth.  MMP-9, MMP-13, and VEGF are all critical mediators of the vascular invasion 
portion of endochondral ossification (Ferguson et al., 1999; Gerber et al., 1999; Colnot et 
al., 2003).  Coupled to vascular ingrowth is the formation of the bony callus by 
osteoblasts in which primary woven bone is laid down to replace the cartilage callus.  The 
exact source of osteoprogenitors/chondroprogenitors that direct bone regeneration 
remains unclear, and potential contributors are thought to arise from the surrounding soft 
tissue, bone marrow space, and periosteum (Einhorn, 1998), with the latter being of 
particular importance (Ushiku et al., 2010; Yu et al., 2010).  Other hypotheses include 
the contribution of circulating progenitor cells (Matsumoto et al., 2008) or a perivascular 
source of osteoprogenitor cells (Towler, 2007; Crisan et al., 2008; Caplan and Correa, 
2011).  Coordination of the cellular and molecular processes of bone repair is spatially 
and temporally regulated by a broad array of growth factors, cytokines, systemic 
regulators, and extracellular matrix proteins (Deschaseaux et al., 2009; Kempen et al., 
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2010).  Although a complex symphony of signals directs postnatal bone repair, BMP-2 
has specifically been identified as an indispensible molecule in this process (Tsuji et al., 
2006). 
 Ultimately, bone healing culminates in the remodeling stage as the anatomical and 
mechanical properties of the bone are restored.  In a nearly identical cellular process to 
developmental bone formation and homeostatic adaptation, bone resorption performed by 
osteoclasts is coupled to the deposition of highly-organized secondary llamelar bone by 
osteoblasts (Gerstenfeld et al., 2003; Schindeler et al., 2008).  
Neuronal Interactions in Bone Repair 
 The innervation of the skeletal system has long been established, both clinically 
and experimentally (Hurrell, 1937; Sherman, 1963); however, the anatomical distribution 
is yet to be thoroughly characterized and the physiological implications of innervation 
remains incompletely understood.  In general, the periosteum is densely innervated, and 
nerves predominantly enter bones alongside arterial blood supply, after which they 
branch to Haversian canals, bone marrow, and even mineralized bone tissue (Serre et al., 
1999; Mach et al., 2002).  While the number of nerve fibers in bone may not be 
numerous, they are thought to provide two specific regulatory roles: 1) mediators of 
mechanical forces in bone and 2) a source of trophic factors necessary for bone form and 
function (Masi, 2012).   
 Nerve growth factor (NGF), a neurotrophin modulating sensory and sympathetic 
pathways,  has been shown to be present in developing skeletal tissues (Frenkel et al., 
1990).  A growing body of work continues to elucidate neurotransmitter and 
neuropeptide signaling pathways in the skeletal system and a neuronal arm contributing 
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to the regulation of bone modeling and remodeling (Imai and Matsusue, 2002; Spencer et 
al., 2004; Elefteriou, 2008).  Notably, Ducy et al. demonstrated a leptin-mediated central 
nervous system control of bone mass (Ducy et al., 2000).  In addition, others have 
reported a neural contribution in the regulation of functional adaptation to loading 
(Sample et al., 2008), at least partially mediated via the sympathetic nervous system 
(Kondo et al., 2005; Nagao et al., 2011).  Furthermore, the neuropathy-induced reduction 
in bone mineral density is not strictly a result of reduced load bearing (Whiteside et al., 
2006).   
 During fracture healing, regenerating nerve fibers have experimentally been 
shown to be present in the hematoma at early stages, followed by presence in the fracture 
callus, periosteum, fibrocartilage, and ultimately new woven bone at later time points (Li 
et al., 2001).  Immunological characterization of tissue samples from non-infected, 
human diaphyseal fractures that experienced delayed or nonunion revealed a virtually 
non-existent presence of peripheral nerve fibers (Santavirta et al., 1992).  Furthermore, 
clinical observation of enhanced osteogenic activity in fracture patients with head injuries 
provides anecdotal evidence for the role of the nervous system in bone physiology 
(Perkins and Skirving, 1987; Spencer, 1987; Garland, 1988).  However, it remains 
controversial whether this increase in osteogenesis is an actual acceleration of fracture 
healing, or rather, a form of heterotopic ossification (Kushwaha and Garland, 1998; 
Morley et al., 2005). 
Existing Models of Composite Bone and Nerve Injury 
 While increasing effort is being devoted to investigating the complexity of cross-
talk between the nervous and skeletal systems, interactions in instances of composite 
 14 
bone and nerve injuries have largely been left unexplored.  Among the experiments that 
have been performed, the primary model employed has been disrupted innervation in 
tibial fracture healing by way of sciatic nerve transection.  Aro et al. studied the effect of 
sciatic nerve transection, spinal cord transection, or both on tibial fracture healing in a rat 
model (Aro et al., 1981).  Weight bearing controls (fracture alone) and non-weight 
bearing controls (fracture with hip dislocations) were included.  Groups with disrupted 
innervation displayed more frequent fracture union at early time points, but possessed 
noticeably less dense calluses than control groups.  By the study end point, all fractures 
had achieved union; however, irregularities in shape and/or density were reported for 
fracture calluses with denervation.  While tensile testing of specimens indicated greater 
load to failure at early time points for fracture groups with disrupted innervation 
compared to control groups, this method of loading is of minimal physiological 
relevance.  In a subsequent study, Aro again used transection of the sciatic nerve to 
further study the effect of nerve injury on fracture healing and callus formation in the rat 
(Aro, 1985).  In this study, no attempt was made to control for unequal weight bearing in 
groups with or without nerve injury.  In confirmation of previous findings, radiographs 
and histology indicated more rapid bridging in fractures with nerve transection, but 
smaller, less dense calluses.  A smaller amount of collagenous matrix was also reported 
for denervated fracture calluses compared to controls.   
 Nordsletten et al. also used a rat model to study the effect of sciatic nerve 
resection on tibial fracture healing, but included cast-immobilization of the fractured 
limbs to control for differences in weight bearing between denervated animals and 
controls (Nordsletten et al., 1994).  Larger fracture calluses were reported for the nerve 
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resection group compared to controls.  In fact, radiographs of control fractures indicated 
very little callus formation.  Furthermore, nerve resection fractures possessed 
significantly higher bone mineral content.  The larger, more mineralized nerve resection 
fracture calluses did not demonstrate better mechanical properties, however, when 
evaluated in three-point bending.  A parallel experiment from these authors using 
histological techniques to study the growth of neural fibers into fracture calluses in this 
model corroborated the observed radiographic results (Hukkanen et al., 1995).  In a 
follow-up to this study, Madsen et al. investigated fracture healing and callus innervation 
after resection of both the sciatic and femoral nerves (Madsen et al., 1998).  Again, cast-
immobilization was used to control for differences in weight bearing.  When assessed 
radiographically, calluses from the nerve resection group were larger than controls.  
Immunostaining of the fracture callus for nerve fibers and neuropeptides indicated the 
pattern of innervation is altered following nerve resection, but total denervation is not 
experienced.  Mechanical testing of the femora in three-point bending demonstrated 
decreased mechanical properties for nerve resection fractures.  These results suggest that 
maturation of the fracture callus may be dependent on the innervation status of the bone. 
 The discrepancies in callus formation and bone healing results for fractures with 
sciatic nerve transection from seemingly similar surgical models may be explained by 
differences in fixation stability.  All experiments used intramedullary nailing for internal 
fixation; however, Nordsletten et al. (Nordsletten et al., 1994), Hukkanen et al. 
(Hukkanen et al., 1995), and Madsen et al. (Madsen et al., 1998) attempted to control for 
unequal weight bearing between groups by immobilizing fractured limbs in casts, 
whereas the work from Aro et al. (Aro et al., 1981; Aro, 1985) allowed for weight 
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bearing on fractured limbs.  Although, cast-immobilization may prevent unequal load 
bearing during ambulation, it also precludes functional mechanical stimulation of the 
healing fracture, a factor known to influence bone modeling and remodeling.  Thus, it is 
possible that cast-immobilized control fractures were stable enough to proceed through 
primary fracture healing, which would explain the absence of callus formation.  If true, 
this may suggest modulation of fracture healing via sensory innervation feedback on 
fracture stability.  Consideration should also be given to the physiological loading 
imparted by skeletal muscle.  While immobilization can attempt to tease out effects of 
load bearing, it cannot account for disruption of the resting muscle tone in the lower limb 
as a result of nerve transection.  
 While sciatic nerve transection in combination with tibial fracture is the 
predominant composite bone and nerve injury model found in the literature, other models 
have been described.  Frymoyer and Pope used a rat model of fibular fractures absent 
fixation to study the effect of sciatic nerve resection on healing (Frymoyer and Pope, 
1977).  No attempt was made to control for possible differences in weight bearing due to 
sciatic nerve injury.  Histological scoring of fracture healing was performed at multiple 
time points, with no observed differences except in one instance, at which time fractures 
from the sciatic nerve injury group displayed better healing than controls.  Differences in 
mechanical properties from tensile testing of samples were reported, with denervated 
fractures outperforming controls, but are of questionable relevance to physiological 
loading conditions.  Others have taken an additional step with this model and investigated 
the effect of sciatic nerve transection on fibular fracture healing including the surgical 
removal of periosteal neural mechanoreceptors located in the distal portion of the rat 
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fibula (Aro et al., 1985).  In relative agreement with Frymoyer and Pope, this study found 
that fibular fracture healing proceeded undisturbed by transection of the sciatic nerve.  
However, surgical stripping of mechanoreceptors was associated with fracture nonunion 
that, at times, became atrophic.  Inclusion of sciatic nerve transection exacerbated this 
effect, with all fractures going on to atrophic nonunion.  Histological analysis of atrophic 
fragments indicated they were active sites of osteoclastic bone resorption.  Interestingly, 
two control samples with stripped mechanoreceptors and intact sciatic nerves presented 
hypertrophic nonunions in the distal fibula, visible as early as one month post-surgery.  
No such instances were observed in intact control fibulae with stripped mechanoreceptors 
and transected sciatic nerves, but thinner appearance was noted, potentially attributable to 
altered weight bearing in response to the sciatic nerve injury.  Recently, Apel et al. used 
neurotoxin injection at the cortex of the femur to model fracture healing in instances of 
local sensory denervation (Apel et al., 2009).  Intramedullary rods were used for fixation, 
and no attempt was made to control for weight bearing in this model.  Sensory 
denervation resulted in decreased type I and II collagen deposition during early fracture 
healing, but an eventual increase in the size of the fracture callus when evaluated 
histologically and via microcomputed tomography.  Despite larger fracture calluses, 
sensory-denervated samples failed at lower loads in three-point bending.     
 Although not specifically a composite limb injury model, Boes et al. recently 
investigated experimental fracture healing with associated traumatic brain injury in a 
reproducible rat model (Boes et al., 2006).  To do so, a standard closed femoral fracture 
with intramedullary fixation was combined with a model of traumatic brain injury 
produced from an impact acceleration system.  The brain-injury group demonstrated 
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smaller fracture calluses with increased torsional stiffness compared to fracture alone, 
which may suggest enhanced progression through the remodeling stage of fracture 
healing.  Further, to investigate possible systemic mitogenic differences between groups, 
serum collected at euthanasia was used to supplement in vitro cell culture media.  
Increased proliferation was observed in a mesenchymal stem cell line when 
supplemented with serum from the brain-injury group compared to serum from the 
fracture-only group, but enhanced proliferation was not observed in osteoblastic or 
fibroblastic cell lines. 
Mechanisms of Bone and Nerve Interaction 
 Several potential means of interaction between bones and the nervous system 
exist, including a regulatory arm in bone metabolism and neuropeptide/neurotransmitter 
signaling pathways (Fig. 2.1).   
 
 
Figure 2.1.  Mechanisms of interaction between bone and the nervous system.  
Neurotransmitter and neuropeptides offer pathways for direct signaling, and the nervous 
system has a regulatory role in loading-induced bone metabolism.  Indirect interactions 
(shown with dotted lines) are also exerted via nervous system control of muscle 
contractions and blood vessel tone. 
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Given the relative paucity of research in this area to date, the cellular and molecular 
mechanisms involved are far from completely understood, though.  Several studies have 
implicated sensory neuropeptide calcitonin gene-related peptide (CGRP) as a potential 
mechanism to exert a neural influence on bone repair.  CGRP-immunoreactive sensory 
fibers are known to innervate normal bone tissue (Bjurholm et al., 1988; Hukkanen et al., 
1993; Mach et al., 2002).  Additionally, CGRP-immunoreactive fibers are reported to 
sprout and proliferate in bone tissue during normal fracture healing (Hukkanen et al., 
1993), but exhibit a reduced presence in tibial fracture healing when innervation to the 
lower limb has been disrupted by sciatic nerve resection (Hukkanen et al., 1995).  
Modulation of skeletal repair by CGRP could occur directly, as CGRP has been shown to 
have osteogenic capacity in vitro, with CGRP-supplemented media increasing bone 
forming colonies in a dose-dependent manner (Bernard and Shih, 1990), and in vivo, as 
CGRP expression in osteoblasts gives way to a skeletal phenotype with increased bone 
density in mice (Ballica et al., 1999).  The influence may also be exerted in an indirect 
route through the vasculature given the potent vasodilator action of CGRP (Brain et al., 
1985) and its ability to stimulate endothelial cell proliferation (Haegerstrand et al., 1990).   
 Neurotrophins NGF, brain-derived neurotrophic factor (BDNF), and and 
neurotrophin-3 (NT-3), as well as their receptors, have been shown to be expressed at 
both protein and gene expression levels in bone forming cells during murine rib fracture 
healing, suggesting potential autocrine and paracrine regulatory functions in bone repair 
(Asaumi et al., 2000).  Local delivery of NGF at the fracture site via mini-osmotic pump 
has also been suggested to accelerate the rate of repair of rib fracture healing in a rat 
model, and was associated with increased concentrations of catecholamines epinephrine 
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and norepinephrine in the callus (Grills et al., 1997).  Another potential mediator of 
neural-osseous crosstalk in bone repair is neuropeptide Y (NPY).  The NPY signaling 
axis exerts strong control on bone metabolism through the G-protein coupled receptors 
Y1 (via PNS) and Y2 (via CNS), primarily thought to occur via negative regulation of 
osteoblast activity (Shi and Baldock, 2012).  Involvement of NPY in fracture repair and 
remodeling has also recently been proposed, however, the exact role remains 
undetermined (Long et al., 2010).   
 An effect of denervation on fracture healing may also be modulated indirectly by 
changes in blood perfusion and hemodynamics in the surrounding skeletal muscle.  
Previously, transection of the sciatic or femoral nerves was shown to result in transient 
hyperemia in the muscles of the hind limb (Midrio et al., 1968).  Others have reported 
that denervation of a muscle flap produces an acute increase in arteriole diameters and a 
more sustained increase in perfused capillaries compared to innervated controls 
(Siemionow et al., 1994).  An increase in blood flow in the bones of the lower leg have 
also been associated with transection of the sciatic nerve (Shim et al., 1966).  The 
coupling of tissue blood perfusion in response to nerve injuries is most likely explained, 
at least in part, by sympathetic nervous system control of vascular tone. 
Vascular Interactions in Bone Repair 
 Although the importance of blood vessels in skeletal system physiology has been 
documented for well over 200 years (Haller, 1763; Hunter, 1794), complexities in this 
relationship continue to be discovered.  Healthy bones are highly vascularized, with long 
bones receiving blood supply from the intramedullary nutrient artery (or arteries), arteries 
in the periosteum, and metaphyseal and epiphyseal arteries that enter near bone ends.  
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Branching of these arterial sources, such as the supply to Volkmann’s canals, is abundant 
and complex, with significant anastomosis.  During skeletal development, blood vessel 
invasion is a critical step in the conversion of the cartilage intermediate to bone in the 
endochondral bone formation process (Ferguson et al., 1999; Gerber et al., 1999; 
Kronenberg, 2003).  Postnatal skeletal repair is also tightly coupled to, and dependent on, 
vascular supply and angiogenesis (Glowacki, 1998; Carano and Filvaroff, 2003).  
Sufficient vascular supply is imperative for bone healing due to its physiological role in 
oxygen and nutrient transport, but it also serves as a conduit for migrating inflammatory 
and progenitor cells as well as soluble factors.  In addition, disrupted blood perfusion 
may have potential consequences for local cell fate in the region of bone repair (Muschler 
et al., 2004).  Clinical risk factors for delayed or nonunion fracture healing include 
diminished blood supply (Einhorn, 1995) and concomitant vascular injury (Dickson et 
al., 1994; Brinker and Bailey, 1997).  Furthermore, lower limb fractures with vascular 
injuries are associated with higher rates of amputation (Glass et al., 2009). 
Existing Models of Composite Bone and Vascular Injury 
 Despite the established links between vasculature and bone healing, few models 
of composite bone and vascular injuries are found in the literature.  Kase et al. 
incorporated transient, acute hindlimb ischemia (via tourniquet and microvascular clip 
application) in a rat tibial fracture model to investigate how bone healing was affected 
(Kase et al., 1998).  Interestingly, no differences in fracture healing were found 
radiographically or in three-point bending mechanical testing.  Labeled microspheres 
were used to evaluate blood perfusion to the tibia and surrounding muscles, with no 
differences found between ischemic and control groups.  While surprising, the lack of 
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differences observed in bone healing may be due to insufficient ischemia produced by the 
transient, acute ischemia-reperfusion procedure, or the lack of quantitative outcome 
measures of tissue composition at the fracture site.  In a mouse model, Lu et al. found 
that ischemia induced by resection of the femoral artery impaired healing of non-
stabilized tibial fractures (Lu et al., 2007).  At early time points, reduced blood vessels 
were present in and around fractures in ischemic legs.  Ischemic fractures also displayed 
decreased cell proliferation, increased cell death, and delayed chondrocyte maturation at 
early time points.  Fracture calluses in ischemic limbs were smaller than controls, and 
possessed less bone and cartilage.  Nearly all ischemic fractures failed to achieve bony 
bridging, whereas all control fractures proceeded normally to bridging. 
 While few studies have used definitive models of composite bone and vascular 
injuries, a significant amount of work has focused on the intimate relationship between 
angiogenesis and bone repair.  Most relevant to this chapter is the research incorporating 
interventions to impair angiogenesis in an effort to determine what effect this decoupling 
has on bone repair.  Street et al. used murine models for femoral fracture healing and 
tibial cortical defects to demonstrate that inhibition of angiogenesis will disrupt 
endochondral and intramembranous bone repair, respectively (Street et al., 2002).  In 
fracture repair, angiogenesis was shown to be a mediator of both soft callus formation 
and calcification of the hard callus.  In cortical defects, where repair proceeds primarily 
through intramembranous ossification, the effects of angiogenesis inhibition were more 
prominent at early time points than later.  Similar results have been reported by Hausman 
et al. in a rat femoral fracture model, where administration of a pharmaceutical 
angiogenesis inhibitor impaired both the endochondral and intramembranous osteogenic 
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pathways (Hausman et al., 2001).  Fractures in the treatment group developed little to no 
bony callus, displayed minimal periosteal woven bone formation, and typically proceeded 
to nonunion.  Additionally, the treatment group fractures demonstrated decreased 
mechanical properties compared to control fractures when tested in torsion.  Wan et al. 
used a transgenic mouse model to impair angiogenesis at the level of gene expression 
during distraction osteogenesis in the tibia (Wan et al., 2008).  Compared to wild-type 
controls, the transgenic mice displayed decreased vascularity in the distraction region and 
subsequent reduction in bone regeneration.  Administration of a pharmaceutical 
angiogenesis inhibitor (the same as that used by Hausman et al.) was used by Fang et al. 
in a mandibular distraction osteogenesis model in rats to investigate the effect on bone 
regeneration (Fang et al., 2005).  Once again, inhibition of angiogenesis was shown to 
preclude successful bone formation in the distraction region, giving way to fibrous scar 
tissue.  Although this study did not use a limb injury model, it reported the particularly 
interesting finding that both an osteogenic mechanical environment and angiogenic gene 
expression are necessary conditions for the formation of a vascular network to support 
bone regeneration, and that either stimuli alone is insufficient.  
 An ability of the mechanical environment to influence formation of vascular 
networks, and ultimately bone healing, has been reported by several investigators.  
Wallace et al. investigated the difference between rigid or semi-rigid axial fixation 
stiffness in an ovine tibial osteotomy model with external fixation (Wallace et al., 1994).  
The semi-rigid fixation group experienced transiently increased micromovement at the 
osteotomy site and increased corticomedullary blood flow compared to rigid fixation.  
While differences in blood flow or interfragmentary movement did not persist at later 
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time points, differences were apparent in the morphology of healing bones, as the semi-
rigid group displayed increased callus perimeter and cross-sectional area with decreased 
cortical porosity.  In a similar design, Lienau et al. used external fixators of rigid or semi-
rigid bending stiffness in an ovine tibial osteotomy model to study vascularization and 
tissue differentiation (Lienau et al., 2005).  Larger interfragmentary movement was 
observed in the semi-rigid group at early time points, and was accompanied by an 
initially reduced number of blood vessels compared to rigid fixation.  Differences in 
callus size and tissue composition at later time points were indicative of semi-rigid 
fixation leading to delayed healing.   
 The effects of interfragmentary movement on vascularity reported by Lienau et al. 
(Lienau et al., 2005) are in contrast to those previously reported by Wallace et al. 
(Wallace et al., 1994).  Clearly, altering fixation bending stiffness as opposed to axial 
stiffness may be the source of the discrepancy.  It may also be in part due to a difference 
in evaluation methods and the regions analyzed.  Wallace et al. measured blood flow to 
the bone 10 mm proximally and distally to the osteotomy based on the accumulation of 
systemically delivered labeled microspheres, whereas Lienau et al. 
histomorphometrically quantified blood vessels in the region that extended only 6 mm 
proximally and distally.  Additionally, Wallace et al. were unable to distinguish whether 
the increase in blood flow was due to increased perfusion to existing vessels, new vessel 
formation, or a combination of both.  
 Boerckel et al. used a critically-sized rat femoral defect model and contrast-
enhanced 3-D vascular imaging to demonstrate an effect of the timing of load initiation 
on vascular growth and remodeling during bone repair (Boerckel et al., 2011).  Whereas 
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application of early axial mechanical loading resulted in decreased vascularity in the 
defect and attenuated bone regeneration compared to unloaded controls, delayed loading 
enhanced bone regeneration and was associated with apparent vascular remodeling, 
exhibiting a decrease in the number of small vessels and an increase in the number of 
large vessels.  When taken together with the ovine model studies, the evidence for an 
effect of mechanical loading on blood vessel network formation and bone healing is both 
compelling and complex.  If applied too soon or in excess, mechanical loading has the 
potential to disrupt vascular ingrowth and negatively influence bone healing, whereas 
when applied with the appropriate timing and magnitude, mechanical signals can have 
stimulatory effects. 
Mechanisms of Bone and Vascular Tissue Interaction 
 Means of interaction between bones and vascular tissue networks extend beyond 
the physiological supply of oxygen and nutrients, as the vessels also serve as a conduit 
for soluble vactors and cellular exchange (Fig. 2.2).   
 
 
Figure 2.2.  Mechanisms of interaction between bone and blood vessels.  In addition to 
providing oxygen and nutrients, blood vessels provide a conduit for transport of soluble 
factors and cellular exchange. 
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The molecular coupling of angiogenesis and osteogenesis by a “vascular stimulating 
factor” was first proposed by Trueta in 1963 (Trueta, 1963).  Since then, a variety of 
growth factor and cytokine molecular players have been implicated, including members 
of the transforming growth factor beta (TGF-β), bone morphogenetic protein (BMP), 
platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), 
fibroblast growth factor (FGF), and insulin-like growth factor (IGF) families, as well as 
systemic regulators (e.g., vitamin D and parathyroid hormone) (Carano and Filvaroff, 
2003; Kempen et al., 2010).  Of these, VEGF has been perhaps the most thoroughly 
studied.  VEGF-mediated angiogenesis is an essential component for coordinating 
conversion of cartilaginous anlage to bone during endochondral bone formation in 
skeletal development (Ferguson et al., 1999; Gerber et al., 1999).  Endogenous VEGF is 
also necessary for normal bone healing in both intramembranous and endochondral 
ossification, and delivery of exogenous VEGF enhances fracture and segmental bone 
defect repair (Street et al., 2002).  This contribution to bone repair is, at least in part, 
controlled at the gene expression level by hypoxia-inducible transcription factor one 
alpha (HIF-1α), an angiogenic transcription factor under inhibitory control in normoxic 
conditions.  During skeletal development, the HIF-1α/VEGF pathway couples 
angiogenesis and osteogenesis (Wang et al., 2007; Araldi and Schipani, 2010).  HIF-1α is 
also a mediator of postnatal skeletal repair, as constitutively active osteoblast HIF-1α via 
genetic mutation was shown to enhance angiogenesis and bone regeneration in a VEGF-
dependent process, whereas osteoblast-specific knock out of the HIF-1α gene resulted in 
impaired angiogenesis and bone regeneration (Wan et al., 2008).  Furthermore, 
pharmacological small molecule activation of HIF-1α has been shown to effectively 
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augment vascularity and bone repair in models of fracture healing (Shen et al., 2009), 
distraction osteogenesis (Wan et al., 2008), and segmental defect repair (Stewart et al., 
2011).   
 Another important source of molecular cross-talk between bone and vasculature is 
provided by members of the BMP family of proteins.  Given their osteoinductive capacity 
(Urist, 1965), BMPs play a vital role in osteogenesis; however, they also provide an 
important contribution in the angiogenesis-osteogenesis interaction by stimulating 
osteoblast VEGF production and increasing blood vessel formation (Deckers et al., 2002; 
Zhang et al., 2009).  VEGF may also up-regulate BMP-2 expression in vascular tissues 
via paracrine loops (Bouletreau et al., 2002; Matsubara et al., 2012) and/or act through 
direct binding with osteoblast VEGF receptors (Deckers et al., 2000; Clarkin and 
Gerstenfeld, 2013).  BMPs may also act directly on endothelial progenitor cells to 
promote angiogenesis (Smadja et al., 2008).  Furthermore, sequential co-delivery of 
exogenous VEGF followed by BMP-2 was reported to enhance bone formation (Kempen 
et al., 2009), whereas delivery of stem cells engineered to co-express VEGF and BMP-4 
demonstrated synergistic enhancement of bone regeneration in a calvarial defect model 
(Peng et al., 2002).  In a follow-up to previous work in a mouse model of ischemic tibial 
fractures (Lu et al., 2007), rhBMP-7 treatment appeared sufficient to overcome the 
limitations of diminished blood supply, providing enhanced healing in fractures that 
would otherwise proceed to delayed or nonunion (Lu et al., 2010).   
 Beyond osteogenic-angiogenic coupling, interactions from traditional 
mechanisms of arteriogenic blood vessel growth are also plausible contributors to bone 
regeneration.  Indeed, it was recently shown that during distraction osteogenesis, 
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arteriogenic vessel growth in the surrounding skeletal muscle envelope precedes 
angiogenic vessel growth in the regenerating space (Morgan et al., 2012).  The 
extracellular matrix protein osteopontin (OPN) is significantly up-regulated in response 
to HLI (Lyle et al., 2012), plays a definitive role in collateral vessel development and 
recovery from ischemia (Duvall et al., 2008), and is involved in regulating several 
aspects of fracture healing (Duvall et al., 2007).  Other growth factors thought to be 
associated with arteriogenesis such as platelet derived growth factor (PDGF), 
transforming growth factor-β (TGF-β), fibroblast growth factor-2 (FGF-2) (Buschmann 
et al., 2003), have also been implicated in bone regeneration (Kempen et al., 2010), and 
provide additional posssible means of molecular cross-talk in these processes.  At a 
cellular level, monocyte/macrophage invasion plays a significant role in collateral vessel 
growth following arterial occlusion (Arras et al., 1998), and macrophages may possess a 
capacity for osteoinductive signaling through BMP-2 secretion (Champagne et al., 2002).  
Vascular smooth muscle cells (SMC) also play a critical cellular role in arteriogenic 
vessel remodeling, with phenotypic changes and proliferation initiating early in the 
process (Schaper and Scholz, 2003).  Cell populations expressing smooth muscle alpha-
actin (SMAA) that actively participate in bone repair are thought to arise from a 
perivascular or myofibroblast lineage (Kinner et al., 2002; Kalajzic et al., 2008).  
Additionally, SMCs are considered at least partially responsible for vascular tissue 
calcification (Trion and van der Laarse, 2004), potentially in a process also involving 
macrophages (Trion and van der Laarse, 2004; Ikeda et al., 2012).  Pericytes, a mural cell 
“relative” of vascular SMCs more commonly associated with the microvessels, could also 
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conceivably play some role as a perivascular source of osteoprogenitor cells (Towler, 
2007; Crisan et al., 2008; Caplan and Correa, 2011).   
Postnatal Vascular Growth 
 Blood vessels provide several essential physiological functions including oxygen 
and nutrient transport, as well as serving as a conduit for circulating cells and soluble 
factors.  The essential components of blood vessels are endothelial cells which form the 
vessel lumen, mural cells that provide vessel stability (pericytes for capillaries, vascular 
SMCs for arteries and veins), the basement membrane, and extracellular matrix.  
Postnatal vascular growth occurs predominantly through two distinct processes: 
angiogenesis and arteriogenesis (Carmeliet, 2000).  Whereas angiogenesis is defined as 
the sprouting of new capillaries from preexisting ones, arteriogenesis consists of the 
development of collateral vessels via the growth and remodeling of preexisting arterioles 
(Schaper and Scholz, 2003).  A third process, vasculogenesis, consists of the de novo 
formation of vessels by way of angioblast mobilization and differentiation, but its 
contributions to vascular growth beyond embryonic development remain controversial.  
Given the dissimilar process definitions, it is unsurprising that the mechanisms 
responsible for angiogenesis and arteriogenesis appear to be largely distinct. 
Angiogenesis 
 The physiological trigger initiating sprouting angiogenesis is tissue ischemia.  
Initial steps in angiogenesis include vasodilation of existing vessels, an increase in 
vascular permeability, and degradation of the surrounding extracellular matrix.  The 
basement membrane degradation is performed primarily by members of the MMP family, 
and is an essential step in the sprouting process to allow for the migration of proliferating 
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endothelial cells referred to as the tip cell (Carmeliet, 2000).  New sprouts are then driven 
by environmental cues to resolve tissue oxygen demands.  Molecular players directing 
sprouting angiogenesis are multiple, including VEGFs and their receptors, FGFs, 
placental growth factor (PlGF), and angiopoietins (ANG-1 and ANG-2), of which VEGF 
is known to be a critical mediator (Carmeliet, 2000; Isner, 2000; Spyridopoulos et al., 
2002).  Endogenous VEGF is essential for successful capillary sprouting in ischemic 
tissue (Couffinhal et al., 1998), and delivery of exogenous VEGF has been reported to 
provide some degree of therapeutic benefit in animal models of limb ischemia (Takeshita 
et al., 1994).   The upregulation of VEGF production in response to tissue ischemia is 
mediated by hypoxia-inducible transcription factors (HIFs) (Levy et al., 1995; Forsythe 
et al., 1996).  HIFs are constitutively expressed, but under normoxic conditions are 
marked for degradation based on the oxygen-sensing mechanisms of prolyl hydroxylases 
(PHDs).  When oxygen tension decreases and hypoxia persists, the activity of PHDs 
becomes impaired allowing for accumulation of HIF-1α and the resultant downstream 
VEGF expression (Bruick and McKnight, 2001; Schipani et al., 2009).  While 
angiogenesis has an undeniable place as a postnatal vascular growth process, it remains 
controversial as to what degree therapeutic angiogenesis alone can compensate for 
increased flow demands required in instances of peripheral and cardiac ischemia (Isner, 
2000; Schaper and Scholz, 2003).   
Arteriogenesis 
 In contrast to the ischemic trigger for angiogenesis, arteriogenesis is thought to be 
brought on by the increased fluid shear stress experienced by arterioles as they attempt to 
compensate for greater flow demands (Ito et al., 1997; Schaper and Scholz, 2003).  As 
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with angiogenesis, the precise mechanisms of arteriogenesis include a myriad of 
molecular and cellular components.  Initially, the increase in fluid shear stress results in 
an “activated” endothelium, prompting the production of endothelial nitric oxide synthase 
(eNOS) and MCP-1, as well as upregulation of endothelial ICAM-1 and VCAM 
expression (Scholz et al., 2000; Cai and Schaper, 2008).  These signals combine to 
promote circulating monocyte extravasation into the vessel wall which initiates 
remodeling.  Unsurprisingly, monocytes have been shown to play a significant role in the 
cellular response during collateral vessel growth (Arras et al., 1998).  Furthermore, 
targeted disruption of the MCP-1 receptor, C-C chemokine receptor type 2 (CCR2) will 
impair arterial occlusion-induced collateral artery growth (Heil et al., 2004), and delivery 
of exogenous MCP-1 has been shown to enhance arteriogenesis (Ito et al., 1997).   
 Although monocytes/macrophages are required for initiation of remodeling, 
vascular SMCs do most of the heavy lifting of arteriogenesis.  Vascular SMCs display a 
high level of plasticity in arteriogenesis and undergo a transition on their phenotypic 
continuum from contractile to synthetic (Cai and Schaper, 2008).  In this synthetic 
phenotype, SMCs become much more proliferative and increase production of extra 
cellular proteins such as collagens, osteopontin, MMPs, and growth factors (Rensen et 
al., 2007; Beamish et al., 2010).  Degradation of the vessel basement membrane and 
ECM by MMPs, including MMP-9, is an important event allowing for SMC proliferation 
and arteriogenesis.  Monocytes and macrophages are the likely source of initial MMP 
production, with continued secretion from synthetic SMCs (Cai and Schaper, 2008).  
Also of significance in arteriogenesis is the ECM protein osteopontin.  
Monocytes/macrophages, endothelial cells, and SMCs are all capable of synthesizing 
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osteopontin (O'Brien et al., 1994), and it has been demonstrated to possess a definitive 
biological role in the arteriogenic recovery from hind limb ischemia (Duvall et al., 2008).  
Other cell types thought to perhaps play a role in arteriogenesis are bone marrow-derived 
cells, but primarily through paracrine activity as they have not been shown to incorporate 
into the remodeling vessels (Heil and Schaper, 2004).  
 To date, there are few growth factors that have been identified as possessing a 
dominant regulatory role in arteriogenesis, with many of the most likely candidates 
proving nonessential (Buschmann et al., 2003; Cai and Schaper, 2008).   While the 
importance of VEGF in angiogenesis is undisputed, its role in arteriogenesis is less clear.  
Deindl et al. reported that femoral artery occlusion-induced arteriogenesis was not 
associated with increased VEGF or hypoxia-inducible genes (HIF-1α, LDH A) (Deindl et 
al., 2001).  Furthermore, any increase in expression of VEGF and FGF-2 appears very 
limited following induction of hind limb ischemia in the rat (Luo et al., 2002).  Targeted 
deletion of the Fgf-2 was shown to have no effect on recovery from hind limb ischemia in 
a murine model (Sullivan et al., 2002), and double knockout of Fgf-1 and Fgf-2 genes 
produced only mild phenotypic differences (Miller et al., 2000).  Interestingly, while it 
has been shown that while mRNA levels of FGF-1 and FGF-2 are relatively unchanged 
after arterial occlusion, application of a chemical agent that inhibits FGF receptor binding 
does impair arteriogenesis (Deindl et al., 2003).  Angiopoietin-2 has been shown to be 
involved in mediating inflammation and arteriogenesis during recovery from hind limb 
ischemia (Tressel et al., 2008).  Other growth factors with incompletely understood roles 
in arteriogenesis include granulocyte-macrophage colony-stimulating factor (GM-CSF) 
(Schaper and Scholz, 2003) and PDGF (Cao et al., 2003; Wu et al., 2010).   
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CHAPTER 3 
CHARACTERIZATION OF A COMPOSITE INJURY MODEL OF 




 Severe extremity trauma often results in large zones of injury comprising multiple 
types of tissue and presents many clinical challenges for reconstruction.  Considerable 
investigation is ongoing in tissue engineering and regenerative medicine therapeutics to 
improve reconstruction outcomes; however, the vast majority of musculoskeletal trauma 
models employed for testing the therapeutics consist of single-tissue defects, offering 
limited utility for investigating strategies for multi-tissue repair.  Here we present the first 
model of composite lower limb bone and nerve injury, characterized by comparison to 
well-established, single-tissue injury models using biomaterials-based technologies 
previously demonstrated to show promise in those models.  Quantitative functional 
outcome measures were incorporated to facilitate assessment of new technologies to 
promote structural and functional limb salvage following severe extremity trauma.  Nerve 
injury induced significant changes in the morphology and mechanical properties of intact 
bones.  However, BMP-mediated segmental bone regeneration was not significantly 
impaired by concomitant nerve injury as evaluated via radiographs, microcomputed 
tomography (micro-CT), and biomechanical testing.  Nor was nerve regeneration 




 Portions of this chapter were adapted from Uhrig BA, Clements IP, Boerckel JD, Huebsch N, 
Bellamkonda RV, Guldberg RE. Characterization of a composite injury model of severe lower limb bone 
and nerve trauma. J Tissue Eng Regen Med. 2012; [Epub ahead of print]. 
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significantly impaired by bone injury when evaluated via histology and 
electrophysiology.  Despite the similar tissue regeneration observed, the composite injury 
group experienced a marked functional deficit in the operated limb compared to either of 
the single-tissue injury groups as determined by quantitative, automated CatWalk gait 
analysis.  As a whole, this work presents a challenging, clinically-relevant model of 
severe extremity trauma to bone and nerve tissue, and emphasizes the need to incorporate 
quantitative functional outcome measures to benchmark tissue engineering therapies. 
Introduction 
 Severe extremity trauma resulting in significant injury to multiple tissues – 
including bone, skeletal muscle, nerve, and vasculature – presents a multitude of clinical 
challenges that often cannot be treated with conventional reconstruction techniques. 
Furthermore, a lack of consensus exists for surgical intervention strategies (Yazar et al., 
2004; DeFranco and Lawton, 2006).  Even if limb salvage and reconstruction is 
successful, the complex nature of the injuries often requires multi-stage treatment and 
results in diminished long-term function (Bosse et al., 2002; MacKenzie et al., 2005). 
 Historically, extremity injuries have been the predominant combat wound for 
members of US armed forces.  This trend has continued in the ongoing conflicts in Iraq 
and Afghanistan, with the primary combat casualty mechanism being explosive 
munitions (Owens et al., 2007; Owens et al., 2008).  These penetrating blast wounds 
result in large deficits to multiple tissue types in the extremities, and yield a high 
incidence of bone and soft tissue trauma (Owens et al., 2007).  In addition to comprising 
the largest number of combat casualties, extremity injuries present the greatest demand 
for medical resources, account for the most number of disabilities, and project as the 
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highest incurred future disability costs (Masini et al., 2009).  The civilian sector 
contributes an additional patient population from high-energy trauma incidents, such as 
motor vehicle collisions.  Engineering of improved safety features for automobiles has 
increased passenger survival in these incidents, though many still sustain severe 
extremity trauma (Burgess et al., 1995; Richter et al., 2005).  The consequences of 
extremity injuries are well documented, and encumber patients with profound functional 
disabilities and financial burden (Holbrook et al., 1999; Bosse et al., 2002; MacKenzie et 
al., 2005; MacKenzie et al., 2007). 
 Currently, autograft procedures are the clinical gold standard of care for both 
large bone defects and long peripheral nerve gaps.  In both cases, these procedures face 
limitations due to the volume of tissue available for grafting and the associated morbidity 
at the donor site.  Nerve autograft procedures are associated with additional drawbacks 
given the functional loss experienced at the donor site and possible modality mismatch 
between the donor and repaired nerves.  A variety of potential therapeutic strategies to 
circumvent such limitations are under investigation throughout the field of tissue 
engineering and regenerative medicine.  However, current animal models of 
musculoskeletal trauma used in evaluating emerging technologies typically consist of 
critically-sized, single-tissue defects, which offer limited utility for investigating 
therapeutic strategies for multi-tissue repair.  Accordingly, there exists a need for 
challenging animal models of composite tissue injury.  Moreover, such models would 
allow investigators to probe for endogenous interactions that may occur in the healing 
response for multiple tissue defects.  Elucidating such interactions would open the door 
for development of novel therapeutics to leverage combinatorial or synergistic tissue 
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repair and regeneration.  Therefore, the goal of this study was to develop a rat model of 
composite lower limb bone and nerve injury featuring quantitative functional outcome 
measures to facilitate assessment of new technologies to promote structural and 
functional limb salvage following severe extremity trauma.  To do so, we characterized 
the healing response in the selected composite injury model to biomaterials-based 
therapeutics previously demonstrated to show promise in well-established, single-tissue 
injury models (Clements et al., 2009; Kolambkar et al., 2011). 
Materials and Methods 
Nanofiber Mesh Tube and Nerve Guidance Channel Fabrication 
 Perforated nanofiber mesh tubes were created as previously described 
(Kolambkar et al., 2011).  Briefly, a 12% (m/v) polymer solution was created by 
dissolving poly(ε-caprolactone) (PCL) pellets (Sigma-Aldrich, St. Louis, MO) in a 90:10 
volume ratio of hexaflouro-2-propanol:dimethylformamide (Sigma-Aldrich).  The 
solution was electrospun onto a static collector to obtain nanofiber mesh sheets.  
Rectangular sections were manually cut from the sheets and then patterned with 1 mm 
diameter perforations.  Sheets were then glued into tubes of approximately 4.5 mm 
diameter and 12 mm length with a medical grade UV/visible light curing adhesive (1187-
M, Dymax, Torrington, CT).  Mesh tubes were sterilized via 100% ethanol evaporation 
and then re-hydrated with sequential sterile phosphate buffered saline (PBS) washes. 
 Thin-film-enhanced nerve guidance channels were fabricated as previously 
described (Kim et al., 2008; Clements et al., 2009).  Briefly, aligned films of electrospun 
poly(acrylonitrile-co-methylacrylate, random copolymer, 4 mol% methylacrylate) (PAN–
MA) fibers were created through an electrospinning process.  2.2 mm x 14 mm sheets of 
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aligned thin-films were manually cut with a razor blade for incorporation within 
polysulfone tubes (17 mm length, 1.6 mm inner diameter, 2.2 mm outer diameter, 50 kDa 
molecular weight cutoff, Koch Membrane Systems, Willmington, MA).  The polysulfone 
tubes were first halved lengthwise into two longitudinal sections, and a single aligned 
thin-film was fixed within the interior length of one of the sections before reattaching the 
sections with a medical grade UV light curing adhesive (Dymax).  Significantly, due to 
the negligible thickness of each thin-film, a minimal percentage of luminal cross-
sectional area is occupied by scaffolding. The channels were sterilized by overnight 
incubation under UV light followed by immersion in 70% ethanol for 30 min. This 
process was immediately followed by two 20 min washes in sterilized deionized water 
and a final wash in sterile PBS. The channels were then stored in sterile PBS until 
surgery. 
Preparation of rhBMP-2-containing Alginate Hydrogel 
 Sterile syringes of pre-gelled, recombinant human bone morphogenetic protein 2 
(rhBMP-2)-containing alginate were prepared as previously described (Kolambkar et al., 
2011).  Irradiated RGD-functionalized alginate (Alsberg et al., 2003) was reconstituted in 
αMEM (Invitrogen, Carlsbad, CA).  Lyophilized rhBMP-2 (R&D Systems, Minneapolis, 
MN) was reconstituted in 0.1% rat serum albumin (Sigma-Aldrich) in 4 mM HCl 
according to manufacturer instructions, and then mixed with the RGD-alginate solution to 
obtain a final solution of 2% alginate (m/v) containing 10 µg/ml rhBMP-2.  The rhBMP-
2-containing alginate solution was cross-linked via rapid mixing with a calcium sulfate 
(Sigma-Aldrich) solution.  The syringes were stored at 4 °C overnight for use in surgery 
the following day. 
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Surgical Procedure 
 Thirteen-week-old female Lewis rats (Charles River Labs, Wilmington, MA) 
were anesthetized via isoflurane inhalation and received unilateral surgeries on right hind 
limbs comprising three experimental groups: bone injury (BI, n=9), nerve injury (NI, 
n=8), and composite bone and nerve injury (CI, n=8).  The bone injury was a critically-
sized 8 mm mid-femoral bone defect, created using a previously described surgical 
technique and stabilized by custom-made modular internal fixation plates (Oest et al., 
2007).  Treatment was based on a hybrid growth factor delivery system recently 
described by Kolambkar and colleagues (Kolambkar et al., 2011).  Briefly, an 
electrospun poly(ε-caprolactone) (PCL) nanofiber mesh tube was placed into each bone 
defect region such that it overlapped at the endswith native bone tissue.  A treatment dose 
of 2 μg rhBMP-2 was delivered in 200 μl of 2% (wt) RGD-functionalized alginate 
hydrogel (Alsberg et al., 2003) that was injected into the tube lumen.  The nerve injury 
was a 14 mm sciatic nerve gap, and was created using a previously described surgical 
technique (Kim et al., 2008).  Treatment consisted of implanting a 17 mm nerve guidance 
channel containing a single thin-film of electrospun poly(acrylonitrile-co-methylacrylate, 
random copolymer, 4 mol% methylacrylate) (PAN–MA) with aligned-fiber topography 
(Clements et al., 2009).  Proximal and distal nerve stumps were sutured 1.5 mm into each 
end of the channel to yield a 14 mm nerve gap.  The composite injury consisted of both 
the bone defect and nerve gap, and treatment was a combination of the single injury 
methods.  Un-operated, age-matched animals served as intact tissue controls (n=6).  For 
pain relief, animals received subcutaneous injections of buprenorphine upon recovery 
from anesthesia and again every 8 hours for the first 72 post-operative hours.  Animals 
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were housed in a temperature and humidity controlled environment, maintained on a 
12:12 hour light/dark cycle, and allowed access to food and water ad libitum.  All 
procedures were reviewed and approved by the Georgia Institute of Technology 
Institutional Animal Care and Use Committee and the United States Army Medical 
Research and Materiel Command Animal Care and Use Review Office. 
Gait Analysis 
 Quantitative, computerized gait analysis was performed using CatWalk 
equipment and software (CatWalk 7.1, Noldus Information Technology, The 
Netherlands),  technology originally detailed by Hamers et al. (Hamers et al., 2001).  The 
system has been previously used to assess functional deficit in spinal cord (Koopmans et 
al., 2005) and sciatic nerve injury (Deumens et al., 2007; Bozkurt et al., 2008; Bozkurt et 
al., 2011) animal models, as well as models of traumatic brain injury (Wang et al., 2011), 
neurological disorders (Vandeputte et al., 2010), and osteoarthritis (Ferland et al., 2011).  
One week prior to data acquisition (two weeks prior to surgery), animals were run on the 
CatWalk system for acclimation and training.  Pre-injury baseline data was acquired one 
week prior to surgery, and data acquisition was again performed 4, 8, 12, and 16 weeks 
post-surgery.  Only uninterrupted runs were included for analysis.  Three runs were 
analyzed per animal per time point whenever possible.  
In Vivo Radiographs and Microcomputed Tomography 
 To qualitatively assess longitudinal bone regeneration and defect bridging, two-
dimensional in vivo radiographs (Faxitron MX-20 Digital, Faxitron X-ray Corp., 
Wheeling, IL) were taken at 2, 4, 8, 12, and 16 weeks post-surgery.  Radiographs were 
acquired at an exposure time of 15 s and an energy of 25 kV.  Bony bridging, defined as 
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continuous bone spanning the defect region, was evaluated in the radiographs by two 
blinded investigators.  In instances of disagreement, a third blinded investigator provided 
resolution. 
 At 4, 8, 12, and 16 weeks post-surgery, animals were anesthetized via isoflurane 
inhalation and in vivo microcomputed tomography (micro-CT) scans (vivaCT 40, Scanco 
Medical, Brüttisellen, Switzerland) were performed to quantitatively assess three-
dimensional bone regeneration in the defect.  Defects were scanned with an applied 
electric potential of 55 kVp, a current of 109 μA, and an isometric voxel size of 38 μm.  
The volume of interest (VOI) for in vivo scan analysis spanned a constant length of 5.43 
mm (143 slices) at the center of each defect.  To segment new mineral formation in the 
VOI, a global threshold corresponding to 50% of the native cortical bone density was 
applied.  Additional post-mortem micro-CT analysis was performed after harvest and is 
detailed below. 
Electrophysiology 
 In order to assess the extent of peripheral nerve regeneration, electrophysiological 
testing was performed as previously described (Clements et al., 2009).  Each animal was 
deeply anesthetized via inhaled isoflurane, and the site of nerve injury was re-exposed 
and kept moistened with mineral oil warmed to 37 °C.  Portions of the sciatic nerve, 
approximately 15 mm proximal and distal to the ends of the nerve guidance channel, 
were freed from the surrounding tissue, and fitted with stainless steel bipolar hook 
electrodes.  The distally positioned pair of electrodes, which was attached to a stimulator 
(Model S88, Grass Technologies, West Warwick, RI) and stimulus isolation unit (Model 
SIU5B, Grass Technologies), was used to stimulate the regenerated nerve with 0.1 to 0.5 
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ms square pulses of variable amplitude applied at a rate of 1 Hz.  The evoked compound 
nerve action potentials (CNAPs) were recorded from the proximal pair of electrodes, 
amplified (Gain=1000), bandpass filtered (10–5000 Hz, Model 1700, A-M Systems, 
Sequim, WA), and digitally sampled (25 kS/s, Multichannel Systems DAQ card). The 
recordings were averaged up to 200 times, using a trigger signal provided by the 
stimulator, and the latencies of the onset of the evoked CNAPs were determined off-line.  
The precise distances between stimulating and recording electrodes were measured and 
divided by the latencies to calculate the conduction velocity of the CNAPs through the 
regenerated nerves.  Qualitative assessment of whether regenerating axons crossed the 
injury gap and functionally reinnervated lower leg musculature was performed by 
observing contraction of the appropriate muscles in response to stimulation of the 
proximal nerve segment.  These observations were performed before and after crushing 
the regenerated nerve distal to the site of stimulation. 
Ex Vivo Microcomputed Tomography 
 After euthanasia (16 weeks post-surgery), femora were harvested for ex vivo µCT 
analysis and mechanical testing.  Explanted femora were placed in 15ml conicals with 
phosphate buffered saline and oriented to the z-axis of scanning.  Scans were performed 
with an applied electric potential of 55 kVp, a current of 109 μA, and an isometric voxel 
size of 21 μm.  The ex vivo VOI consisted of a 6.99 mm (333 slices) region at the center 
of each defect.  For segmentation of new mineral formation, a global threshold 
corresponding to 50% of native cortical bone density was applied.   
 Additionally, geometry and morphology of intact, unoperated femora were 
assessed for mid-diaphyseal cortical bone and epiphyseal trabecular bone.  The cortical 
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bone VOI was a 2.96 mm (141 slices) region of the mid-diaphysis centered at the 
midpoint of each femur.  A global threshold for cortical bone was determined via 
inspection and applied for segmentation.  The entire epiphyseal trabecular bone 
compartment, extending from the distal end of the growth plate to divergence of the 
condyles, was contoured using an automatic algorithm adapted from Buie et al.(Buie et 
al., 2007)  Contours were all visually inspected for accuracy and manually adjusted as 
necessary.  The trabecular bone VOI consisted of a 0.67 mm (32 slices) region at the 
center of each epiphyseal compartment.  A global threshold for trabecular bone was 
determined by visual inspection and applied for segmentation.  For all micro-CT analysis, 
a Gaussian filter was used for noise suppression (σ = 1.2 and support = 2 for all analyses 
except trabecular bone, which used σ = 0.8 and support = 1).   
Biomechanical Testing 
 Femora were biomechanically tested to failure in torsion immediately following 
ex vivo micro-CT scans using a previously described protocol (Oest et al., 2007).  Briefly, 
excess soft tissue was carefully removed from the sample, the ends were potted into 
blocks with Wood’s metal (Alfa Aesar, Wood Hill, MA), and the fixation plate was 
removed.  Potted samples were mounted in torsion fixtures on a Bose ElectroForce 
system (ELF 3220, Bose EnduraTEC, Minnetonka, MN) and rotated through failure at a 
ramp rate of 3°/s, with rotation and torque data recorded.  For each sample, failure 
strength and torsional stiffness (given by the maximum torque experienced and the slope 




 2 mm-long sections of regenerated nerve were removed from the center of each 
guidance channel and from approximately the same region in intact sciatic nerves.  These 
explants were fixed overnight with 1% osmium tetroxide in PBS.  Samples were then 
washed with PBS, dehydrated in a graded ethanol series, and embedded in LX112 resin 
(Ladd Research Industries, Inc., Burlington, VT).  Transverse 1 µm-thick sections were 
slide-mounted and stained with toluidine blue to visualize myelinated axons.  Bright field 
microscopy (Nikon mEclipse 80i, Japan) was used to obtain high power (40x) 
photomicrographs of mounted nerve cross-sections.  Mosaic images were compiled using 
a Neurolucida Plus software system (MBF Bioscience, Williston, VT) coupled to a 
mechanized stage and camera (MicroFireTM, Optronics, Goleta, CA).  
Histomorphometric parameters were obtained from these mosaic images using Image-Pro 
Plus software (Media Cybernetics, Inc., Bethesda, MD).  Axon counts were performed by 
manually counting subsets of the entire axonal population and applying the density for 
the counted area to the whole area of nerve.  Manual counts were performed on 10-25% 
of the total nerve area from each cross-section.   
Data Presentation and Statistical Analysis 
 All data are presented as mean ± standard error of the mean (SEM).  In vivo µCT 
data were analyzed for differences between groups using unpaired t-tests at each time 
point.  One-factor analysis of variance (ANOVA), with pairwise comparisons made by 
Tukey’s post hoc test, or unpaired t-tests were used for analyzing end point data, as 
appropriate.  CatWalk data are expressed as a ratio between ipsilateral and contralateral 
hind paws.  CatWalk data were analyzed by ANOVA with repeated measures to evaluate 
overall differences based on group, time, and the interaction of the two.  Cross-sectional, 
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one-factor ANOVA was used for comparisons amongst groups at each time point.  Paired 
t-tests with Bonferroni correction were used to make within-group comparisons of post-
surgical time points to pre-injury baseline values.  A significance level of 0.05 was used 
for all analyses.  Statistical analysis was performed in Minitab 15 (Minitab, State College, 
PA) or SPSS Statistics 19 (IBM, Somers, NY). 
Results 
 All operated animals tolerated surgical procedures and recovered well.   One 
animal in the bone injury group was excluded from analysis due to abscess formation in 
the defect.  An additional animal from this group was lost due to anesthesia 
complications during the week 8 in vivo micro-CT scan.  One animal from each of the 
nerve injury and composite injury groups developed pododermatitis on the operated limb 
and were excluded from CatWalk analysis. 
Bone Regeneration Radiography and Micro-CT Analysis 
 Longitudinal radiographs revealed a qualitatively similar bone healing response in 
the composite injury group compared to the bone injury group (Fig. 3.1).  Bridging rates 
were comparable for the two groups.  In the bone injury group, six of eight samples had 
bridged by week 4, and all but one sample had bridged by week 12, with the exception 
going on to non-union.  In the composite injury group, 7 of 8 samples had bridged by 
week 4, and all samples had bridged by week 12.  Three-dimensional micro-CT 
reconstructions confirmed these results (Fig. 3.2A).  No quantitative differences were 
observed between groups at any in vivo time point in terms of the volume of mineral 
formation (Fig. 3.2B) or the mean mineral density (data not shown).  Both groups 
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exhibited similar trends for increasing mineral volume and mean density over time.  Ex 
vivo quantitative analysis also revealed no differences between groups (data not shown). 
 
 
Figure 3.1.  Radiographic evaluation of bone healing.  Representative 2-D radiographs 
for bone injury and composite injury groups.   
 
 
Figure 3.2.  Quantitative micro-CT analysis of bone regeneration.  (A) Representative 3-
D reconstructions of ex vivo scans and cross-sections with density mapping.  Native 
cortical bone ends have been included for orientation.  (B) Longitudinal quantification of 
new mineral volume in the defect region from in vivo scans.  n = 7-8 per group per time 
point. 
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Intact Femora Micro-CT Analysis 
 Ex vivo analysis of intact femora yielded several notable results.  Intact ipsilateral 
femora from the nerve injury group were analyzed to evaluate the effect of the sciatic 
nerve injury on adaptation in the femur.  The mid-diaphyseal region of these femora 
demonstrated lower polar moment inertia, total cross-sectional area, cortical bone cross-
sectional area, cortical bone thickness, and cortical bone density compared to controls 
(Fig. 3.3).  Medullary cavity cross-sectional area was not significantly different (Fig. 3.3).  
Epiphyseal trabecular bone from these femora exhibited a significantly lower bone 
volume fraction compared to controls, and a decrease in mean density that did not reach 
significance (Fig. 3.4). 
 The intact contralateral femora from each group were also assessed to determine 
whether adaptation in the mid-diaphysis or distal femur had occurred.  In analysis of mid-
diaphyseal cortical bone, the composite injury group demonstrated a significantly 
increased polar moment of inertia, cortical bone cross-sectional area, and cortical bone 
thickness compared to controls (Fig. 3.5).  A trend toward increased total cross-sectional 
area was noted (p = 0.107); no difference was detected for medullary cavity cross-
sectional area (Fig. 3.5).  Epiphyseal trabecular bone from the bone injury and composite 
injury groups exhibited greater bone volume fraction values than those in the nerve injury 
group and controls, but only trended toward significance versus controls (Fig. 3.6).  Mean 
density also appeared increased for the bone injury and composite injury groups 
compared to the nerve injury group and controls, but did not reach statistical significance. 
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Figure 3.3.  Micro-CT analysis of mid-diaphyseal cortical bone in ipsilateral intact 
femora from the nerve injury group.  * = significantly different as indicated (p < 0.005). n 





Figure 3.4.  Micro-CT analysis of epiphyseal trabecular bone in ipsilateral intact femora 





Figure 3.5.  Micro-CT analysis of mid-diaphyseal cortical bone in contralateral intact 
femora.  * = significantly different as indicated (p < 0.05).  n = 7-8 for BI, NI, and CI.  n 





Figure 3.6.  Micro-CT analysis of epiphyseal trabecular bone in contralateral intact 
femora.  * = significantly different as indicated (p < 0.05).  n = 7-8 for BI, NI, and CI.  n 
= 12 for Control. 
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Biomechanical Testing 
 No differences were detected between bone injury and composite injury groups 
for maximum torque at failure, and both groups failed at significantly lower torque than 
intact controls (12.1% and 17.0% of controls, respectively) and intact ipsilateral femora 
from the nerve injury group (Fig. 3.7A).  Intact ipsilateral femora from the nerve injury 
group also exhibited lower torque at failure than the control group (83.5% of controls, 
Fig. 3.7A).  Torsional stiffness data presented slightly different results.  The bone injury 
group exhibited significantly lower stiffness than the composite injury group, and both 
had lower stiffness than controls and ipsilateral nerve injury group femora (Fig. 3.7B).  
Differences in torsional stiffness were not significant between the ipsilateral nerve injury 
femora and controls (Fig. 3.7B).  Intact contralateral femora from the composite injury 
group demonstrated a trend toward increased torque at failure (p = 0.118) compared to 







Figure 3.7.  Biomechanical properties for functional assessment of regenerated bone 
tissue.  (A) Maximum torque at failure.  a = significant vs. NI and Control (p < 0.0001).  
b = significant vs. Control (p < 0.005).  (B) Torsional stiffness.  c = significant vs. NI, CI, 
and Control (p < 0.05).  d = significant vs. NI and Control (p < 0.005). n = 7-8 for BI, NI, 
and CI.  n = 12 for Control. 
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Figure 3.8.  Mechanical properties of contralateral intact femora.  n = 7-8 for BI, NI, and 
CI.  n = 12 for Control. 
 
 
Nerve Regeneration Histology 
 Regenerating nerves in nerve injury and composite injury groups appeared to 
have much smaller overall cross-sectional area in comparison to intact controls, in 
addition to possessing smaller, more densely organized myelinated axons.  However, 
nerve injury and composite injury group sections did not appear markedly different (Fig. 
3.9).  Intact ipsilateral sciatic nerves from the bone injury group appeared qualitatively 
similar in morphology to intact controls (Fig. 3.9).  Histomorphometric parameters were 
investigated to further probe for semi-quantitative differences in the regenerating nerves.  
No differences were observed between the nerve injury and composite injury groups for 
nerve cross-sectional area, axon density, or total axon count.  Confirming qualitative 
observations, both groups had significantly less cross-sectional area, greater axon density, 








Figure 3.9.  Histological assessment of nerve regeneration.  Representative high-power 
fields (40x) from slide-mounted cross-sections of intact control sciatic nerves (Control, 
BI) and regenerating nerves in guidance channels (NI, CI) stained with toluidine blue to 





Figure 3.10.  Histomorphometric analysis of nerve regeneration.  (A) Total nerve tissue 
cross-sectional area.  (B) Cross-section axon density.  (C) Total number of axons in 
cross-sectional area.  a = significant vs. Control (p < 0.0005).  n = 8 per group. 
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Electrophysiology 
 Contractions of lower leg musculature were observed for all animals in the 
composite injury and nerve injury groups upon stimulation of the sciatic nerve proximal 
to the nerve guidance channel.  No quantitative differences in evoked CNAP conduction 
velocity were found between the nerve injury and composite injury groups; however, 
both groups demonstrated significantly slower velocities compared to controls, achieving 
only 34% of the control nerve conduction velocity (Fig. 3.11). 
 
 
Figure 3.11.  Electrophysiological determination of compound nerve action potential 
conductance velocity for functional assessment of regenerated nerve tissue.  a = 




 Quantitative gait analysis indicated that the composite injury group experienced 
significantly impaired limb function compared to either single-injury group.  Hind paw 
duty cycle was investigated as a dynamic gait parameter indicative of favoring one limb 
versus another, with significant differences observed amongst groups.  Duty cycle is 
calculated per step cycle as the ratio of the time a paw is in contact with the floor to the 
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total time of the step cycle.  The nerve injury group exhibited a decrease compared to the 
bone injury group, whereas the composite injury group showed a decrease compared to 
both (Fig. 3.12A), an indication that the composite injury group spent less time weight-
bearing on the injured limb compared to either single-injury group, instead favoring the 
contralateral limb.  No groups demonstrated significant change in duty cycle over time.  
Hind paw print area was also used to investigate the degree of functional deficit 
associated with each injury model.  Again, differences were observed amongst groups, 
but these difference varied with time post-surgery (Fig. 3.12B).  In general, the nerve 
injury and composite injury groups had significantly lower hind paw print area ratios 
compared to the bone injury group.  While significantly different at week 4, differences 
in print area ratio were not found between the nerve injury and composite injury groups 
at subsequent time points.  Compared to pre-injury baseline measurements, all groups 
demonstrated a significant decrease in duty cycle and print area at week 4 that remained 










Figure 3.12.  CatWalk gait analysis of limb function for parameters (A) Hind Paw Duty 
Cycle and (B) Hind Paw Print Area.  All data represented as percent of contralateral hind 
paw.  a = BI vs. CI significant within time point (p < 0.05).  b = NI vs. CI significant 
within time point (p < 0.05).  c = BI vs. NI significant within time point (p < 0.05).  n = 7 
per group per time point. 
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Discussion 
 To our knowledge, this study is the first to describe a rat composite injury model 
of severe lower limb bone and nerve trauma.  Characterization of the model was 
performed using biomaterials-based therapeutics previously demonstrated to show 
promise in well-established, single-tissue injury models.  Outcome parameters 
investigated tissue regeneration, morphological skeletal changes in the uninjured 
contralateral limb, and quantitative functional assessments.  The latter included an 
evaluation of overall limb function in addition to traditional measures of individual tissue 
function.  Interestingly, bone regeneration in the femoral defect was not significantly 
impaired by concomitant injury to the sciatic nerve, nor was nerve regeneration 
significantly impaired by bone injury.  Nonetheless, despite the similar tissue 
regeneration observed, the composite injury group experienced a marked functional 
deficit in the operated limb compared to either of the single-tissue injury groups.   
 Although treatment resulted in consistent bridging of the defects, mechanical 
properties were much lower than those of intact controls.  This result is attributable to the 
relatively low dose of rhBMP-2 (2 µg), which was chosen to limit the possibility of 
masking potential interactions in the healing response.  Previously, Kolambkar et al. 
demonstrated that this hybrid delivery system is capable of restoring intact bone 
mechanical properties at a 5 µg rhBMP-2 dose (Kolambkar et al., 2011).  With no 
treatment, or vehicle alone, these defects will not heal and will progress to non-union 
(Oest et al., 2007; Kolambkar et al., 2011).  Comparison of the mechanical properties 
between the bone injury and composite injury groups indicated no differences in the 
failure torque of regenerated new bone; however, the composite injury group 
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demonstrated greater stiffness.  The latter result does not appear consequential, though, 
given the lack of increase in failure torque and the fact that the mean stiffness value is 
still only 38.7% of controls.  Although there were marked differences in functional use of 
the operated limb between the bone injury and composite injury groups, we have little 
reason to believe local mechanical stimuli at healing defects were different, as much of 
the ambulatory load is shielded by fixation hardware (Boerckel et al., 2011).  
Furthermore, while sciatic nerve resection would disrupt resting muscle tone in the lower 
leg, it would unlikely have much effect on upper leg muscle tone.  
 The observed decreases in mid-diaphyseal cortical bone and epiphyseal trabecular 
bone, as well as the decrease in failure torque, for intact ipsilateral femora in the nerve 
injury group are likely attributed to disuse-induced remodeling (or lack of modeling) 
associated with sciatic nerve resection (Robling et al., 2006).  Similarly, the significant 
increases observed in cortical bone morphology in contralateral femora from the 
composite injury group are likely explained by an adaptive response resulting from the 
demonstrated functional deficit in the injured limb.  Duty cycle data clearly indicated that 
this group favored the contralateral limb during ambulation, and this increased weight 
bearing manifested itself as increased polar moment of inertia, total cross-sectional area, 
cortical bone cross-sectional area, and cortical bone thickness in the femur mid-diaphysis.  
Although changes in mid-diaphyseal cortical bone morphology were significant, the 
increase is failure torque trended toward, but did not quite reach, significance.  These 
results are likely reconciled with solid mechanics theory (Boerckel et al., 2011).  Failure 
torque is a function of the minimum polar moment of inertia, whereas the µCT 
morphology values are only representative of the mean values in the mid-diaphysis.  The 
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increases, although not all statistically significant, in epiphyseal bone volume fraction 
and mineral density in the bone injury and composite injury groups could be attributable 
to a systemic response to the bone injury in these groups, the osteogenic intervention, or 
some combination of the two.  The disparity in trends between the mid-diaphysis and 
distal femur results may be a function of the physiological loading experienced during 
ambulation in the rat.   
 Qualitative electrophysiology indicated that all treated nerve gaps achieved some 
degree of functional reinnervation, with lower leg muscle contractures observed upon 
stimulation of the sciatic nerve proximal to the repaired gap.  Regenerated nerve tissue, 
however, exhibited less cross-sectional area than normal sciatic nerve, and demonstrated 
significantly slower conduction velocities, the latter at least partially attributable to the 
former (Rushton, 1951).  Unsurprisingly, the regenerating axons appeared smaller in 
diameter and possessed greater area density than those in native tissue.  These results are 
in accordance with reports that the early stage of peripheral nerve repair is characterized 
by an increase in the number and density of nerve fibers as regenerating axons sprout, 
and these axons are smaller in diameter compared to normal nerves.  Over time, 
regenerated axons undergo a selective pruning process, and values for axon number and 
density return to more normal values with an accompanying increase in average diameter 
(Mackinnon et al., 1991).  Although unable to restore fully-functional nerve tissue in the 
16-week time frame, these conduits still provide a therapeutic response.  Previous work 
has demonstrated that empty constructs are insufficient for nerve regeneration (Dodla and 
Bellamkonda, 2008; Kim et al., 2008), and that the aligned nanofiber topography 
improves healing compared to random orientation (Kim et al., 2008). 
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 The exact mechanism responsible for the marked functional deficit observed in 
the composite injury group is unknown.  This response may simply be a result of bone 
trauma compounding the loss of innervation to the lower leg.  Presence of the fixation 
hardware may also augment the muscle contractures observed in sciatic nerve resection 
and contribute to an increased functional deficit.  The time course for full functional 
restoration may also be longer than the 16 weeks of healing allotted in this study.  The 
decrease in functional measures over time in the nerve injury group was another 
interesting result from this data.  These observations may be partially explained by 
previous work that demonstrated slowly retreating mechanical allodynia following 
sensory recovery in a sciatic nerve crush model (Vogelaar et al., 2004).  Muscle 
contractures in the lower limb associated with sciatic nerve transection may also 
contribute if they progress in severity over time.  It would be an oversight to not consider 
the role of a physical therapy protocol (or lack thereof) in assessing functional outcomes 
following extremity trauma.  Physical therapy is a vital component in the rehabilitation 
and recovery process for human patients.  In this study, the lack of a physical therapy 
protocol may be at least partially responsible for the persistent functional deficit; 
however, implementation of a standardized protocol for rats would present a multitude of 
logistical hurdles. 
 Although our primary motivation in this study was developing a small animal test 
bed model of limb trauma that was more clinically-relevant than traditional single-tissue 
models, we recognize the additional potential for composite injury models to facilitate 
investigation of endogenous cellular and molecular interactions that may occur in the 
healing response of multiple-tissue defects.  Identification of such interactions could 
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stimulate research for innovative therapeutics to leverage combinatorial, or even 
synergistic, tissue repair and regeneration.  Previous work has demonstrated a neural 
component in several aspects of bone physiology (Imai and Matsusue, 2002; Spencer et 
al., 2004; Elefteriou, 2008).  Specifically, Sample et al. recently demonstrated a neural 
contribution in the regulation of functional adaptation to loading (Sample et al., 2008), 
and Whiteside et al. showed that neuropathy-induced reduction in bone mineral density is 
not strictly a result of reduced weight bearing on the affected limb (Whiteside et al., 
2006).  More closely related to the research covered here, sciatic nerve resection has 
experimentally been shown to influence fracture healing in the tibia, yielding a larger, 
less dense fracture callus with diminished mechanical properties (Nordsletten et al., 
1994; Madsen et al., 1998).  Although these studies immobilized the fractured limb to 
prevent unequal loading for groups with or without sciatic nerve resection, disruption of 
resting muscle tone associated with nerve injury may have imparted differing local 
mechanical stimuli.  Subsequent studies in the same model have implicated sensory 
neuropeptide calcitonin gene-related peptide (CGRP) in the impaired healing response.  
CGRP-immunoreactive sensory fibers are known to innervate normal bone (Bjurholm et 
al., 1988; Mach et al., 2002), have been shown to sprout and proliferate in normal 
fracture healing (Hukkanen et al., 1993), but are reduced in tibial fracture healing 
disrupted by sciatic nerve resection (Hukkanen et al., 1995).  The specific mechanism of 
this response may be the potent vasodilator action of CGRP (Brain et al., 1985), and its 
ability to stimulate endothelial cell proliferation (Haegerstrand et al., 1990).  
Additionally, CGRP has been shown to have osteogenic capacity in vitro (Bernard and 
Shih, 1990) and in vivo (Ballica et al., 1999).     
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 In this study, no clear healing interactions between bone and nerve tissue were 
observed, which may be a consequence of the model design.  Given the close anatomical 
proximity of the sciatic nerve and the femur (the former running just posterior to the 
latter in the musculature of the hamstrings), it is susceptible to injury in instances of 
lower extremity trauma that damage the femur.  This relationship made it a logical choice 
for a trauma model.  From a functional perspective, though, the two are not as closely 
related.  The primary function of the sciatic nerve is to innervate the lower leg and foot.  
This inability for direct signaling between the femur and sciatic nerve injury sites is a 
potential explanation for the lack of observed healing response interactions.  It may be 
necessary to disrupt the specific nerves responsible for innervation of the injured bone in 
order to observe a neuronal influence on bone healing.  In support of this idea, a recent 
study showed that chemically-induced local sensory denervation was associated with 
impaired healing of femur fractures by way of a larger, less dense fracture callus, with a 
significantly decreased failure load (Apel et al., 2009).  Alternatively, it is plausible that 
endogenous healing of large tissue defects does not parallel the cellular and molecular 
responses observed in fracture healing.  Additional insight may have been gained by 
including experimental composite injury groups in which one of the defects was left 
untreated (e.g., treated bone defect with untreated nerve gap).  Such groups would have 
been able to tease out whether untreated nerve defects negatively influenced bone repair, 
or perhaps whether delivery of BMP-2 affected nerve regeneration.   
 Although differences between the composite injury model and single-injury 
models were not observed in tissue regeneration for outcome parameters investigated 
here, the difference in functional deficit was quite profound.  Restoration of limb function 
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remains a major obstacle in limb salvage following extremity trauma in human patients.  
Taken together with our results, this highlights the need for tissue engineering and 
regenerative medicine research to benchmark technologies using quantitative measures of 
both tissue and limb function. 
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CHAPTER 4 
RECOVERY FROM HIND LIMB ISCHEMIA ENHANCES BMP-2-





 Although severe extremity trauma is often inclusive of skeletal and vascular 
damage in combination, segmental bone defect repair with concomitant vascular injury 
has yet to be experimentally investigated.  To this end, we developed a novel rat 
composite limb injury model by combining a critically-sized segmental bone defect with 
surgically-induced hind limb ischemia (HLI).  Unilateral 8 mm femoral defects were 
created alone (BD) or in combination with HLI (BD+HLI), and all defects were treated 
with rhBMP-2 via a hybrid biomaterial delivery system.  Based on reported clinical and 
experimental observations on the importance of vascular networks in bone repair, we 
hypothesized that HLI would impair bone regeneration.  Interestingly, the BD+HLI group 
displayed improved radiographic bridging, and quantitative micro-CT analysis revealed 
enhanced bone regeneration as early as week 4 (p<0.01) that was sustained through week 
12 (p<0.001) and confirmed histologically.  This effect was observed in two independent 
studies and at two different doses of rhBMP-2.  Micro-CT angiography was used to 
quantitatively evaluate vascular networks at week 12 in both the thigh and the 




 Portions of this chapter were adapted from Uhrig BA, Boerckel JD, Willett NJ, Li MA, Huebsch N, 
Guldberg RE. Recovery from hind limb ischemia enhances rhBMP-2-mediated segmental bone defect 
repair in a rat composite injury model. Bone. 2013; [Epub ahead of print]. 
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regenerated bone defect.  No differences were found between groups in total blood vessel 
volume in the thigh, but clear differences in morphology were present as the BD+HLI 
group possessed a more interconnected network of smaller diameter vessels (p<0.001).   
Accordingly, while the overall thigh vessel volume was comparable between groups, the 
contributions to vessel volume based on vessel diameter differed significantly.  Despite 
this evidence of a robust neovascular response in the thigh of the BD+HLI group, 
differences were not observed between groups for bone defect blood vessel volume or 
morphology.  In total, our results demonstrate that a transient ischemic insult and the 
subsequent recovery response to HLI significantly enhanced BMP-2-mediated segmental 
bone defect repair, providing additional complexity to the relationship between vascular 
tissue networks and bone healing.  Ultimately, a better understanding of the coupling 
mechanisms may reveal important new strategies for promoting bone healing. 
Introduction 
 Vascular tissues play an intricate role in many aspects of bone physiology, 
including bone repair.  Blood vessel invasion is a critical step in developmental 
skeletogenesis as the cartilaginous intermediate is converted to bone (Gerber et al., 1999; 
Kronenberg, 2003). Skeletal repair also recapitulates much of the developmental coupling 
of vascular and osseous growth (Ferguson et al., 1999).  A commendable amount of 
orthopaedic research has explored the role of angiogenesis in bone formation and repair, 
significantly advancing our understanding of angiogenic-osteogenic crosstalk.  
Angiogenesis is a necessary component in bone healing (Glowacki, 1998; Carano and 
Filvaroff, 2003), and inhibition has experimentally been shown to disrupt both 
endochondral and intramembranous pathways of bone repair (Street et al., 2002).  
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Beyond experimental results, clinical observations reinforce the importance of 
vasculature in bone healing.  Diminished blood supply and concomitant vascular injury 
are clinical risk factors for delayed or nonunion fracture healing (Dickson et al., 1994; 
Einhorn, 1995; Brinker and Bailey, 1997), while lower limb fractures with vascular 
injuries experience higher rates of amputation (Glass et al., 2009). 
 The deleterious effects of impaired vascular supply or concomitant vascular insult 
on clinical bone repair are certainly not surprising.  Beyond the obvious physiological 
role of oxygen and nutrient transport, vascular networks likely also function as conduits 
for migrating inflammatory and progenitor cells as well as soluble factors essential for 
modulating the molecular signaling cascades of repair.  Despite such a well-established 
understanding of the importance of adequate vascular networks for successful bone 
healing, only a few studies have investigated experimental bone repair with concomitant 
vascular injury (Kase et al., 1998; Lu et al., 2007), and none have involved bone defect 
repair.  The lack of such research models is noteworthy, as extremity trauma with 
substantial skeletal damage is often accompanied by insults to the surrounding 
vasculature, and these injuries present unique and significant complications for clinicians 
(Nauth et al., 2011).  Additionally, insufficient vascularization is an acknowledged 
shortcoming of status quo bone tissue engineering strategies (Muschler et al., 2004; 
Kanczler and Oreffo, 2008), further complicating clinical treatment strategies.  
Continuing to unravel the complex interactions between vascular networks and bone 
regeneration will help to advance the design of therapeutic interventions for skeletal 
repair, and ultimately improve orthopaedic trauma patient treatment outcomes.   
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 Accordingly, our aim here was to develop a rat model of composite lower limb 
bone and vascular trauma to serve as a test bed for evaluating technologies to improve 
bone regeneration, as well as provide new insights on interactions between bone healing 
and vascular tissues.  To do so, we incorporated surgically-induced hind limb ischemia 
(HLI) with a well-established segmental bone defect model.  Bone defects were treated 
using a previously reported recombinant human bone morphogenetic protein-2 (rhBMP-
2) hybrid biomaterial delivery system (Boerckel et al., 2011; Kolambkar et al., 2011; 
Kolambkar et al., 2011).  This system has demonstrated efficacious bone regeneration, 
producing bone defect bridging with functional restoration.  Based on reported clinical 
observations and experimental results, we hypothesized that HLI would impair bone 
regeneration in this model. 
Materials and Methods 
Experimental Design 
 The work described here consists of two independent experiments with pooled 
results.  Thirteen-week-old female SASCO Sprague-Dawley rats (Charles River 
Laboratories) were designated for one of two injury model groups: 8 mm mid-femoral 
bone defects alone (BD) or in combination with hind limb ischemia (BD+HLI).  The 
initial experiment consisted of n=10 per group with each bone defect receiving a 2 μg 
rhBMP-2 treatment dose.  This dose was chosen as it was previously shown to produce 
consistent bridging of defects in this model (Boerckel et al., 2011), but would not be so 
high as to overwhelm potential effects of HLI.  A second experiment was performed to 
confirm the findings of the first study at 2 μg rhBMP-2 (n = 4 - 5 per group) as well as 
evaluate a lower 0.5 μg treatment dose of rhBMP-2 previously shown to be inadequate 
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for bone bridging (n=5 per group) (Boerckel et al., 2011).  Within groups, no differences 
were found between experiments for the 2 μg dose, thus, results have been pooled for that 
dose level.  All procedures were reviewed and approved by the Georgia Institute of 
Technology Institutional Animal Care and Use Committee and the United States Army 
Medical Research and Materiel Command Animal Care and Use Review Office. 
Surgical Procedure 
 Animals were anesthetized via isoflurane inhalation and received unilateral 
surgeries to the left hind limb.  The bone defect surgery and fixation was performed as 
described previously (Oest et al., 2007).  The hind limb ischemia technique was adapted 
from methods previously described for mouse models (Couffinhal et al., 1998; Duvall et 
al., 2004).  Briefly, the femoral artery and vein (spanning from the inguinal ligament to 
the popliteal bifurcation) were dissected free from associated nerves, ligated with 6-0 silk 
suture, and excised.   Each bone defect was treated with a hybrid nanofiber mesh and 
RGD-functionalized alginate hydrogel rhBMP-2 delivery system previously described 
(Kolambkar et al., 2011).  The rhBMP-2 treatment dose was 2 μg per defect, except 
where a lower 0.5 μg dose is indicated.  Subcutaneous injections of buprenorphine were 
given for post-op analgesia.  Animals were allowed access to food and water ad libitum, 
housed in a temperature and humidity controlled environment, and maintained on a 12:12 
hour light/dark cycle.   
Laser Doppler Perfusion Imaging 
 Laser Doppler perfusion imaging (LDPI) was used to assess blood flow to the 
hind limb immediately following surgery and confirm successful induction of ischemia.  
Anesthetized animals were shave of hair on their legs, placed on a heating pad in a supine 
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position and imaged (moorLDI2-IR-HR, Moor Instruments).  Regions of interest 
analyzed were the entire leg, the foot, and the thigh.  To control for possible effects of 
ambient temperature and lighting, each data point was expressed in terms of blood flow 
in the operated limb as percentage of the contralateral control limb. 
Radiography 
 Digital 2-D radiographs (Faxitron MX-20 Digital, Faxitron X-ray Corp.) were 
used for qualitative in vivo assessment of bone regeneration.  Radiograph acquisition 
settings were 15 s exposure time at 25 kV.  Radiograph imaging was performed at 2, 4, 8, 
and 12 weeks post-surgery.  Bony bridging was evaluated in radiographs by three blinded 
investigators. 
Microcomputed Tomography 
 In vivo micro-CT scans (vivaCT 40, Scanco Medical) were performed at 4, 8, and 
12 weeks post-surgery to quantitatively assess 3-D bone regeneration.  Legs were 
oriented along the z-axis and scanned with an applied electric potential of 55 kVp, a 
current of 109 μA, and an isometric voxel size of 38 μm.  The volume of interest (VOI) 
for analysis was the center 5 mm (132 slices) of each defect.  New mineral was 
segmented through application of a global threshold corresponding to 50% of native 
cortical bone density.  A Gaussian low-pass filter was applied for noise suppression (σ = 
1.2 and support = 1).   
Micro-CT Angiography 
 At the week 12 study end-point, contrast agent-enhanced micro-CT angiography 
was used to quantitatively evaluate hind limb vasculature.  The technique has been 
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previously described in detail elsewhere (Duvall et al., 2004; Boerckel et al., 2011).  
Briefly, the vasculature was cleared with physiological saline containing 0.4% papaverine 
hydrochloride (Sigma-Aldrich), perfusion fixed with 10% neutral buffered formalin, 
rinsed again with physiological saline, and finally injected with lead chromate-based 
radiopaque contrast agent (2 parts Microfil MV-122 : 1 part diluent, Flow Tech).  
Samples were stored at 4 °C overnight to allow for polymerization of the contrast agent.  
Hind limbs were excised and decalcified (Cal-Ex II, Fisher Scientific) over a period of 2-
3 weeks under gentle agitation with routine solution changes.      
  Samples were oriented with the femur along the z-axis for micro-CT scanning 
(vivaCT 40, Scanco Medical).  Two sets of scans and VOIs were used in this analysis.  
Initial scans were performed on the upper leg with an applied electric potential of 55 
kVp, a current of 109 μA, and an isometric voxel size of 38 μm.  The VOI for the initial 
set of scans consisted of the entirety of the cross-section of the leg spanning between the 
metal fixation plate components (Thigh VOI, refer to Fig. 4.7A for illustration).  A 
second set of higher resolution scans focused on the defect region was performed with an 
isometric voxel size of 21 μm.  The VOI for the second set of scans consisted of a 
cylindrical volume 5 mm in diameter that spanned the center 7 mm of the bone defect 
(Defect VOI, refer to Fig. 4.9A for illustration).  A global threshold was applied for 
segmentation of vasculature and a Gaussian low-pass filter was used for noise 
suppression (σ = 0.8 and support = 1).   
Histology 
 Samples designated for histology were fixed in 10% neutral buffered formalin for 
48 h at 4 °C and then decalcificied (Cal-Ex II, Fisher Scientific) over a period of 2 weeks 
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under gentle agitation with routine solution changes.  Decalcified samples were paraffin 
processed and embedded.  Longitudinal, 5 μm-thick sections were obtained from the 
central region of the defect, slide mounted, and stained with hematoxylin & eosin (H&E) 
or Safranin-O & fast green (Saf-O). 
Mechanical Testing 
 Explanted femora were mechanically tested to failure in torsion as previously 
described (Oest et al., 2007).  Briefly, excess soft tissue was carefully dissected from 
each sample, fixation hardware was removed, and femur ends were potted in custom 
blocks with Wood’s metal (Alfa Aesar).  Potted samples were mounted in torsion fixtures 
and rotated through failure at a ramp rate of 3 °/s (Bose ELF 3200, Bose EnduraTEC).  
Rotation and torque data were recorded for each sample, from which maximum torque 
and torsional stiffness were determined.   
Data Analysis 
 All data are presented as mean ± standard error of the mean (SEM).  Data were 
analyzed using analysis of variance (ANOVA) with Tukey’s post hoc test for pairwise 
comparisons or unpaired t-tests, as appropriate.  The significance level was a p-value < 
0.05.  All data analysis was performed in Minitab 15 (Minitab, Inc.) or GraphPad Prism 5 
(GraphPad Software, Inc.).   
Results 
 All operated animals tolerated the initial surgical procedure well and returned to 
normal activity. A small number of samples were excluded from the study due to abscess 
 72 
formation at the defect, unstable fixation, or additional bone fracture (3 animals in total).  
Successful induction of ischemia was demonstrated in a separate experiment (Fig. 4.1).   
Higher BMP-2 Dose Bone Regeneration 
 At the 2 μg rhBMP-2 dose, digital 2-D radiographs displayed qualitatively similar 
bone regeneration between groups across the 2, 4, 8, and 12 week time points examined 
(Fig. 4.2A).  Overall, 11 of 13 defects in the BD group went on to bony bridging.  In the 
BD+HLI group, all 15 defects achieved bridging.   
 Interestingly, micro-CT analysis quantitatively demonstrated a significant 
increase in the amount of regenerated bone for the BD+HLI group compared to BD alone 
(Fig. 4.2B, C).  The increase was evident as early as week 4 (p < 0.01, 53% increase), and 
was sustained through week 12 (p < 0.001, 44% increase).   
Micro-CT results were further corroborated with histological analysis performed 
at week 12.  H&E stained tissue sections displayed qualitatively more robust bone 
formation in the defects of the BD+HLI group compared to BD alone (Fig. 4.3A, B).  
Bone formation at the periphery of the defect (along the nanofiber mesh) was similarly 
robust in both groups (Fig. 4.3C, F).  Differences were apparent in the central region of 
defects, however, with the BD+HLI group possessing qualitatively more bone tissue and 
less fibrous tissue (Fig. 4.3D, E, G, H).  In both groups, small pockets of alginate 
persisted at week 12.   Safranin-O staining was used to assess cartilage composition in 
repaired defects.  Small pockets of cartilage persisted in each group, but no notable 
differences between groups were observed (Fig. 4.4). 
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Figure 4.1.  Demonstration of surgically-induced hind limb ischemia at Day 0:  (A) 
Representative LDPI image of ischemic (left) and contralateral control (right) legs.  (B) 
Quantified decrease in perfusion for the entire leg as well as ROIs focused on the foot 
and thigh.  (C) Representative micro-CT angiography 3D reconstruction of ischemic (left 
leg, right image) and unoperated contralateral controls (right leg, left image).  (D & E) 
Vessel volume and morphological parameters for the upper leg VOI (D) and lower leg 
VOI (E).    (F & G) Frequency distributions of blood vessel voxel sizes for the upper leg 












Figure 4.2.  Longitudinal analysis of bone regeneration.  (A) Representative digital 
radiographs acquired at post-surgery weeks 2, 4, 8, and 12.  (B) Quantification of new 
mineral volume in the defect obtained from longitudinal in vivo micro-CT scans.  (C) 
Representative 3D reconstructions of ex vivo micro-CT scans with cross-sectional 
mineral density maps.  Native cortical bone ends have been included for reference.  Scale 
bars: Density = 2.5 – 5 1/cm, Length = 1 mm.  *: p < 0.01, **: p < 0.001.  n = 13 – 15 per 






Figure 4.3.  H&E histology of bone healing at 12 weeks.  (A,B) Mosaic images of H&E 
stained mid-defect sagittal sections from the BD (A) and BD+HLI (B) groups confirmed 
increased bone regeneration in BD+HLI group. (C-H) Higher magnification fields from 
mosaic images demonstrating more robust bone formation in BD+HLI group.  
Magnification = 4x (A,B) and 10x (C-H). Scale bars = 1 mm (A,B) and 100 μm (C-H). 






Figure 4.4.  Saf-O histology of bone healing at 12 weeks.  Both groups displayed new 
bone formation integrated with alginate hydrogel (A,C) with very few small pockets of 
cartilage (B,D).  Magnification = 10x.  Scale bars = 100 μm. Annotations: a = alginate, 
bm = bone marrow, c = cartilage, nb = new bone.   
 76 
Torsional testing to failure was used to assess functional restoration of the 
regenerated bone at week 12.  The BD+HLI group exhibited greater maximum torque 
(77% increase) and torsional stiffness (59% increase) compared to the BD group (Fig. 
4.5), but differences were not statistically significant (p = 0.214 and p = 0.434, 
respectively).  Compared to historical data of age-matched, naïve intact femur controls 
(maximum torque = 0.31 ± 0.04 N*m, torsional stiffness = 0.030 ± 0.003 N*m/deg, n = 6 
(Kolambkar et al., 2011)), the BD group achieved only 42% of maximum torque and 
77% of torsional stiffness, whereas the BD+HLI group achieved 74% of maximum 
torque and 123% of torsional stiffness. 
 
 
Figure 4.5.  Torsional testing mechanical properties of regenerated bone at 12 weeks.  
(A) Maximum torque to failure and (B) torsional stiffness.  Dashed lines indicate mean 
values for historical naïve intact controls.  n = 3-4 per group. 
 
Lower  BMP-2 Dose Bone Regeneration 
 To further investigate these findings, an experiment was conducted using a lower 
0.5 μg treatment dose of BMP-2, a dose previously demonstrated to be insufficient for 
consistent bridging (Boerckel et al., 2011).  In agreement with the findings at 2 μg dose, 
improved bone healing was observed in the BD+HLI group.  Radiograph evaluation 
determined only 2 of 4 defects in the BD group achieved bony bridging; in contrast 
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bridging was achieved in 4 of 4 BD+HLI samples (Fig. 4.6A).  Micro-CT results also 
showed an increase in regenerated bone volume in the BD+HLI group compared to BD 
alone, but did not reach statistical significance (p = 0.069 and 67% increase at week 12, 
Fig. 4.6A, B).  Torsional testing revealed additional differences between groups (Fig. 
4.6C), as the BD+HLI group displayed significantly increased maximum torque (p < 
0.05, 118% increase) and a nearly 14-fold increase in torsional stiffness (p = 0.1146, 
1382% increase).  Compared to historical data of age-matched, naïve intact femur 
controls (maximum torque = 0.31 ± 0.04 N*m, torsional stiffness = 0.030 ± 0.003 
N*m/deg, n = 6 (Kolambkar et al., 2011)), the BD group achieved only 19% of 
maximum torque and 7% of torsional stiffness, whereas the BD+HLI group achieved 
42% of maximum torque and 83% of torsional stiffness. 
Vascular Networks 
 A micro-CT angiography technique was used at week 12 to quantitatively 
evaluate vascular volume and morphology.  In the Thigh VOI (Fig. 4.7A, B), no 
differences in vessel volume or vessel volume fraction were evident between groups (Fig. 
4.7C, D), suggesting a robust neovascular recovery response and only transient ischemia.  
Morphological differences were observed, however, with a more interconnected (p < 
0.001) network of smaller diameter (p < 0.0001) vessels apparent in the BD+HLI group 
compared to BD alone (Fig. 4.7E - H).  Compared to contralateral controls, both groups 
exhibited an approximately 60% increase in vessel volume.  Both groups also showed 
increased vessel connectivity and number of vessels, with a decrease in vessel separation.  
The BD group exhibited an increase in mean vessel diameter compared to contralateral 




Figure 4.6.  Bone repair at lower 0.5 μg rhBMP-2 dose.  (A) Representative digital 
radiographs from week 12 and 3D micro-CT reconstructions with mineral density 
mapping.  (B) Quantification of new mineral volume in the defect obtained from 
longitudinal in vivo micro-CT scans.  (C) Maximum torque to failure and (D) torsional 
stiffness.  Dashed lines indicate mean values for historical naïve intact controls.  Scale 













Figure 4.7.  Thigh blood vessel volume and morphology at week 12.  (A) Illustration of 
Thigh VOI.  (B) Representative 3D micro-CT reconstructions with vessel diamater 
mapping.  (C-H) Angiography parameters in the Thigh VOI: blood vessel volume (C), 
tissue vessel volume fraction (D), connectivity density (E), mean vessel number (F), 
mean vessel lumen diameter (G), and mean vessel separation (H).  Dashed lines indicate 
mean values for contralateral controls.  Scale bars: Diameter 0 – 1 mm, Length = 5 mm.  
*: p < 0.001, **: p < 0.0001.  n = 8 per group.   
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 Voxel count histograms provided an indication of vessel size frequency 
distribution.  The BD+HLI group displayed a distribution skewed toward smaller 
diameter vessels, with an increase in vessels of luminal diameter less than ~500 μm and a 
lack of vessels with luminal diameter greater than ~1 mm in the BD+HLI group (Fig. 
4.8A).  Furthermore, while the overall vessel volume was comparable between groups, 
the contributions to vessel volume based on vessel diameter were significantly different 
between groups (Fig. 4.8B).  Specifically, the BD+HLI group had a significantly greater 
contribution from vessels with diameters of ~200-500 μm compared to BD alone (p < 
0.005) and significantly less contribution from vessels with diameter larger than ~1 mm 
(p < 0.0001).  While contributions to vessel volume were rather uniform in the BD group 
(22% - 28% across the 4 bins of analysis), 75% of vessel volume in the BD+HLI group 
came from vessels with diameter less than ~500 μm (Fig. 4.8C).   
 Analysis of the Defect VOI revealed no differences between groups in terms of 





Figure 4.8.  Thigh blood vessel diameter frequency distributions and contributions to 
vessel volume at week 12. (A) Frequency distribution of blood vessel voxel sizes from 
the Thigh VOI that give a representative distribution of blood vessel diameter.  (Inset) 
Magnification of the 0 – 494 μm bins.  (B) Contributions to blood vessel volume from 
different vessel diameter ranges.  (C) Contributions to vessel volume expressed as a 













Figure 4.9.  Bone defect blood vessel volume and morphology at week 12. (A) 
Illustration of Defect VOI.  (B) Representative 3D micro-CT reconstructions with vessel 
diameter mapping.  Side views (upper) and proximal top down views (lower) of the 
cylindrical volume are shown.  (C-H) Angiography parameters in the Defect VOI: blood 
vessel volume (C), connectivity density (D), mean vessel number (E), mean vessel lumen 
diameter (F), mean vessel separation (G), and vessel diameter frequency distribution (H).  




 The established relationships between vascular tissues and bone repair provide 
compelling motivation for new research models to advance our understanding of the 
coupling mechanisms, as well as methods to improve treatment for orthopaedic trauma 
patients with concomitant vascular insults.  Here we sought to address the specific lack of 
a small animal model of severe composite bone and vascular trauma by pairing a 
critically-sized mid-femoral defect with surgically-induced hind limb ischemia in the rat.  
Interestingly, our data did not support our original hypothesis, as recovery from transient 
HLI enhanced bone regeneration compared to bone defects without concomitant vascular 
injury.  These observations were both repeatable and robust across varying levels of 
rhBMP-2 stimulation.  Although initially unexpected, these findings are notable, and 
understanding the underlying mechanisms may have important implications for clinical 
therapeutics.   
 Bone regeneration and mechanical properties for the BD group here were 
consistent with previously published data for both the 2 μg and 0.5 μg rhBMP-2 doses 
(Boerckel et al., 2011; Kolambkar et al., 2011).  Importantly, with no treatment, or 
vehicle alone, these defects will not heal and will progress to non-union (Oest et al., 
2007; Kolambkar et al., 2011).  One of the most interesting observations here was the 
transformation of the non-healing 0.5 μg rhBMP-2 dose to a healing one with 
concomitant HLI.  In general, bone healing in the BD+HLI group was comparable with 
results historically observed in bone defects treated with higher rhBMP-2 doses (e.g., 2 
μg similar to 5 μg; 0.5 μg similar to 1 – 2.5 μg) (Boerckel et al., 2011; Kolambkar et al., 
2011).  These historical comparisons were consistent with the results here, as both bone 
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regeneration and mechanical properties for the 0.5 μg BD+HLI group were comparable 
to those of the 2 μg BD group.  This is an interesting point for future consideration given 
the high costs and incompletely understood (and at times negative) effects associated 
with current supraphysiologic doses of BMPs administered to human patients (Garrison 
et al., 2007; Cahill et al., 2009; Devine et al., 2012; Even et al., 2012).  Furthermore, the 
delivery hydrogel used here provides more prolonged growth factor release kinetics than 
the clinical gold standard for rhBMP-2 delivery (Boerckel et al., 2011; Kolambkar et al., 
2011), which may be important in allowing for crosstalk between vascular growth 
processes and bone repair.  In addition, given the wide variety of physiological processes 
that BMP-2 has been implicated in, including blood vessel growth and remodeling 
(Deckers et al., 2002; Langenfeld and Langenfeld, 2004), it is conceivable that in this 
specific model the rhBMP-2 provided an additional indirect bone healing stimulus by 
augmenting the vascular tissue response to ischemia.  A better understanding of the 
coupling mechanisms involved in the model presented here may produce new therapeutic 
strategies that would allow for lower doses of rhBMP-2 to be used in humans without 
sacrificing efficacy.   
 One potential explanation for the enhanced bone regeneration in the BD+HLI 
group is a robust endogenous vascular response to ischemia.  While the HLI surgical 
procedure was demonstrated to effectively create an initial substantial reduction in 
perfusion of the leg, it is understood from other work that this is a transient effect due 
primarily to arteriogenic growth of collateral vessels in the limb (Couffinhal et al., 1998; 
Duvall et al., 2004).  Murine models of HLI are widely used in the field of vascular 
biology and recovery from HLI induced by femoral artery ligation has been shown to be 
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background strain dependent in mice, ranging from necrosis of the limb to restoration of 
perfusion within a few days (Helisch et al., 2006).  In rat models of femoral artery 
ligation, restoration of resting perfusion appears to possess an intermediate recovery 
length, having been reported at 5 -7 days (Seifert et al., 1985; Corcoran et al., 2009).  
Deficits in reserve blood flow have longer duration, extending beyond 14 days (Corcoran 
et al., 2009), and it is unknown what influence a concomitant orthopaedic injury may 
have on the recovery time.  As evidenced by the micro-CT angiography results, blood 
vessel volume was not different between groups at week 12.  One limitation of the micro-
CT angiography technique (as with other angiography techniques), however, is an 
inability to distinguish between arterial and venous supply, perhaps obscuring important 
insights regarding vascular networks.  Vessels with luminal diameters larger than 1 mm 
are almost exclusively the femoral artery and vein (especially the latter).  This vessel size 
range exhibited significantly different contributions to vessel volume between groups 
(25% for BD, 1% for BD+HLI).  The fact that the femoral vessels were excised in the 
BD+HLI group, yet no differences in total blood vessel volume were observed, may 
suggest increased arterial blood supply to the thigh in this group.  The increases in vessel 
volume, connectivity, number of vessels, and decrease in vessel separation in each group 
compared to contralateral controls is an expected wound healing response.  Whereas the 
BD+HLI group exhibited a decrease in mean vessel lumen diameter compared to 
contralateral controls, the BD group actually exhibited an increase.  This may be 
indicative of vasodilation of vessels in this group or some degree of arteriogenesis.   
Importantly, the results presented here provide only a single snapshot of post-injury 
blood vessel growth and remodeling at the week 12 end point, and do not preclude 
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additional differences at earlier time points.  Ongoing experiments are studying vessel 
networks early in the healing process in order to provide additional insight into the 
transient response characteristics and to better interpret these results.   
 Post-injury vascular growth in this model likely occurs through a combination of 
angiogenesis and arteriogenesis.  Angiogenesis is understood to be an essential 
component to the bone healing processes (Glowacki, 1998; Carano and Filvaroff, 2003).  
Previous work has demonstrated the role of hypoxia inducible transcription factor-1α 
(HIF-1α), an angiogenic transcription factor under inhibitory control in normoxic 
conditions, in coupling angiogenesis and osteogenesis during bone repair primarily 
through a VEGF-mediated mode of action (Wan et al., 2008; Schipani et al., 2009).  The 
HLI surgery may affect tissue oxygen tension which would implicate a role for HIF-1α 
and VEGF in the results observed here. Endogenous VEGF is known to be essential in 
both intramembranous and endochondral bone healing processes, and delivery of 
exogenous VEGF has been shown to improve fracture and bone defect repair (Street et 
al., 2002).  VEGF may also up-regulate BMP-2 expression in vascular tissues via 
paracrine loops (Bouletreau et al., 2002; Matsubara et al., 2012) or act through direct 
binding with osteoblast VEGF receptors (Deckers et al., 2000; Clarkin and Gerstenfeld, 
2013). 
 Arteriogenesis offers a viable additional, if not alternative, method of augmented 
post-injury vascular growth.  In small animal models of HLI, the upper leg is thought to 
primarily undergo arteriogenic growth of collateral arteries due to increased shear stress 
experienced by arterioles as they attempt to compensate for greater blood flow demands, 
whereas the lower leg primarily experiences angiogenesis in response to hypoxia 
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(Schaper and Scholz, 2003).   This would seem to imply that although new vessel 
formation in the bone defect may be due to angiogenesis, arteriogenesis may be a more, 
relevant vascular tissue growth process in our model; however, a direct role for 
arteriogenesis in bone repair is not yet well-defined.  In agreement with this hypothesis, 
recent work from Morgan et al. demonstrated that the vascular growth associated with 
distraction osteogenesis is characterized by initial arteriogenic remodeling of vessels in 
the surrounding skeletal muscle compartment with subsequent vessel ingrowth to the 
regenerating distraction space (Morgan et al., 2012) .   
 It is also possible that HLI augments the gene expression, soluble factor 
availability, cellular populations mobilized to the injury site and surrounding areas, or 
some combination thereof.  In this way, the endogenous vascular response to HLI may 
play more of an indirect role in enhancing the bone repair process in the BD+HLI group 
as opposed to exerting a direct influence.  The extracellular matrix protein osteopontin  is 
significantly up-regulated in response to HLI (Lyle et al., 2012), plays a definitive role in 
collateral vessel development and recovery from ischemia (Duvall et al., 2008), and is 
involved in regulating several aspects of fracture healing (Duvall et al., 2007).  Other 
growth factors associated with arteriogenesis such as platelet derived growth factor, 
transforming growth factor-β, fibroblast growth factor-2  (Buschmann et al., 2003), have 
also been implicated in bone regeneration (Kempen et al., 2010), and provide additional 
means of molecular cross-talk in these processes.  At a cellular level, 
monocyte/macrophage invasion plays a significant role in collateral vessel growth 
following arterial occlusion (Arras et al., 1998).  Arteriogenic macrophages have been 
reported to be of an M2/wound-healing phenotype (Takeda et al., 2011), and 
 88 
macrophages may possess a capacity for osteoinductive signaling through BMP-2 
secretion (Champagne et al., 2002).  Through such mechanisms, activation or 
mobilization of an augmented macrophage population due to concomitant HLI may have 
had downstream effects on bone repair in our model.  Vascular smooth muscle cells 
(SMC) also play a critical cellular role in arteriogenic vessel remodeling, with phenotypic 
changes and proliferation initiating early in the process (Schaper and Scholz, 2003).  
Additionally, SMCs are considered at least partially responsible for vascular tissue 
calcification (Trion and van der Laarse, 2004), potentially in a process also involving 
macrophages (Trion and van der Laarse, 2004; Ikeda et al., 2012).  Pericytes, which are 
more commonly associated with the microvessels, may also play some role in the bone 
regeneration results observed here as a perivascular source of osteoprogenitor cells 
(Towler, 2007; Crisan et al., 2008; Caplan and Correa, 2011).   
 Consideration should also be given to the role that the surrounding skeletal 
muscle envelope plays in this model, given that at the very least it is the site of extensive 
vascular growth and remodeling.  In related work, our group recently demonstrated that 
volumetric muscle loss attenuated rhBMP-2-mediated segmental bone defect repair in a 
rat model of composite bone and skeletal muscle injury (Willett et al., 2012).  This effect 
is thought to be at least partially attributable to diminished vascular growth, but may also 
involve reduced availability of skeletal muscle resident osteoprogenitor cells and 
cytokines/growth factors involved in transmitting the necessary signaling cascades.   
 To our knowledge, the work here is the first to combine segmental bone defect 
repair with concomitant vascular injury.  Two previously published models have 
investigated fracture healing in combination with an ischemic injury.  Lu et al. found that 
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ischemia induced by femoral artery resection impaired healing of murine tibial fractures, 
with reduced blood vessels in and around ischemic leg fractures (Lu et al., 2007).  Kase 
et al. reported no differences in rat tibial fracture healing when acute 
ischemia/reperfusion was incorporated via tourniquet and microvascular clip 
application/removal (Kase et al., 1998).  The disparity in results from those two studies is 
most likely attributable to the varying degrees of ischemia induced.  The model of Lu et 
al. is most similar to our own, with the inverse bone repair findings perhaps resulting 
from the location of orthopaedic injury, and the implications this would have on the 
relevant vascular growth processes.  In our model, the bone defect is adjacent to the 
vascular injury by design in order to mimic a localized injury, whereas in the model of Lu 
et al., the fracture is further downstream of the vascular injury, perhaps producing a more 
hypoxic environment.  The other confounding factor between the models is the rhBMP-2 
delivery included here.  Interestingly, in a follow-up study, Lu et al. found that delivery 
of rhBMP-7 improved ischemic fracture healing and was associated with increased tissue 
vascularity (Lu et al., 2010).   
 Overall, our results did not validate our original hypothesis and suggest that this 
model does not recapitulate complications associated with vascular compromised clinical 
bone healing.  This is most likely due to differences in scale of human patients versus 
small animal models, and the observation that the rat HLI injury induced a robust 
vascular response and only transient limb ischemia.  However, the unexpected results of 
this study are important as they shed further light on the complex interactions between 
bone healing and vascular tissue growth.  Future work to improve understanding of the 
underlying mechanisms could provide useful insight to exploit this interaction and guide 
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development of novel therapeutic strategies for challenging clinical bone healing 
scenarios. 
 Bone repair is intimately linked to vascular growth and remodeling processes.  
Here we describe a novel model of composite tissue trauma combining a segmental bone 
defect with concomitant vascular injury.  Contrary to our original hypothesis, our results 
demonstrated that the recovery response to HLI significantly enhanced BMP-2-mediated 
segmental bone defect repair in this model.  Despite a robust neovascular response in the 
thigh of the group with HLI, differences were not observed between groups for bone 
defect blood vessel volume and morphology.  These results suggest additional 
mechanisms of interaction beyond the direct vascular response, perhaps inclusive of 
augmented cellular exchange, gene expression, soluble factor availability, or some 
combination thereof.  In sum, the work presented here provides additional complexity to 
the relationship between vascular tissues and bone healing, and a better understanding of 





EARLY VASCULAR GROWTH AND GENE EXPRESSION IN BMP-
2-MEDIATED SEGMENTAL BONE DEFECT REPAIR WITH OR 
WITHOUT CONCOMITANT HIND LIMB ISCHEMIA 
Abstract 
Bone repair involves a highly coordinated orchestration of complex physiological 
processes, with growth of vascular networks and initiation of biological signaling 
cascades serving as critical early events.  Previously, our group reported the interesting 
results of enhanced rhBMP-2-mediated bone regeneration in a rat composite injury model 
where a critically-sized 8 mm mid-femoral bone defect was combined with surgically-
induced hind limb ischemia (BD+HLI) compared to the bone defect alone (BD).  To 
explain these findings, we hypothesized that inclusion of HLI had coupled to the bone 
repair process by way of an augmented vascular tissue growth response or perturbed 
signaling cascades initiated in the bone defect region or surrounding skeletal muscle 
envelope.  Laser Doppler perfusion imaging and micro-CT angiography data 
demonstrated a robust neovascular growth response rapidly initiated in the thigh of the 
BD+HLI group; however, ingrowth of blood vessels at the bone defect did not differ 
significantly between groups, indicating that HLI does not augment vascularization at the 
site of bone regeneration.  Using qRT-PCR analysis, the expression of a panel of genes 
related to osteogenesis, vascular growth, and inflammation was investigated in the bone 
defect and the adjacent adductor muscle tissue.  While multiple genes were upregulated 
compared to naïve control tissue in both the bone defect and the adductor muscle, only 
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minor differences in gene expression were observed between the BD and BD+HLI 
groups.  Thus, the stimulatory effects of HLI on bone regeneration cannot be explained 
by gene expression alone for the genes and time points investigated here.  In total, the 
work here provides important new insights on early vascular growth and gene expression 
in segmental bone defect models, but does not completely explain how recovery from 
HLI enhances bone regeneration.  Additional future work to further elucidate 
mechanisms coupling the HLI response with bone repair may reveal important new 
strategies for promoting bone healing in challenging clinical scenarios.   
Introduction 
 Vascular network growth and biological signaling cascades are critical early 
events in the progression of bone repair.  Complex biological processes, beginning with 
the initial injury, inflammation, and hematoma formation, are orchestrated by a variety of 
inflammatory signaling molecules, growth and differentiation morphogens, and 
extracellular matrix proteins (Mehta et al., 2012).   Invading inflammatory cell types 
involved in hematoma formation are inclusive of polymorphonuclear cells, platelets, 
macrophages, and lymphocytes that coordinate and secrete a variety of cytokines and 
growth factors necessary for the initiating the proper cascade of morphogenetic events.  
Such factors include tumor necrosis factor-α (TNF-α), interleukins-1 and -6 (IL-1 and IL-
6), receptor activator of nuclear factor kappa-B ligand (RANKL), macrophage colony 
stimulating factor (M-CSF), and multiple chemokines including monocyte chemotactic 
protein-1 (MCP-1/CCL-2) (Mountziaris and Mikos, 2008; Kolar et al., 2010; Pape et al., 
2010).  Additional secreted signaling molecules such as member of the transforming 
growth factor-β (TGF-β), bone morphogenetic protein (BMP), platelet derived growth 
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factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor 
(FGF), insulin-like growth factor (IGF) and matrix metalloproteinase (MMP) families 
will then facilitate the ongoing mediation of inflammation, promote vascular growth, and 
initiate the recruitment of osteoprogenitors and uncommitted mesenchymal stem cells 
that will actively participate in bone repair  (Gerstenfeld et al., 2003; Schindeler et al., 
2008; Mehta et al., 2012). 
 Angiogenic blood vessel ingrowth is a subsequent and necessary component in 
bone healing, initiating within the first few weeks of the repair process and continuing 
through resolution of callus remodeling (Glowacki, 1998; Carano and Filvaroff, 2003).   
Furthermore, targeted disruption of angiogenesis is known to impair bone healing 
through both the endochondral and intramembranous repair pathways (Hausman et al., 
2001; Street et al., 2002).  Given the significance of vascular support networks in bone 
healing outcomes, extremity trauma involving significant skeletal injuries and 
concomitant insults to the surrounding vasculature presents unique and significant 
complications for clinical management (Nauth et al., 2011).  Tissue engineering and 
regenerative medicine represent potential solutions for the current unmet clinical needs of 
reconstruction; however, bone tissue engineering strategies have yet to overcome the 
status quo limitations of poor vascularization (Muschler et al., 2004; Kanczler and 
Oreffo, 2008).   
 In addition to angiogenesis, arteriogenesis – the development of collateral vessels 
via the growth and remodeling of preexisting arterioles – may play a role in bone healing.  
Recently, it was reported that arteriogenesis in the surrounding skeletal muscle precedes 
angiogenesis at the site of distraction osteogenesis bone repair (Morgan et al., 2012).  
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Yet, the degree to which arteriogenesis might influence bone repair, directly or indirectly, 
remains unclear.  In animal models of hind limb ischemia (HLI), arteriogenesis is the 
primary vascular growth process by which tissue blood perfusion is restored (Scholz et 
al., 2002; Schaper and Scholz, 2003).  Arteriogenesis is an inflammation driven process, 
brought about by an increase in fluid shear stress that results in an “activated” 
endothelium, prompting the production of endothelial nitric oxide synthase (eNOS) and 
MCP-1, as well as upregulation of endothelial cell adhesion molecules (Scholz et al., 
2000; Cai and Schaper, 2008).  These signals combine to promote circulating monocyte 
extravasation into the vessel wall which initiates remodeling.  Although 
monocytes/macrophages are required for the initiation of remodeling, vascular smooth 
muscle cells (VSMCs) perform most of the work load of arteriogenesis.  While the key 
cellular mediators of arteriogenesis are known, to date, no growth factors have been 
identified as possessing an essential regulatory function, although the CSF, FGF, PDGF, 
and angiopoietin (ANG) signaling axes are thought to have potential roles (Cao et al., 
2003; Deindl et al., 2003; Schaper and Scholz, 2003; Tressel et al., 2008) 
 In Aim II of this thesis, we developed a novel composite tissue injury model of 
severe bone and vascular trauma in the rat to better understand experimentally the 
complex interactions between vascular tissue growth and segmental bone defect repair 
(Uhrig et al., 2013).  The model consisted of a critically-sized 8 mm mid-femoral bone 
defect in combination with surgically-induced hind limb ischemia.  Interestingly, we 
observed enhanced bone regeneration in the group with HLI compared to the bone defect 
alone.  We hypothesized that inclusion of HLI had coupled to the bone repair process by 
way of an augmented vascular tissue growth response or perturbed signaling cascades 
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initiated in the bone defect region or surrounding skeletal muscle envelope.  The aim of 
the present work was to begin to test this hypothesis by characterizing early 
spatiotemporal changes in blood flow and vascular tissue growth, as well as gene 
expression within the bone defect and adjacent adductor muscle tissues. 
Materials and Methods 
Experimental Design 
 Thirteen-week-old female SASCO Sprague-Dawley rats (Charles River 
Laboratories) were designated for one of two surgical injury model groups: 8 mm mid-
femoral bone defects alone (BD) or in combination with hind limb ischemia (BD+HLI).  
Each bone defect received a 2 μg rhBMP-2 treatment dose delivered in a hybrid 
nanofiber mesh and RGD-modified alginate hydrogel system previously described 
(Kolambkar et al., 2011).  This dose was chosen as it was known to produce consistent 
bridging of defects in the bone defect model (Boerckel et al., 2011), was previously used 
for investigating long-term bone repair in the composite bone and vascular injury model 
(Uhrig et al., 2013), and was unlikely to be high enough to overwhelm any effects of 
HLI.  In some experiments a third group was included in which an additional set of 
BD+HLI rats were treated with alginate containing no rhBMP-2 (BD+HLI Blank).  All 
procedures were reviewed and approved by the Georgia Institute of Technology 
Institutional Animal Care and Use Committee and the United States Army Medical 
Research and Materiel Command Animal Care and Use Review Office. 
Surgical Procedure 
 96 
 Animals were anesthetized via isoflurane inhalation and received unilateral 
surgeries to the left hind limb.  The bone defect surgery and fixation was performed as 
described previously (Oest et al., 2007).  Briefly, a critically-sized 8 mm bone defect was 
created in the mid-diaphysis of the femur and stabilized by custom-made modular 
internal fixation plates with the use of miniature screws.  The hind limb ischemia 
technique was adapted from methods previously described for mouse models (Couffinhal 
et al., 1998; Duvall et al., 2004), and was performed as previously described (Uhrig et 
al., 2013).  Briefly, the femoral artery and vein (spanning from the inguinal ligament to 
the popliteal bifurcation) were dissected free from associated nerves, ligated with 6-0 silk 
suture, and excised.   Each bone defect was treated with a hybrid nanofiber mesh and 
RGD-modified alginate hydrogel rhBMP-2 delivery system previously described 
(Kolambkar et al., 2011).  A perforated, tubular electrospun nanofiber mesh was placed 
into the defect region such that it enveloped the cut ends of native bone.  A 150 μL 
volume of rhBMP-2-containing functionalized alginate hydrogel was then injected into 
the defect space (lumen of the nanofiber mesh).  The rhBMP-2 treatment dose was 2 μg 
per defect, except in the case of the blank group where the injected alginate hydrogel 
contained no rhBMP-2.  Subcutaneous injections of a sustained-release formulation of 
buprenorphine (ZooPharm) were given for post-op analgesia (Foley et al., 2011).  
Animals were allowed access to food and water ad libitum, housed in a temperature and 
humidity controlled environment, and maintained on a 12:12 hour light/dark cycle.   
Laser Doppler Perfusion Imaging 
 Laser Doppler perfusion imaging (LDPI) was used to assess blood flow to the 
hind limb immediately prior to surgery and at post-surgery days 1, 3, 7, and 14 (n = 5-17 
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per group per time point).  Anesthetized animals were shaved of hair on both legs, placed 
on a heating pad, and imaged (moorLDI2-IR-HR, Moor Instruments).  A prone position 
was used for imaging of the foot pad, and in a supine position for imaging of the leg.  
Regions of interest (ROI) analyzed were the footpad, the entire leg, and a focal adductor 
muscle region.  To control for possible effects of ambient temperature and lighting, each 
data point was expressed in terms of blood flow in the operated limb as percentage of the 
contralateral control limb.  Age-matched, unoperated control animals were also included 
(n = 4 per group per time point).   
Radiography 
 Digital 2-D radiographs (Faxitron MX-20 Digital, Faxitron X-ray Corp.) were 
used for qualitative in vivo assessment of bone regeneration.  Radiograph acquisition 
settings were 15 s exposure time at 25 kV.   
Micro-CT Angiography 
 Contrast agent-enhanced micro-CT angiography was used to quantitatively 
evaluate hind limb vasculature at post-surgery day 3, 7, and 14 time points (n = 3-5 per 
group per time point except BD+HLI at day 3 where n = 2).  The technique has been 
previously described in detail elsewhere (Duvall et al., 2004; Boerckel et al., 2011).  
Briefly, the vasculature was cleared with physiological saline containing 0.4% papaverine 
hydrochloride (Sigma-Aldrich), perfusion fixed with 10% neutral buffered formalin, 
rinsed again with physiological saline, and finally injected with a lead chromate-based 
radiopaque contrast agent (2 parts Microfil MV-122 : 1 part diluent, Flow Tech).  
Samples were stored at 4 °C overnight to allow for polymerization of the contrast agent.  
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Hind limbs were excised and decalcified (Cal-Ex II, Fisher Scientific) over a period of 2-
3 weeks under gentle agitation with routine solution changes.      
  Samples were oriented with the femur along the z-axis for micro-CT scanning 
(vivaCT 40, Scanco Medical).  Two sets of scans and VOIs were used in this analysis.  
Initial scans were performed on the upper leg with an applied electric potential of 55 
kVp, a current of 109 μA, and an isometric voxel size of 38 μm.  The VOI for the initial 
set of scans consisted of the entirety of the cross-section of the leg spanning between the 
metal fixation plate components (Thigh VOI, refer to Fig. 5.5C for illustration).  A 
second set of higher resolution scans focused on the defect region was performed with an 
isometric voxel size of 21 μm.  The VOI for the second set of scans consisted of a 
cylindrical volume 7 mm in diameter that spanned the center 7 mm length of the bone 
defect (Defect VOI, refer to Fig. 5.7C for illustration).  The 7 mm diameter used for the 
Defect VOI was inclusive of the 5 mm diameter of nanofiber mesh and the immediately 
adjacent tissue extending 1 mm radially.  A global threshold was applied for 
segmentation of vasculature and a Gaussian low-pass filter was used for noise 
suppression (σ = 0.8 and support = 1).   
Histology 
 Samples designated for histology (n = 1-2 per group per time point) were fixed in 
10% neutral buffered formalin for 48 h at 4 °C and then decalcified (19% EDTA) over a 
period of 2 weeks under gentle agitation with routine solution changes.  Decalcified 
samples were paraffin processed and embedded.  Longitudinal, 5 μm-thick sections were 
obtained from the central region of the defect, slide mounted, and stained with 
hematoxylin & eosin (H&E) or Safranin-O & Fast Green (Saf-O). 
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Quantiative Real-Time Reverse Transcription Polymerase Chain Reaction 
 Gene expression analysis was performed for post-surgery days 7, 14, and 21(n = 
3-6 per group per time point) using quantitative real-time reverse transcription 
polymerase chain reaction (qRT-PCR).  A detailed protocol can be found in Appendix 
A.4.  Tissue samples were harvested from the bone defect region (tissue contained within 
nanofiber mesh) and adductor muscles using instruments cleaned with RNaseZap 
(Sigma-Aldrich) and were immediately placed in RNAlater reagent (Ambion).  Samples 
were stored overnight at 4 °C and then transferred to -20 °C storage until RNA isolation.  
Purified RNA was obtained from homogenized tissue samples using the RNeasy Mini Kit 
(Qiagen) by following the manufacturer’s protocol for fibrous tissues with two minor 
modifications: 1) homogenized samples were incubated in lysis buffer for 5 min at room 
temperature prior to proceeding with proteinase K incubation and 2) following proteinase 
K incubation, samples were transferred to QIAshredder columns (Qiagen) for 
centrifugation.  Concentration and purity of RNA samples were determined by 
spectrophotometry (NanoDrop 1000, Thermo Scientific). 
 Synthesis of cDNA samples was performed from 500 ng of total RNA using RT
2
 
First Strand Kits (SABiosciences) according to manufacturer’s instructions.  Preliminary 
gene expression data was generated using commercially available rat-specific pathway-
focused microarrays for osteogenesis and inflammatory cytokines & receptors 
(SABiosciences) on a MyiQ real-time PCR cycler (Bio-Rad).  Gene expression of a 
selected panel of genes (Table 5.1) was then investigated using custom designed arrays 
(SABiosciences).  Expression of each gene of interest was normalized to endogenous 
controls hypoxanthine phosphoribosyltransferase 1 (Hprt1) and ribosomal protein, large, 
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P1 (Rplp1) which were empirically selected based on their stability of expression in 
prelimary data.  Gene expression was then normalized to control tissue from unoperated 
animals (femur bone and adductor muscles) using the ΔΔCt method.  RNA quality 
control was performed to test for RNA integrity, inhibitors of reverse transcription, PCR 
amplification, and DNA contamination.  Consistency of Ct values was verified by 
performing linear regression on a scatter plot of technical replicates.  The fitted line had a 
slope of 1.01 and an r
2
 value of 0.97.   
 
Table 5.1.  Genes selected for custom qRT-PCR arrays 
Gene Symbol Full Name Refseq # 
Opn (Spp1) Osteopontin NM_012881 
Col1a1 Collagen, type I, alpha 1 NM_053304 
Runx2 (Cbfa1) Runt-related transcription factor 2 NM_053470 
Osx (Sp7) Osterix NM_181374 
Rankl (Tnfsf11) Receptor activator of nuclear factor kappa-B ligand NM_057149 
Bmp2 Bone morphogenetic protein 2 NM_017178 
Pdgfb Platelet-derived growth factor beta polypeptide  NM_031524 
Igf1 Insulin-like growth factor 1 NM_178866 
Vegfa Vascular endothelial growth factor A NM_031836 
Vegfr2 (Kdr) Vascular endothelial growth factor receptor 2 NM_013062 
Fgfr1 Fibroblast growth factor receptor 1 NM_024146 
Fgfr2 Fibroblast growth factor receptor 2 NM_001109892 
Acta2  Smooth muscle alpha-actin NM_031004 
Mmp9 Matrix metallopeptidase 9 NM_031055 
Ccl2 (Mcp1) Chemokine (C-C motif) ligand 2 NM_031530 
Cd163 CD163 molecule NM_001107887 
Ccr7 Chemokine (C-C motif) receptor 7 NM_199489 
Cxcl5 Chemokine (C-X-C motif) ligand 5 NM_022214 
Cxcl10 (Ip10) Chemokine (C-X-C motif) ligand 10 NM_139089 
Hprt1 Hypoxanthine phosphoribosyltransferase 1 NM_012583 





 All data are presented as mean ± standard error of the mean (SEM).  Data were 
analyzed using two-factor analysis of variance (ANOVA) with Tukey’s post hoc test for 
pairwise comparisons as appropriate.  Gene expression data was transformed using Box-
Cox methodology prior to statistical analysis (Box and Cox, 1964).  The significance 
level was a p-value < 0.05.  All data analysis was performed in Minitab 15 (Minitab, Inc.) 
or GraphPad Prism 5 (GraphPad Software, Inc.).   
Results 
 All operated animals tolerated the initial surgical procedure well and returned to 
normal activity following surgery.   
Early Bone Regeneration 
 Histological evaluation of bone regeneration at early time points supported our 
previously reported results (Uhrig et al., 2013) that bone formation was enhanced in the 
BD+HLI group compared to BD alone.  At day 7, no bone formation was observed 
within the defect for either group, but new bone had begun forming on the outside of the 
nanofiber mesh in the BD+HLI group (Fig. 5.1A, D).  By day 14, new bone formation 
was evident in both groups along the outside of the nanofiber mesh, and in some 
perforations in the BD+HLI group (Fig. 5.1B, E).  Within the defect, small pockets of 
chondrocytes were also found for both groups.  By day 28, new bone was forming 
throughout the defect in both groups (Fig. 5.1C, F), but appeared qualitatively more 











Figure 5.1. Histological evaluation of early bone regeneration.  Micrographs of H&E 
stained sections showing progression of bone regeneration demonstrated enhanced 
regeneration in BD+HLI group.  At day 7, no bone formation was observed within the 
defect for either group, but new bone had begun forming on the outside of the nanofiber 
mesh in the BD+HLI group (A,D).  By day 14, new bone formation was evident in both 
groups along the outside of the nanofiber mesh, and in some perforations in the BD+HLI 
group (B,E).  By day 28, new bone was forming throughout the defect in both groups 
(C,F), but appeared qualitatively more robust in the BD+HLI group, an observation 
supported by radiographs (Insets).  Annotations: a=alginate, hc=hypertrophic 
chondrocytes, nb=new bone, nfm=nanofiber mesh, v=blood vessel. Scale bar=100μm. 
Images acquired at 10X. 
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Early Vascular Response 
 LDPI was used to evaluate blood perfusion in multiple ROIs following surgery.  
A sustained impairment of distal perfusion was observed in the foot pad of the operated 
limb in the BD+HLI group, with significantly reduced blood flow compared to the BD 
group at all time points investigated (p < 0.0001 for all time points).  Initially reduced to 
15% of the contralateral leg at day 1, a gradual increase in perfusion was evident for the 
BD+HLI group, but by day 14, foot pad perfusion had still only achieved 42% of the 
contralateral limb (Fig. 5.2).  When examining the ROI encompassing the whole leg, the 
BD+HLI group displayed a significant reduction in perfusion at day 1compared to 
controls (p < 0.05, 55% of contralateral leg) but had recovered to 82% by day 3, a level 
that was no longer statistically significant.  The BD group displayed gradually increasing 
perfusion as early as day 1 and peaking with a significant increase over naïve controls at 
day 7 (p < 0.01, 145% of contralateral leg).  Perfusion in the BD+HLI group was 
significantly less than the BD group at all post-surgery time points for the leg ROI (Fig. 
5.3 A, B).  When evaluating an ROI focused on the adductor region of the legs, however, 
the BD+HLI group displayed a significant increase in perfusion compared to both the BD 
group and naïve controls at all post-surgery time points.  Conversely, no change in 
adductor region perfusion was observed in the BD group compared to naïve controls (Fig. 
5.3A, C).  Additionally, no differences in perfusion were observed between the BD+HLI 
















Figure 5.2. LDPI footpad analysis for BD and BD+HLI groups.  (A) Representative 
images show the time course of changes in distal limb perfusion.  (B) Quantitative 
analysis of footpad perfusion in the operated limb as a percent of the unoperated 






Figure 5.3. LDPI leg and adductor analysis for BD, BD+HLI, and naïve controls.  (A) 
Representative images show the time course of changes in perfusion.  (B) Quantitative 
analysis of perfusion in the operated limb as a percent of the unoperated contralateral 
limb using an ROI encompassing the whole leg.  (C) Quantitative analysis of adductor 
perfusion in the operated limb as a percent of the unoperated contralateral limb.  *p < 
0.05 for BD vs. BD+HLI.  **p < 0.01 for BD vs. BD+HLI.  ***p < 0.001 for BD vs. 
BD+HLI.  
#
p < 0.05 vs. control.  
##
p < 0.01 vs. control.  
###
p < 0.001 vs. control.  n = 5-17 
per group per time point except controls where n = 4.   
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Figure 5.4. LDPI leg and adductor analysis for BD+HLI, BD+HLI Blank, and naïve 
controls.  
#
p < 0.05 for both BD+HLI and BD+HLI Blank vs. Control. n = 5-17 per group 
per time point except controls where n = 4.   
 
 Micro-CT angiography was used to quantitatively evaluate vascular volume and 
morphology at days 3, 7, and 14 post-surgery.  Collateral vessel formation in the adductor 
muscle tissue was evident in the BD+HLI group as early as day 3 as evidenced by newly 
identifiable, tortuous vessels (Fig. 5.5A, B).  Vascular growth was observed in both 
groups with increased vessel volume in the Thigh VOI of the operated legs compared to 
contralateral legs at all time points.  Despite the loss of the conduit femoral artery and 
vein, the BD+HLI group had a greater normalized blood vessel volume compared to BD 
alone at all 3 time points, and a statistically significant difference between these two 
groups (p < 0.05) was found in two-factor ANOVA analysis of the data (Fig 5.5C).  
Morphological parameters showed similar vessel connectivity, mean vessel number and 
mean vessel separation between groups; however, the BD+HLI group had a significant 
reduction in mean vessel thickness and was significantly more isotropic in orientation (p 
< 0.01, Fig. 5.6). Analysis of the Defect VOI showed similar vascular growth and 
morphology between groups.  In both groups, vessel volume increased over time (Fig. 
5.7), as did connectivity density, mean vessel number, and mean vessel thickness, with 
mean vessel separation and degree of anisotropy decreasing over time (Fig.5.8).   
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Figure 5.5. Micro-CT angiography analysis of the thigh vascular volume.  (A) 
Representative scout view radiographs at each time point investigated.  Arrows indicate 
collateral vessels.  (B) Representative 3D micro-CT vessel reconstructions with vessel 
diameter mapping.  Scale bars: diameter = 0-1mm, length = 5mm.  (C) Quantification of 
vessel volume in the thigh of the operated limb normalized to the unoperated 















Figure 5.6. Micro-CT angiography analysis of thigh vasculature morphometry.  *p<0.05 









Figure 5.7. Micro-CT angiography analysis of the defect vascular volume.  (A) 
Representative 3D micro-CT vessel reconstructions.  Scale bar = 5mm.  (B) 
Quantification of vessel volume in the defect.  n = 3-5 per group per time point except 













Figure 5.8. Micro-CT angiography analysis of defect vascular morphometry.  n = 3-5 per 
group per time point except BD+HLI at day 3 where n = 2.   
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 Histological analysis at days 7, 14, and 28 revealed notable phases in vascular 
ingrowth at the defect site.  Quantitative angiography data from the Defect VOI was 
supported by histology as the vascular response progressed similarly between the BD and 
BD+HLI groups in the defect region and surrounding tissue.  At day 7, the defect was 
heavily populated by erythrocytes (Fig 5.9A, D), with no clearly identifiable blood 
vessels within the defect space and sparse vessels along the exterior of the nanofiber 
mesh. More vessels were evident in the tissue adjacent to nanofiber mesh by day 14 (Fig. 
5.9B, E).  Vessels were found entering the nanofiber mesh at perforations and in 
proximity to new bone forming in the defect by day 28 (Fig. 5.9C, F). 
 
 
Figure 5.9. Histological evaluation of early vascular growth in the bone defect.  
Micrographs of H&E stained sections showed similar progression of vessel growth in 
both groups.  At day 7, the defect was heavily populated by erythrocytes (A,D), with no 
clearly identifiable blood vessels within the defect space and sparse vessels along the 
exterior of the nanofiber mesh. More vessels were evident in the tissue adjacent to 
nanofiber mesh by day 14 (B,E).  Vessels were found entering the nanofiber mesh at 
perforations and in proximity to new bone forming in the defect by day 28 (C,F) 
Annotations: a=alginate, nb=new bone, v=blood vessel. Scale bar=100μm. Images 
acquired at 10X. 
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Early Gene Expression in the Bone Defect Region 
 The time course of mRNA expression in the bone defect space was evaluated for 
19 genes of interest using qRT-PCR.  Interestingly, although expression of several of the  
genes investigated changed significantly over time and compared to control tissue, at no 
time point was there statistically significant differential mRNA expression between the 
BD and BD+HLI groups.  Expression of Opn was highly upregulated at all time points 
for all groups, achieving its highest level for  rhBMP-2 treated groups at day 7 with a 
~60-fold increase, but never falling below a ~30-fold increase at later time points (Fig. 
5.10A).  Multiple genes associated with osteogenesis displayed increasing expression 
profiles from day 7 through day 21 for rhBMP-2 treated groups, including Col1a1, 
Runx2, Osx, Bmp2, and Rankl (Fig. 5.10B-F).   By day 14, Col1a1 expression was 
upregulated ~10-fold compared to controls in both the BD and BD+HLI group, and went 
on to even higher levels by day 21 (Fig. 5.10B).  In groups receiving rhBMP-2, both Osx 
and Runx2 expression was increased compared to controls, but the fold increases for Osx 
expression (~6-fold at day 14 and ~7- to 9-fold at day 21) were greater than those for 
Runx2 (~2-fold at day 14 and ~3-fold at day 21) at the same time points (Fig. 5.10C, D).  
At day 7, expression of Bmp2 was below control levels for both BD and BD+HLI groups, 
then steadily climbed to a ~3- to 4-fold upregulation by day 21 (Fig. 5.10E).  Expression 
of Rankl was significantly increased at all time points for both rhBMP-2 treated groups 
compared to controls, showing ~5-fold upregulation at day 7 and reaching greater than 
10-fold upregulation by day 21 (Fig. 5.10F).  The temporal changes in expression of 
osteogenesis-related genes showed stark contrast in groups treated with rhBMP-2 
compared to the group treated with blank alginate, especially for Runx2, Osx, Bmp2, and 
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Rankl where mRNA levels in the blank alginate group were significantly lower than 
rhBMP-2 treated groups and rarely above the 1-fold control tissue expression level (Fig. 
5.10C-F).   
 Expression of Igf1 and Pdgfb steadily increased in all groups from levels observed 
at day 7 (Fig. 5.10G, H).  Whereas expression of Vegfa did not differ significantly over 
control levels for any group at any time point (Fig. 5.10I), Vegfr2 mRNA expression 
increased from day 7 through day 21, reaching a significant increase compared to 
controls at day 21 (Fig. 5.10J).   Both Fgfr1 and Fgfr2 showed increasing expression over 
time from their levels at day 7; however, while Fgfr1 displayed greater fold changes 
relative to controls (Fig. 5.10K), Fgfr2 showed more pronounced differences with 
rhBMP-2 treatment (Fig. 5.10L).  Expression of Acta2 was highly upregulated in all 
groups, with differing profiles (Fig. 5.10M).  For the BD group, Acta2 expression was 
highest at day 7 (~15-fold upregulation) before reducing to roughly half that level at day 
14 (~8-fold upregulation) and remaining relatively constant between days 14 and 21 (Fig. 
5.10M).  The BD+HLI group exhibited a similar ~16-fold upregulation in Acta2 at day 7 
that was sustained through day 14 before falling to ~8-fold expression at day 21 (Fig. 
5.10M).  The blank group showed a temporal delay in maximum Acta2 expression, 
possessing a ~7-fold upregulation at day 7 before going on to a ~20-fold upregulation at 
day 14 (Fig. 5.10M).  In rhBMP-2 treated groups, expression of Mmp9 increased over 
time, achieving a ~ 15-fold upregulation by day 21 while expression remained relatively 
unchanged in the blank group compared to controls (Fig. 5.10N).   
 A significant increase in expression of Ccl2 mRNA was observed in all groups at 
all time points, but showed a decreasing profile from day 7 to day 21 (Fig. 5.10O).  Also, 
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upregulation of Ccl2 was less intense in rhBMP-2 treated groups compared to the blank 
alginate group (Fig. 5.10O).  Expression of Cd163 was increasing from levels at day 7 in 
all groups, but was downregulated at all time points compared to control levels (Fig. 
5.10P).  Expression of Ccr7 was upregulated at least 2-fold at all time points, but was 
highest at day 7 in rhBMP-2 treated groups, whereas the blank alginate group showed 
highest expression at day 14 (Fig. 5.10Q).  In all groups, expression of Cxcl5 was highest 
at day 14 (Fig. 5.10R).  At all time points, Cxcl10 expression was elevated compared to 
controls, achieving statistical significance for all groups at days 14 and 21 (Fig. 5.10S).   
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Figure 5.10.  Bone defect gene expression analysis.  Fold regulation normalized to levels 
in control tissue is shown for all genes investigated.  *p < 0.05 vs. Control.  
#
p < 0.05 as 
indicated.  n = 3-6 per group per time point.   
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Early Gene Expression in the Adductor Muscle Tissue 
 Temporal changes in mRNA expression were also evaluated in the adductor 
muscles of the leg.  Again, Opn expression was highest at day 7, with greater than 100-
fold upregulation in all groups, before falling precipitously by day 14 to more modest 
levels on the order of 10-fold upregulation (Fig. 5.11A).  Day 7 expression levels did 
appear slightly higher in groups with HLI compared to the BD group, but the differences 
were not statistically significant.  Expression of Col1a1 was significantly upregulated 
over controls in all groups at day 7 (~10- to 15-fold), but expression profiles differed 
between groups at later time points (Fig. 5.11B).  While Col1a1 expression remained 
elevated in the BD group through day 14 before falling at day 21, the BD+HLI group 
experienced a marked drop at day 14 (statistically lower expression compared to the BD 
group) before returning to a significantly elevated level at day 21 (Fig. 5.11B).  In the 
blank alginate group, Col1a1 expression fell from day 7 to day 14, but remained 
significantly higher than controls (Fig. 5.11B).  Expression of Runx2 mRNA was 
elevated at day 7, but afterward decreased over time (Fig. 5.11C).  Other osteogenesis 
related genes Osx, Bmp2, and Rankl were relatively unchanged over time compared to 
control levels (Fig. 5.11D-F).   
 At day 7, expression of Igf1 was upregulated ~2- to 3-fold in all groups, and 
remained at similar levels through day 21 (Fig. 5.11G).  Both Pdgfb and Vegfa mRNA 
expression initially fell to levels below controls for all groups at day 7, but showed 
increased expression thereafter achieving ~2-fold upregulation by day 21 (Fig. 5.11H,I).  
Expression of Vegfr2 remained relatively unchanged through day 14 compared to 
controls before reaching a ~3- to 4-fold upregulation at day 21 (Fig. 5.11J).  Similar 
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expression profiles were also observed for Fgfr1, Fgfr2, and Acta2 (Fig. 5.11K-M), but 
more modest 2- to 3-fold upregulation was observed for Fgfr1 and Fgfr2 at day 21.  
Expression of Mmp9 was upregulated in all groups at day 7, but was increased more in 
BD and BD+HLI groups (~21-fold and ~35-fold, respectively) than the blank alginate 
group (~6-fold).  By day 14, Mmp9 expression had fallen substantially and was similar to 
controls or upregulated on the order of ~2- to 3-fold (Fig. 5.11N).   
 At all time points, Ccl2 expression was elevated to at least 2-fold upregulation in 
all groups, but expression profiles differed between groups (Fig. 5.11O).  In the BD 
group, the ~3-fold upregulation at day 7 climbed to ~7-fold at day 14 before falling back 
to 2-fold at day 21.  In the BD+HLI group, a relatively consistent ~2- to 4-fold 
upregulation was sustained through all time points.  The highest Ccl2 expression was 
observed in the blank alginate group, where a 23-fold upregulation at day 7 (significantly 
increased compared to both rhBMP-2 treated groups) fell to 2.5-fold by day 14 (Fig. 
5.11O).  Expression profiles for Cd163 and Ccr7 also differed between groups.  The BD 
group displayed a relatively consistent ~2-fold upregulation in Cd163 across all time 
points, whereas the BD+HLI group showed more modest upregulation at days 7 and 14 
before reaching its highest expression with a 3-fold upregulation at day 21 (Fig. 5.11P).  
Expression of Ccr7 in the BD group was upregulated 3-fold at day 7, then achieved its 
highest expression with ~11-fold upregulation at day 14 before returning to a 3-fold 
upregulation at day 21, while the BD+HLI group sustained a ~5- to 6-fold upregulation at 
days 7 and 14 before increasing to a 11-fold upregulation at day 21 (Fig. 5.11Q).  In the 
blank alginate group, expression of both Cd163 and Ccr7 was highest at day 7 and 
elevated at this time point compared to rhBMP-2 treated groups, but dropped 
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considerably by day 14 (Fig. 5.11P,Q).  Only modest changes in Cxcl5 mRNA 
expression were observed over time for all groups, never rising above a 2-fold 
upregulation (Fig. 5.11R).  The BD group exhibited slightly higher upregulation of 
Cxcl10 than the BD+HLI group at all time points, but the highest expression was 
observed in the blank alginate group at day 7 (~20-fold upregulation) before returning to 
control levels by day 14 (Fig. 5.11S).  
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Figure 5.11.  Adductor muscle gene expression analysis.  Fold regulation normalized to 
levels in control tissue is shown for all genes investigated.  *p < 0.05 vs. Control.  
#
p < 
0.05 as indicated.  n = 3-6 per group per time point.   
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Discussion 
 Bone repair involves a highly coordinated orchestration of complex physiological 
processes, with vascular network growth and initiation of biological signaling cascades 
functioning as critical early events.  In Aim II of this thesis, enhanced rhBMP-2-mediated 
bone regeneration was observed for segmental bone defects with concomitant hind limb 
ischemia in a rat composite injury model (Uhrig et al., 2013).  As an explanation for 
these findings, we hypothesized that inclusion of HLI stimulated the bone repair process 
by way of an augmented vascular tissue growth response or perturbed signaling cascades 
initiated in the bone defect region or surrounding skeletal muscle envelope.  Here we 
began to test this hypothesis by investigating early spatiotemporal changes in blood flow 
and vascular tissue growth, as well as gene expression within the bone defect and 
adjacent adductor muscle tissues.  Based on the results obtained, we were able to draw 
multiple conclusions in relation to our hypothesis.  While HLI produced sustained 
reduction in perfusion to the distal limb, it also promoted increased vascular growth in 
the upper leg.  Despite the enhanced vascular growth in the skeletal muscle, blood vessel 
growth into the regenerating defect was not affected by HLI at the time points 
investigated.  Therefore, any effects of ischemia-induced vascular growth on bone 
regeneration appear to be indirect ones.  Finally, the stimulatory effects of ischemia on 
bone regeneration cannot be explained by changes in gene expression alone, and delivery 
of 2 μg rhBMP-2 does not appear to strongly influence gene expression in the adductor 
muscle tissue for the genes and time points investigated here. 
 The histological results of early bone regeneration observed here support our 
previously reported long-term results (Uhrig et al., 2013), with the BD+HLI group 
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exhibiting more robust bone regeneration than the BD group.  Additionally, in previous 
work, it was demonstrated that when combined with HLI a non-healing 0.5 μg rhBMP-2 
dose will produce consistent bone repair (Uhrig et al., 2013).  It has also been shown that 
with no treatment, nanofiber mesh alone, or nanofiber mesh with blank alginate, these 
defects will not heal and will progress to non-union (Oest et al., 2007; Kolambkar et al., 
2011).  Together, those results prompted speculation of whether the response to HLI in 
the absence of rhBMP-2 could promote effective bone repair.  Here we demonstrated the 
necessity of the osteoinductive stimulus, as the BD+HLI Blank group did not display an 
initiation of bone regeneration via osteogenic gene expression.    
 The HLI surgery has been shown to effectively induce significant ischemia in the 
operated leg (Uhrig et al., 2013), but this effect is understood to be transient, with 
recovery attributed primarily to arteriogenic collateral vessel growth (Couffinhal et al., 
1998; Duvall et al., 2004).   In rat models of femoral artery ligation, restoration of resting 
perfusion has been reported at 5 -7 days (Seifert et al., 1985; Corcoran et al., 2009), with 
deficits in reserve blood flow persisting beyond 14 days (Corcoran et al., 2009).  In our 
model, distal limb perfusion remained significantly reduced in the BD+HLI group at day 
14, having only achieved 42% of the contralateral leg, with the extended delay in 
recovery perhaps attributable to concomitant orthopaedic injury or differences in surgical 
technique.   
 The reduction in perfusion for the BD+HLI group was less pronounced for the 
ROI of the entire leg, displaying a significant decrease to 55% of contralateral perfusion 
at day 1.  By day 3, this had recovered to 82%, which was no longer statistically different 
from naïve controls.  Conversely, the BD group showed increasing perfusion to the 
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operated leg beginning as early as day 1 and reaching maximal levels by day 7.  
Interestingly, while HLI clearly affected the perfusion to the limb, both groups displayed 
similar temporal changes in perfusion from their respective day 1 levels through day 14.   
The rapid recovery of perfusion in the leg of the BD+HLI group appears to be 
attributable to the significantly increased perfusion in the region of the adductor muscles, 
given the sustained reduction in the distal limb.  Although perfusion in the adductor ROI 
was unchanged at any time point for the BD group, in the BD+HLI group it was 
significantly increased at day 1, appeared to peak at day 3, but remained highly elevated 
through day 14.  The marked increase in adductor ROI perfusion in the BD+HLI group 
was not unexpected, as arteriogenic growth of collateral vessels in the adductor muscles 
is the predominant restoration mechanism is small animal HLI models (Scholz et al., 
2002; Schaper and Scholz, 2003; Duvall et al., 2004).  
 Delivery of 2 μg rhBMP-2 did not appear to influence perfusion in the operated 
limb, as evidenced by the similar temporal changes in perfusion between the BD+HLI 
and the BD+HLI Blank group.  Importantly, interpretation of LDPI data should consider 
the limitations of this imaging modality.  While providing useful functional assessment, 
the limited penetration depth precludes full characterization of limb blood perfusion.   
Cutaneous inflammation and wound healing may also mask possible differences.   
 The increased adductor perfusion observed in the BD+HLI group with LDPI was 
further supported by micro-CT angiography results.  Collateral vessel growth was readily 
apparent as early as day 3 in contrast agent perfused samples from this group.  These 
collateral vessels were potentially responsible for delivering the functional perfusion 
increase observed with LDPI.  The collateral vessels were quantitatively captured in the 
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Thigh VOI analysis, and in agreement with LDPI, the BD+HLI group showed increased 
normalized vessel volume in the thigh compared to the BD group.  Together, these results 
indicate a robust vascular growth response to ischemia in this model.  Both groups 
possessed increased vascularity in the thigh of the operated leg compared to the 
contralateral leg; however, considering the excision of femoral vessels, the BD+HLI 
group exhibited vascular growth in excess of the BD group.  Although this vascular 
growth did not produce differences in the mean vessel number parameter at the time 
points investigated, the BD+HLI group did possess a more isotropic network of smaller 
diameter vessels.  One limitation of the micro-CT angiography technique (as with other 
angiography techniques) is the inability to distinguish between arterial and venous 
vessels, and perhaps resulted in a failure to detect important differences in vascular 
networks.  For example, the BD+HLI group exhibited greater normalized vessel volume 
in the thigh despite excision of the femoral vessels, perhaps suggesting increased arterial 
blood supply.  In such a scenario, the BD+HLI group may have experienced enhanced 
oxygenation and nutrient supply to the surrounding skeletal muscle envelope, which 
could contribute to the enhanced bone regeneration observed.   
 Although HLI produces differences in vascular network growth in the 
surrounding muscle tissue of the thigh, it does not appear to influence vessel growth at 
the defect site.  Micro-CT angiography results for the Defect VOI demonstrated very 
similar temporal changes for vessel volume and morphological parameters for the BD 
and BD+HLI groups.  As outlined in the methods section, the 7 mm diameter of the 
Defect VOI was inclusive of the 5 mm diameter of the nanofiber mesh and the 
immediately adjacent tissue extending radially outward a distance of 1 mm.  In light of 
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these Defect VOI results, and given the 200 μm limit of blood oxygen diffusion 
(Muschler et al., 2004), any effect of superior tissue oxygenation and nutrient supply in 
the hypothetical scenario above would seem to be an indirect one.  Histological analysis 
was in agreement with these results, showing a similar progression of vascular ingrowth 
at the defect site between groups.  Previously, we reported that vessel volume and 
morphological parameters are not different between groups at 12 weeks (Uhrig et al., 
2013); however, this does not preclude the possibility of differences in the time spanning 
the early time points investigated here and the week 12 end point.  
 The stimulatory effects of HLI on bone repair cannot be explained by differential 
gene expression alone based on the genes and time points investigated in these studies.  
Based on our previous findings that bone regeneration was increased in the BD+HLI 
group by week 4 (Uhrig et al., 2013), we investigated gene expression at multiple 
preceding time points. Although we believe these to have been a thorough effort to 
identify differences between groups, temporal changes in gene expression do not proceed 
at discrete intervals, and differences at other time points may have gone undiscovered.  
Alternatively, while we attempted to capture a range of genes involved in osteogenesis, 
vascular growth, and inflammation, these biological processes are highly complex and 
the critical regulators – be those soluble signaling factors, membrane receptors, or ECM 
proteins – may not have been amongst the genes selected.  Furthermore, given the 
heterogeneity of the bone defect and muscle tissue samples, qRT-PCR may not have been 
sensitive enough to detect changes between groups.  For example, osteoprogenitors and 
vascular tissue cells make up only a small portion of the granulation tissue found at early 
time points in the defect, and in the context of the entire defect sample, may not produce 
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sufficiently large differences in mRNA expression.  In the adductor muscles, focal gene 
expression analysis on vessels in the BD+HLI group undergoing arteriogenic remodeling 
may demonstrate differences compared to vessels from the BD group, but these effects 
may be lost when evaluating gene expression at the skeletal muscle tissue level.   
 In the bone defect, temporal changes in gene expression progressed very similarly 
for the BD and BD+HLI groups.  As expected, in groups treated with rhBMP-2, multiple 
genes associated with osteogenic transcription factors, growth factors, and ECM proteins 
– Runx2, Osx, Bmp2, Igf1, Pdgfb, Opn, Col1a1 – displayed increased mRNA expression 
over control tissue and increasing expression levels over time.  Although the mature 
naïve femoral bone tissue possesses some degree of modeling/remodeling due to growth, 
it has much less activity than newly forming bone.   Furthermore, in the absence of the 
osteoinductive rhBMP-2 stimulus, HLI and blank alginate alone were insufficient to 
promote osteogenic gene expression.  In particular, expression of Runx2 and Osx, master 
transcription factors for osteogenic differentiation, and Bmp2, a necessary morphogen 
required for postnatal bone healing (Tsuji et al., 2006), was significantly lower in the 
blank alginate group than rhBMP-2-treated groups and was depressed compared to 
expression levels in control tissue. Additionally, Opn expression was significantly 
elevated in all groups at all time points, but was ~2x more highly upregulated at day 7 in 
rhBMP-2 treated groups than the blank alginate group.   
 Expression of genes related to vascular growth was similar between groups, with 
a few notable exceptions.  Of all the genes investigated, Acta2 appeared to be the most 
differentially regulated between groups in the bone defect region.  Previous work has 
demonstrated a role for Acta2 expressing cells in bone repair (Kinner et al., 2002), and 
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these cells are believed to be osteoprogenitors of perivascular or myofibroblast lineage 
(Kalajzic et al., 2008).  Furthermore, Acta2 is expressed by VSMCs, a cell population 
thought to be contributors to pathological vascular calcification (Trion and van der 
Laarse, 2004), that are also known to increase proliferation and migration activity during 
arteriogenesis (Schaper and Scholz, 2003).  Thus, the prolonged duration of heightened 
Acta2 expression in the BD+HLI group is thus perhaps indicative of an increased 
residence time of cells at the defect capable of participating in bone repair.  Interestingly, 
Vegfa expression in the defect was only modestly upregulated and did not produce a 
statistically significant increase over the level of controls at any time for any group.  
Although VEGF signaling has been shown to be essential for angiogenic-osteogenic 
coupling and bone repair (Street et al., 2002), the modest upregulation of Vegfa displayed 
here is in agreement with what has been observed in other models (Carvalho et al., 2004; 
Lienau et al., 2009; Matsubara et al., 2012).  The expression levels seen here are also 
perhaps an effect of the time points investigated, as histology showed that vessel 
ingrowth at the defect occurs between days 14 and 28.  The mRNA expression of Mmp9 
in rhBMP-2 treated defects lends support to the possibility of additional downstream 
Vegfa expression.  Matrix degradation by MMP9 is understood to precede VEGF 
signaling and angiogenesis during bone repair (Ferguson et al., 1999; Colnot et al., 
2003), and in the work here Mmp9 expression was observed to still be increasing from 
day 14 to day 21.  In vascular growth signaling, expression of the growth factor receptors 
is perhaps as important, if not more so, than their respective ligands.  In rhBMP-2 treated 
defects, expression of Vegfr2, the primary receptor through which VEGF signaling is 
mediated, as well as Fgfr1 and Fgfr2, all increased over time, achieving statistical 
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significance versus controls or at least a 3-fold upregulation, and in the case of Fgfr1, 
achieving both.  Furthermore, beyond their function in vascular growth, VEGFR2, 
FGFR1, and FGFR2 are also expressed as surface receptors on bone cells and implicated 
in bone repair processes (Du et al., 2012; Clarkin and Gerstenfeld, 2013).  It has also 
been proposed that while both FGFR1 and FGFR2 modulate signaling in 
osteoprogenitors cells, FGFR2 is more involved in receptor signaling for mature 
osteoblasts (Marie, 2003).  In this study, Fgfr1 expression in the defect was more highly 
upregulated compared to controls, however, Fgfr2 was more differentially regulated in 
rhBMP-2 treated groups compared to the blank alginate HLI group, suggesting that in 
this model FGFR2 is more involved in bone healing, perhaps being indicative of further 
osteogenic differentiation.   
 The very strong upregulation of Ccl2 observed in the defect for all groups is 
unsurprising given it is a key molecule in mediating inflammation, particularly 
monocyte/macrophage recruitment.  Furthermore, inhibited CCL2 signaling through 
knockout of its receptor CCR2 has been implicated in delaying the progression fracture 
repair (Xing et al., 2010).  The higher levels of Ccl2 expression in the BD+HLI Blank 
group relative to groups receiving rhBMP-2 may be indicative of an increased 
inflammatory response or prolonged resolution of inflammation at the defect site due to 
an insufficient osteogenic stimulus.  Expression of Ccr7 and Cd163, reported biomarkers 
of M1 (classically activated, pro-inflammatory) and M2 (alternatively activated, wound 
healing) macrophage phenotypes, respectively (Mokarram et al., 2012), was investigated 
to further characterize the inflammatory response.  In all groups, and at all time points, 
expression of Cd163 was downregulated compared to controls, but expression was shown 
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to be increasing over time.  Conversely, expression of Ccr7 was upregulated at all time 
points, but decreased after day 7 in rhBMP-2 treated groups.  Taken together, these 
results suggest a gradual transition from a pro-inflammatory M1 phenotype toward the 
wound-healing M2 phenotype.  The increased Ccr7 expression observed from day 7 to 
day 14 in the blank alginate group, like the Ccl2 expression discussed above, is perhaps 
indicative of prolonged inflammation in this group given the lack of a sufficient 
osteogenic stimulus.   
 For the genes and time points investigated here, HLI did not appear to strongly 
influence gene expression in these muscles when comparing amongst experimental 
groups, nor did delivery of 2 μg rhBMP-2.  The overall lack of differences in temporal 
gene expression patterns in adductor muscles with or without HLI was an unexpected 
observation of this study.  These results are potentially explained by the muscle trauma 
inherent to the segmental bone defect procedure which may elicit upregulation of many 
of the same genes involved in the response to HLI, effectively masking any effect of the 
concomitant vascular injury on gene expression.  This is supported by the stark 
differences in gene expression of all groups compared to naïve controls.  Additionally, 
angiography results demonstrate that a significant amount of collateral vessel growth has 
already occurred prior to day 7; thus, the majority of differential gene expression due to 
HLI may have occurred earlier than the time points investigated here.    
 The higher levels of Opn expression at day 7 in HLI groups compared to controls 
was an expected result, as OPN has been shown to be significantly upregulated in 
response to HLI (Lyle et al., 2012) and plays a definitive role in collateral vessel 
development and recovery from ischemia (Duvall et al., 2008).  The nearly equal increase 
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in Opn expression for the BD group was unexpected, but is not entirely surprising given 
the pervasive muscle trauma inherent to the segmental bone defect surgery.   Although 
the skeletal muscle envelope is thought to contribute in multiple ways to bone repair, 
very little upregulation was observed for osteogenesis related transcription and growth 
factor genes in the adductor muscle tissue for any group.  Thus, any stimulatory effect on 
bone repair from the surrounding skeletal muscle does not appear to be mediated at the 
level of osteogenic gene expression.   
 Expression of genes related to angiogenesis (Vegfa, Vegfr2, Fgfr1, and Fgfr2) 
increased over time in the adductors from their day 7 levels, as might be expected, but at 
most were upregulated only ~3- to 4-fold over controls.  These relatively modest 
increases lend support to the idea that arteriogenesis rather than angiogenesis is the more 
relevant vascular growth process in the surrounding skeletal muscle envelope, especially 
at time points inside 14 days (Scholz et al., 2002; Morgan et al., 2012).  Arteriogenesis is 
an inflammation driven process, with increased MCP-1 (CCL2) secretion promoting 
extravasation of monocytes into the vessel wall to initiate remodeling that is further 
carried out by VSMCs (Scholz et al., 2000; Cai and Schaper, 2008).  Interestingly, 
differential expression of Ccl2 was not observed between the BD and BD + HLI groups.   
This is most likely explained by the time points analyzed, as HLI induced expression of 
CCL2 is highest in the adductor muscles in the first 3 days (Lee et al., 2004), which is 
prior to the earliest time point investigated here.  Although the Ccl2 levels observed for 
the BD+HLI group are in agreement with those previously reported for HLI models at 
day 7 (Lee et al., 2004), Ccl2 expression remains elevated in the BD+HLI Blank group 
for reasons that are not entirely clear.  No differences in mRNA expression were found 
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for Mmp9, a protein known to be involved in the matrix degradation aspects of vessel 
remodeling (Heil and Schaper, 2004), or Acta2 which is highly expressed by VSMCs, the 
cell type most responsible for arteriogenic remodeling (Cai and Schaper, 2008).  
Furthermore, despite the well-established role of monocytes/macrophages in 
arteriogenesis, HLI did not have a clear effect on expression of Cd163 or Ccr7.  Although 
no explanation can be offered for the greater fold increases of Cd163 and Ccr7 
expression found in the BD+HLI Blank group at day 7, these results are perhaps related 
to the higher level of Ccl2 expression also observed.   
 Other areas yet to be tested may provide important insights for explaining the 
stimulatory effect of HLI recovery on rhBMP-2-mediated bone regeneration in this 
model.  Rather than differential gene expression, augmented soluble factor bioavailability 
or cell populations mobilized due to the HLI response may contribute to enhanced bone 
repair.  Monocytes/macrophages play a critical role in arteriogenesis.  Increased 
circulating monocyte concentration and extravasation is associated with HLI (Heil et al., 
2002; Bergmann et al., 2006), and pharmacological depletion of monocytes impairs 
arteriogenesis (Heil et al., 2002).  This could be one key difference between the 
experimental groups here that is yet to be studied.  Increased mobilization of these cell 
populations may increase matrix degradation and soluble factor bioavailability (la Sala et 
al., 2012) or otherwise augment tissue regeneration.  Recent work demonstrating the 
essential role of macrophages in salamander limb regeneration lends supports to such a 
hypothesis (Godwin et al., 2013).  Furthermore, OPN is thought to play a role in 
mediating macrophage migration and adhesion (Giachelli et al., 1998; Duvall et al., 
2008), and increased Opn expression in HLI animals, although not statistically 
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significant, may have been biologically relevant to promote differences in activity of 
these cell populations.  Given the importance of myeloid lineage cells in the recovery 
from HLI, it is conceivable that in response to the ischemic insult, an additional 
population of bone marrow-derived progenitor cells is mobilized into the circulation.  
Although it is believed that the progenitor cells involved in fracture repair arise primarily 
from the periosteum, it would be interesting to investigate whether HLI animals contain 
an additional population of bone-marrow derived cells participating in bone regeneration.  
Endothelial progenitor cells would be an additional cell population worth investigating.  
Migration and neovascularization by endothelial progenitor cells is mediated by 
aniopoietin-2 (Kim et al., 2006), a molecule reported to play a role in the recovery from 
HLI (Tressel et al., 2008). 
In total, the studies here constitute the initial work investigating how the recovery 
response to HLI mechanistically promotes enhanced bone regeneration in a composite 
injury model of bone and vascular trauma.  In partial support of our hypothesis, 
characterization of vascular network growth determined that a robust response is rapidly 
initiated in the thigh following HLI.  Yet despite the enhanced vascular growth in the 
skeletal muscle, blood vessel growth into the regenerating bone defect was not affected 
by HLI at the time points investigated.  Therefore, any effects of ischemia-induced 
vascular growth on bone regeneration appear to be indirect ones.  Gene expression results 
did not support our hypothesis, leading to the conclusion that the stimulatory effects of 
HLI on bone regeneration cannot be explained by differential gene expression alone for 
the genes and time points investigated here.  Additional future work to further elucidate 
potential coupling mechanisms between the recovery response to ischemia and bone 
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SUMMARY AND FUTURE DIRECTIONS 
Overall Summary 
 Improving structural and functional outcomes of intervention for extremity 
trauma patients remains a pressing, unmet clinical need.  Doing so will likely require 
advancing our understanding of the biological interactions between damaged tissues.  
While TE/RM therapeutics offer promising potential to overcome the status quo 
limitations of surgical reconstruction, very few products have transitioned to clinical 
practice.  In the status quo, musculoskeletal trauma research models almost exclusively 
consist of single-tissue defects.  While these models have an undeniable place as valuable 
research tools, they inherently possess limited utility for investigating therapeutic 
strategies for the repair of large, multi-tissue defects and afford little potential for insight 
into endogenous interactions between healing tissues.    Models of composite tissue 
trauma are uniquely positioned to bridge this knowledge gap and advance the TE/RM 
field. 
 Bone tissue is known to be innervated and highly vascularized, and both tissue 
types are involved in bone physiology.  However, the degree to which these tissue 
interactions influence the repair of large, multi-tissue defects remains unknown.  
Accordingly, the overall objective of this project was to investigate interactions occurring 
between tissues following composite limb injuries in support of the long-term goal to 
develop TE/RM therapies for improved reconstruction and functional outcomes 
following severe limb trauma.  The central hypothesis of this work was that interactions 
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exist in the healing response of large, composite tissue deficits, and these interactions 
influence bone tissue regeneration and functional restoration.   
 To test our hypothesis, two novel rat models of composite bone and soft tissue 
trauma were developed.  First, we characterized interactions in tissue regeneration in a 
composite bone and nerve injury model where a segmental bone defect was combined 
with a peripheral nerve gap (Aim I, Chapter 3).  Interestingly, our results indicated that 
bone regeneration was not significantly impaired by concomitant nerve injury, nor was 
nerve regeneration significantly impaired by bone injury in this model.  Yet despite the 
similar tissue regeneration observed, the composite injury group experienced a marked 
functional deficit in the operated limb compared to either of the single-tissue injury 
groups.  Second, we established a model of concomitant bone and vascular extremity 
trauma by combining a critically-sized segmental bone defect with surgically-induced 
hind limb ischemia to evaluate the effects on BMP-2-mediated segmental bone defect 
repair (Aim II, Chapter 4).  Surprisingly, our results demonstrated significantly enhanced 
bone regeneration in the group with ischemia compared to bone defects alone, perhaps by 
way of coupling to the endogenous vascular growth response to HLI.  Finally, building 
on those results, we investigated the potential early vascular growth and gene expression 
mechanisms of interaction between the injury response to HLI and bone defect repair 
(Aim III; Chapter 5).  Although HLI induced a more robust vascular growth response in 
the thigh, ingrowth of blood vessels at the bone defect did not differ, indicating that HLI 
does not directly augment vascularization at the site of bone regeneration.  In addition, 
the expression of multiple genes related to osteogenesis, vascular growth, and 
inflammation were upregulated compared to naïve control tissue; however, the 
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stimulatory effects of HLI on bone regeneration cannot be explained by gene expression 
alone based on the genes and time points investigated.  Taken together, this thesis 
presents pioneering research on a platform of small animal test-bed models of composite 
limb injury and has advanced our understanding of endogenous interactions that occur 
during the repair of concomitant bone & peripheral nerve or bone & vascular injuries.   
Understanding Bone and Nerve Interactions 
 In Aim I (Chapter 3) of this thesis, a novel composite limb injury model of severe 
bone and peripheral nerve trauma was developed to assess tissue interactions during 
concomitant bone and nerve regeneration.  To our knowledge, this was the first work on a 
small animal model of critically-sized bone and neural injuries.  Our working hypothesis 
was that a composite bone and nerve injury would affect bone regeneration and limb 
function compared to bone injury alone.  We characterized the healing response using 
quantitative outcome measures to assess bone regeneration and peripheral nerve 
regeneration, as well as tissue and overall limb function.  Secondarily, we studied 
morphology and mechanical properties of ipsilateral and contralateral femora to test the 
hypothesis that the nerve injury would induce an adaptive response in intact femora.   
 Interestingly, although both single tissue injuries were challenging, our results did 
not support our hypothesis as bone regeneration was not significantly impaired by 
concomitant nerve injury in this model, nor was nerve regeneration significantly impaired 
by bone injury.  Thus, alternative models may be better suited to study interactions in 
bone and nerve tissue regeneration.  Although differences were not observed in tissue 
regeneration for outcome parameters investigated here, the difference in functional deficit 
in the injured limb was quite profound in the composite injury group compared to either 
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single-tissue injury group in agreement with our hypothesis.  Restoration of limb function 
remains a major obstacle in limb salvage following extremity trauma in human patients.  
Taken together with our results, this highlights the need for TE/RM to benchmark 
technologies using quantitative measures of both tissue and limb function.  Additionally, 
in support of our secondary hypothesis we found injury to the sciatic nerve was 
associated with significant changes in the morphology and mechanical properties of 
intact femora.   
 The exact mechanism responsible for the marked functional deficit observed in 
the composite injury group is unknown.  This response may simply be a result of bone 
trauma compounding the loss of innervation to the lower leg.  Muscle contractures in the 
lower limb associated with sciatic nerve transection may also contribute to the persistent 
functional deficit if they are unresolved or progress in severity over time.  Presence of the 
fixation hardware may also augment the muscle contractures and contribute to an 
increased functional deficit.  Additional experimentation including a group where the 
peripheral nerve gap is combined with placement of fixation hardware only (no bone 
defect created) might help to answer such questions.  The time course for full functional 
restoration may also be longer than the 16 weeks of healing allotted in this work, and 
extending experiment duration could potentially provide additional insights.  It would be 
an oversight to not consider the role of a physical therapy protocol (or lack thereof) in 
assessing functional outcomes following extremity trauma.  Physical therapy is a vital 
component in the rehabilitation and recovery process for human patients.  In this study, 
the lack of a physical therapy protocol may be at least partially responsible for the 
persistent functional deficit.  Future studies incorporating physical therapy regimens may 
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prove incredibly insightful; however, implementation of a standardized protocol for rats 
would present a multitude of logistical hurdles. 
 Additional insight may be gained from this model by performing experiments 
with composite injury groups in which one of the defects is left untreated (e.g., treated 
bone defect with untreated nerve gap).  Such groups may be able to tease out whether 
untreated nerve defects negatively influenced bone repair compared to those that are 
treated, or perhaps whether delivery of BMP-2 affected nerve regeneration.  It should be 
noted, however, that the time-course of nerve regeneration in the model we used is such 
that bone repair was in all likelihood well underway by the time axons had bridged the 
nerve gap.  In such a case, there may be little physiological difference in whether or not 
the nerve gap is treated or untreated, or differences would not be observed until 
downstream mechanical loading induced remodeling.   
 The absence of distinguishable interactions between bone and nerve tissue 
regeneration in this work was somewhat unexpected.  A growing body of work continues 
to elucidate neurotransmitter and neuropeptide signaling pathways in the skeletal system 
and a neuronal arm contributing to the regulation of bone modeling and remodeling (Imai 
and Matsusue, 2002; Spencer et al., 2004; Elefteriou, 2008).  While the number of nerve 
fibers in bone may not be numerous, it is postulated that they function in two specific 
regulatory roles: 1) mediators of mechanical forces in bone and 2) a source of trophic 
factors necessary for bone form and function (Masi, 2012).  Clinical observations of 
enhanced osteogenic activity in fracture patients with head injuries provide anecdotal 
evidence for the role of the nervous system in physiological bone healing (Perkins and 
Skirving, 1987; Spencer, 1987; Garland, 1988).  However, it remains controversial 
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whether this increase in osteogenesis is an actual augmentation of fracture healing or a 
form of heterotopic ossification (Kushwaha and Garland, 1998; Morley et al., 2005).  The 
effect of innervation status on fracture healing has also been studied experimentally, with 
inconsistent conclusions.  Sciatic nerve transection has been associated with both smaller, 
less dense fracture calluses compared to innervated controls (Aro et al., 1981; Aro, 
1985), and also with larger, more mineralized calluses (Nordsletten et al., 1994; 
Hukkanen et al., 1995; Madsen et al., 1998).  The apparent confounding fracture healing 
results from similar injury models is very likely explained by differences in fracture 
stabilization employed across the studies.  Although such discrepancies preclude the 
ability to collectively interpret the findings with great accuracy, when taken together with 
clinical reports, it seems clear that concomitant neural insult is at least associated with 
augmented fracture healing or osteogenic response.  Furthermore, in sum, the previous 
experimental results suggest potential modulation of fracture healing via sensory 
innervation feedback on fracture stability.  Work from our own laboratory has 
investigated the role of mechanical loading on repair of segmental bone defects; early 
loading was shown to have deleterious effects, whereas delayed loading enhanced bone 
regeneration (Boerckel et al., 2011; Boerckel et al., 2012).  Future studies of bone defect 
regeneration incorporating nerve injury with or without mechanical loading may help to 
advance our understanding of the coupling of innervation status on mechanoregulation of 
bone repair. 
 The lack of observed interactions in our work here may be a consequence of the 
model design.  Given the close anatomical proximity of the sciatic nerve and the femur 
(the former running just posterior to the latter in the musculature of the hamstrings), it is 
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susceptible to injury in instances of lower extremity trauma that damage the femur.  This 
relationship made it a logical choice for a trauma model.  From a functional perspective, 
however, the two are not as closely related.  The primary function of the sciatic nerve is 
to innervate the lower leg and foot.  An inability for direct signaling between the injury 
sites of the femur and sciatic nerve is a potential explanation for the lack of observed 
healing response interactions.  It may be necessary to disrupt the specific nerves 
responsible for innervation of the injured bone in order to observe a neuronal influence 
on bone healing.  The previously mentioned results from experimental models of 
denervated tibial fracture healing support such a hypothesis (Aro et al., 1981; Aro, 1985; 
Nordsletten et al., 1994; Hukkanen et al., 1995; Madsen et al., 1998), as well as a recent 
study which showed that chemically-induced local sensory denervation was associated 
with impaired healing of femur fractures by way of a larger, less dense fracture callus, 
with a significantly decreased failure load (Apel et al., 2009).  Alternatively, it is 
plausible that endogenous healing of large tissue defects does not completely parallel the 
physiological responses observed in fracture healing.   
 Accordingly, future work could incorporate changes to the model where the 
specific nerves innervating the femur are transected rather than the sciatic nerve in order 
to examine the effect on segmental bone defect repair.  A different model could also be 
designed where sciatic nerve transection is combined with a tibial segmental bone defect.  
In such a model, or even with tibial fracture healing, varying lengths of sciatic nerve gaps 
could be used to better understand how the time course of nerve regeneration may 
influence bone repair.  In addition, incorporation of sciatic nerve transection in a tibial 
distraction osteogenesis model (Aronson et al., 1997), could offer particularly unique 
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insights into how innervation status mediates mechanically-induced bone repair.  
Developing a similar composite injury model based on murine distraction osteogenesis 
(Jacobsen et al., 2008; Wan et al., 2008) would allow investigation of specific 
mechanistic questions using a variety of transgenic mouse lines already available.   
 Model selection should ultimately depend on the type of injury of interest and the 
scientific question under investigation.  Careful consideration should also be given to the 
degree of load bearing allowed and whether muscle tone in surrounding tissue has been 
disrupted, as both may influence the healing response observed in experimental and 
control groups, and ultimately the interpretation of results.  There also exist ethical 
considerations specific to rodent strain selection for peripheral nerve injury models.  
Differences in the degree of autotomy/autophagia (i.e., self-mutilation) have been 
reported amongst varying rat strains following sciatic nerve transection, ranging from a 
complete absence to severe complications (Carr et al., 1992).  Although an increasing 
amount of research is being devoted to studying interactions between the nervous and 
skeletal systems, the complexities are far from being completely understood.  With 
proper design considerations, composite bone and nerve injury models can provide a 
novel avenue to explore the degree of cross-talk during tissue repair and functional 
restoration, as well as the specific pathways involved. 
Understanding Bone and Vascular Interactions 
 In Aim II (Chapter 4), a novel composite tissue injury model of severe bone and 
vascular trauma was developed to evaluate the effects of HLI on segmental bone defect 
repair.  To our knowledge, this was the first work on a small animal model of a critically-
sized bone defect with concomitant vascular injury.  Based on reported clinical and 
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experimental observations on the importance of vascular networks in bone repair, we 
hypothesized that HLI would impair bone regeneration.  Interactions in tissue 
regeneration were clearly evident in this model, but interestingly, our results 
demonstrated significantly enhanced bone regeneration in the group with ischemia 
compared to bone defects alone.  We hypothesized that the bone regeneration may be 
attributable to a robust endogenous vascular growth response to ischemia.  Although the 
HLI surgical procedure was demonstrated to effectively create an initial substantial 
reduction in perfusion of the leg, it is understood from the work in the field of vascular 
biology that this is a transient effect due primarily to arteriogenic growth of collateral 
vessels in the limb.  Indeed, despite excision of the femoral vessels, by week 12 no 
differences were found between in total blood vessel volume in the thigh; however, clear 
differences in morphology were present as HLI group possessed a more interconnected 
network of smaller diameter vessels.   Accordingly, while the overall thigh vessel volume 
was comparable between groups, the contributions to vessel volume based on vessel 
diameter differed significantly.  Yet, despite the evidence of a robust vascular growth 
response occurring in the thigh following ischemia, differences were not observed for 
bone defect blood vessel volume or morphology.   
 Consequently, we proposed a revised hypothesis that inclusion of HLI had 
coupled to the bone repair process by way of an augmented early vascular tissue growth 
response or perturbed signaling cascades initiated in the bone defect region or 
surrounding skeletal muscle envelope.  In Aim III (Chapter 5), this same model was used 
to begin to test that hypothesis by investigating early spatiotemporal changes in blood 
flow and vascular tissue growth, as well as gene expression within the bone defect and 
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adjacent adductor muscle tissues.  Although a rapid induction of vascular growth in the 
thigh was evident in both groups, HLI was associated with a more robust response.  
Ingrowth of blood vessels at the bone defect did not different significantly, however, 
indicating that HLI also does not augment vascularization at the site of bone regeneration 
at early time points.  Thus, any effects of ischemia-induced vascular growth on bone 
regeneration are likely indirect ones.  Additionally, while gene expression changed 
dramatically compared to naïve control tissue, based on the genes and time points 
investigated here, the stimulatory effects of HLI on bone regeneration could not be 
explained by gene expression alone.  Taken together, this work suggests new, additional 
complexity to the coupling of bone repair with vascular growth and remodeling. 
 Overall, the enhanced bone regeneration observed in defects with HLI did not 
validate our original hypothesis of impaired healing with concomitant vascular injury, 
and suggests that this model does not recapitulate complications associated with vascular 
compromised clinical bone healing.  This is most likely due to differences in scale of 
human patients versus small animal models, and the observation that the rat HLI injury 
induced a robust vascular response and only transient limb ischemia.  However, the 
unexpected results of this study are important as they shed further light on the complex 
interactions between bone healing and vascular tissue growth.  Furthermore, these results 
are an especially interesting point for future consideration given the high costs and 
incompletely understood (and at times negative) effects associated with current 
supraphysiological doses of BMPs administered to human patients (Garrison et al., 2007; 
Cahill et al., 2009; Devine et al., 2012; Even et al., 2012).  Future work to improve 
understanding of the underlying mechanisms could provide useful insight to exploit this 
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interaction and guide development of novel therapeutic strategies for challenging clinical 
bone healing scenarios, and perhaps permit lower doses of rhBMP-2 to be used in 
humans without sacrificing efficacy. 
 Rapid vascular growth was evident in the thigh musculature at early time points 
following surgery, but was surpassed by the additional response invoked by concomitant 
HLI, with development of collateral vessels evident as early as post-surgery day 3.  The 
HLI induced vascular growth produced stark differences in the morphology of thigh 
vasculature, resulting in more interconnected networks of smaller diameter vessels.  Yet, 
HLI was not associated with differential vascularization of the bone defect at early time 
points or at the week 12 endpoint.  Although when taken together these results do not 
preclude possible differences at intermediate time points that could be further 
investigated with additional experimentation, they suggest indirect coupling mechanisms 
for the stimulatory effect of HLI on bone regeneration rather than a direct influence on 
blood vessel ingrowth at the defect.  Such mechanisms could perhaps be inclusive of 
augmented cellular exchange, gene expression, soluble factor bioavailability, or some 
combination thereof. 
 Accordingly, we investigated the expression of several genes involved in 
osteogenesis and vascular growth to determine whether HLI was associated with 
differential expression.  Genes associated with inflammation were also investigated given 
its importance to both arteriogenesis (Cai and Schaper, 2008) and bone healing 
(Mountziaris and Mikos, 2008).  Based on our findings that bone regeneration was 
increased with HLI as early as week 4, we investigated gene expression at multiple 
preceding time points.  The overall minor effects of HLI on temporal gene expression in 
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both the defect region and adjacent adductor muscle tissue were unexpected.  These 
results are perhaps indicative of the time points investigated.  Although we believe these 
to have been a thorough effort to identify differences between groups, temporal changes 
in gene expression do not proceed at discrete intervals, and differences at other time 
points may have gone undiscovered.  This is perhaps especially true with regard to the 
adductor muscle analysis.  Angiography results show that collateral vessel development 
is already well underway by day 3, thus the day 7 time point may have missed much of 
the effects of HLI on gene expression.  However, the primary focus of these studies was 
to characterize gene expression in the bone defect, and there was not a great deal of 
confidence that RNA samples of sufficient concentration and quality could be obtained 
from the defect prior to day 7.  Accordingly, future studies could focus on additional 
upstream, downstream, or intermediate time points to further evaluate the effects of HLI 
on gene expression.  Alternatively, while we attempted to capture a range of genes 
involved in osteogenesis, vascular growth, and inflammation, these biological processes 
are highly complex and the critical regulators – be those soluble signaling factors, 
membrane receptors, or ECM proteins – may not have been amongst the genes selected.  
Additional experimentation with expansion of the genes under investigation through the 
use of commercial microarray technology, global gene profiling (Niikura et al., 2006), or 
transcriptome analysis (Grimes et al., 2011) may provide additional insights not 
uncovered in the work here.  Finally, given the heterogeneity of the bone defect and 
muscle tissue samples, qRT-PCR may not have been sensitive enough to detect the 
effects of HLI.   
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 Other areas yet to be tested may provide useful insights for explaining the 
stimulatory effect of HLI recovery on rhBMP-2-mediated bone regeneration in this 
model.  Rather than differential gene expression, augmented soluble factor bioavailability 
or cell populations mobilized due to the HLI response may contribute to enhanced bone 
repair.  Future experiments using immunoblotting and immunohistochemistry techniques 
could assess whether the HLI recovery response is associated with increased circulating 
or localized soluble factor availability that might contribute to stimulatory effects for 
bone regeneration.  Additionally, monocytes/macrophages are known to play a critical 
role in arteriogenesis.  Increased circulating monocyte concentration and extravasation is 
associated with HLI (Heil et al., 2002; Bergmann et al., 2006), and could be one key 
difference between the experimental groups here that is yet to be studied.  Increased 
mobilization of these cell populations might produce additional matrix degradation and 
soluble factor release.  Furthermore, OPN is thought to play a role in mediating 
macrophage migration and adhesion (Giachelli et al., 1998; Duvall et al., 2008), and 
increased OPN expression in HLI animals, although not statistically significant, may 
have been biologically relevant to promote differences in activity of these cell 
populations.  Experiments incorporating immunohistochemistry and flow cytometry 
could be performed to try and characterize the constituents of cell populations.   
Alternatively, experiments could be designed to perturb the activity of a certain cell 
population to determine the downstream effects on vascular growth and bone repair.  One 
such experiment would be the targeted inhibition of monocyte extravasation in the HLI 
model via a pharmacological agent.  Doing so would impair arteriogenesis, affording the 
opportunity to evaluate potential deleterious effects on bone regeneration.   
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 Given the importance of myeloid lineage cells in the recovery from hind limb 
ischemia, it is conceivable that in response to the ischemic insult, an additional 
population of bone marrow-derived progenitor cells is mobilized into the circulation.  
Although it is believed that the progenitor cells involved in fracture repair arise primarily 
from the periosteum, it would be interesting to investigate whether HLI animals contain 
an additional population of bone-marrow derived cells participating in bone regeneration.  
Again, immunohistochemistry and flow cytometry could be two tools used to probe such 
questions.  Bone marrow transplant studies could also be one potential way to evaluate 
such an effect.  In these studies, bone marrow cells from labeled donors (e.g., GFP or 
Rosa26-lacZ) would be transplanted into irradiated wild type rats, and vice versa.  After a 
suitable recovery period, surgery would be performed as usual and the relative 
contributions of bone-marrow derived cells could be assessed histologically.   
 In the work performed here, one limitation of the micro-CT angiography 
technique (as with other angiography techniques) is the inability to distinguish between 
arterial and venous supply, perhaps resulting in a failure to identify important insights for 
vascular networks.  The recovery response to HLI produced rapid vascular growth in the 
thigh as demonstrated by comparable or increased blood vessel volume even at early time 
points despite the femoral vessels having been excised.  This enhanced vascular growth 
may suggest increased arterial blood supply.  In such a scenario, recovery from HLI may 
have resulted in superior oxygenation and nutrient supply to the surrounding skeletal 
muscle envelope, which could contribute to bone repair.  Future work incorporating 
direct measurement of tissue oxygen levels or techniques to discriminate between arterial 
and venous structures may help to better interpret these results.  Immunohistochemistry 
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techniques could provide some degree of insight on the latter, but are imperfect means for 
discerning vessel function and are unable to differentiate between patent and non-patent 
vessels.  Additionally, LDPI was used here as a functional measure of blood perfusion, 
but while providing useful data points, the limited penetration depth of this imaging 
modality precludes full characterization of limb blood perfusion, and cutaneous 
inflammation and wound healing likely bias the data to some degree that is 
unrepresentative of tissue perfusion.  When coupled with micro-CT angiography, a 
compelling evaluation of vascularity can be inferred, but an ability to acquire direct, 
longitudinal measurements of blood flow at the defect and in surrounding tissue would 
advance our understanding of the bone regeneration process.   
 One particularly intriguing future question prompted by the work here is whether 
the mechanisms associated with enhanced bone regeneration are a local effect or a 
systemic one.  To probe this question, an experiment could be conducted where the HLI 
surgery is performed on the contralateral limb from the bone defect surgery.  Were the 
effect to be demonstrated to be systemic, additional analysis would need to be performed 
to examine how the cellular constituents and soluble factor composition differed between 
groups with ischemia and groups without.  A systemic effect would be particularly 
interesting from a clinical perspective, as it may be more readily translational.      
 Transitioning the bone and vascular injury used here to a murine model could 
provide useful insights in the future.  Previously, others have shown that HLI will 
produce deleterious effects on tibial fracture healing in a mouse model (Lu et al., 2007).  
It would be interesting to determine what effect concomitant HLI would have on murine 
femoral fracture healing or segmental bone defect repair.  Were enhanced bone repair 
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results to be observed in femoral bone healing as they were in the work here, it would 
seem to further implicate the differences in vascular processes and tissue oxygenation 
between the upper and lower limb.  Furthermore, a wide variety of transgenic knockout 
mice are already available to researchers.  Coupling this model with transgenic knockout 
mice would allow for more specific mechanistic probing.  Conversely, developing a large 
animal model of composite bone and vascular injury may better represent the size scale 
of humans and recapitulate complications associated with vascular compromised clinical 
bone healing.  Such a model would provide a better platform to investigate the underlying 
mechanisms of impaired bone healing with concomitant vascular injury, as well as a 
suitable test bed to evaluate therapeutics designed to improve outcomes in healing 
challenged scenarios.  In a similar vein, through collaboration with Dr. Dietmar 
Hutmacher at the Queensland University of Technology in Brisbane, Australia, an ovine 
tibial defect model is currently being used to evaluate the efficacy of the hybrid 
alginate/nanofiber mesh system in defects of a similar size to those presented clinically.   
 Beyond additional work using in vivo models, in vitro systems may be able to 
improve interpretation of the work presented here and further elucidate the mechanisms 
of interaction.  The initial trigger for arteriogenesis is thought to be the “activated” 
endothelium produced as pre-existing collateral vessels are exposed to increased fluid 
shear stress in an attempt to compensate for arterial occlusions (Buschmann and Schaper, 
1999).  A series of in vitro experiments could be designed to begin to investigate how this 
activated endothelium may couple to bone repair.  Conditioned media could be collected 
from endothelial cell cultures exposed to a normal level of oscillatory shear stress, high 
oscillatory shear stress, or no flow control.  This conditioned media could then be used to 
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treat osteoblast or mesenchymal stem cell cultures to determine potential osteogenic 
effects.  Osteogenic culture media would serve as a positive control.  Another experiment 
could be performed to evaluate the chemotactic effects of the conditioned media.  To do 
so, cell culture transwell inserts could be seeded with mesenchymal stem cells or 
hematopoietic stem cells with varying conditioned media samples in the lower reservoirs.  
After an allotted culture period, samples would be fixed and migration assessed.   
 Overall, the sparse amount of published experimental work on bone repair with 
concomitant vascular injury is surprising given the known clinical complications and 
poor healing outcomes for patients with these injuries.  Accordingly, this is a clear area 
for future investigation to advance our understanding of this complex relationship and to 
develop TE/RM therapies to improve patient outcomes.   As with all in vivo research, 
selection of the appropriate animal model for the desired objectives is paramount.  Rat 
and mouse models present attractive choices for composite bone and vascular tissue 
trauma research for a variety of reasons, but consideration should be given to the specific 
limitations of models in these species.  Undoubtedly, small animal composite injury 
models are more representative of clinical trauma conditions than their single-tissue 
injury counterparts, and are capable of providing new insight on interactions between 
vascular growth and osteogenesis beyond the scope of normal bone healing.  However, 
interpretation of data from small animal models must take into consideration the robust 
neovascularization response in these species and differences in mass transport due to 
reduced size scale.  This may be of particular importance when developing therapies to 
overcome the increased clinical challenges associated with diminished blood supply.  
Evaluation of therapeutic strategies in models where revascularization is not a limiting 
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factor is unlikely to reveal positive effects.  Location of the orthopaedic injury is another 
important consideration.  Bones of the lower leg have substantially decreased 
surrounding skeletal muscle mass; consequently, they are likely more susceptible to local 
tissue ischemia, and healing may be more strongly influenced by concomitant vascular 
injury.   
 Bone repair is intimately linked to vascular growth and remodeling.  With 
sufficient consideration given to experimental design and intrinsic limitations, animal 
models of composite bone and vascular injuries offer a unique platform to obtain 
valuable insight for bone repair in instances with compromised vasculature, to advance 
our understanding of the complex mechanisms coupling vascular growth to bone repair, 
and ultimately improve outcomes for clinical patients. 
Onward Toward Full Limb Regeneration 
 Ultimately, achieving the potential of TE/RM therapeutics will involve harnessing 
the regenerative potential of endogenous mechanisms – identifying the minimal 
intervention necessary to achieve maximum therapeutic benefit.  Doing so will require a 
more advanced understanding of the interactions between healing tissues than is currently 
possessed.  The overwhelming majority of musculoskeletal trauma models currently used 
for evaluating new TE/RM therapeutics consist of single-tissue defects.  Although 
indispensible research tools, such models inherently possess limited utility for 
investigating strategies for the repair of large, multi-tissue defects and afford only little 
potential for insight into endogenous interactions between healing tissues.  Models of 
composite tissue trauma are uniquely positioned to bridge this knowledge gap and 
advance the TE/RM field.  This is because even in instances when composite injury 
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models fall short of recreating clinical conditions, as occurred with the bone-vascular 
injury model presented here, the additional intrinsic complexity affords potential for 
elucidating new insights.  
 As with all in vivo research, selection of the appropriate animal model for the 
research questions of interest is paramount.  Considerations specific to bone-nerve and 
bone-vascular injury models have been previously discussed in this document.  In 
general, the ramifications of species selection should be considered when designing 
research questions and when interpreting experimental results.  Furthermore, location of 
the musculoskeletal injury should be carefully considered due to anatomical and 
physiological differences between the upper and lower portion of extremities.  For 
effective comparisons of therapeutics, the model must present a challenging tissue defect 
in which a regenerative intervention is required for full recovery.  In all models, 
quantitative outcome measures should be included for evaluation of tissue regeneration 
and composition, with three-dimensional analysis whenever possible.  When evaluating 
therapeutics, functional assessments should be performed for the regenerated tissue, with 
comparisons made to intact or autograft controls.  Additionally, when practical, outcome 
measures should be included to evaluate the degree of functional restoration in the limb 
in vivo. 
 The models covered in this project are primarily representative of controlled 
injuries to just two tissue types (although the surgical procedures possess inherent 
damage to muscle, fascia, and cutaneous tissues).  While these models are undeniably 
more representative of clinical conditions than their single-tissue injury counterparts, the 
most accurate model of extremity trauma would be inclusive of bone, skeletal muscle, 
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vascular, neural, and adipocutaneous injuries.  Such models would certainly present their 
own set of limitations, however, most notably the feasibility of implementation.  As a 
step in that direction, ongoing work in our lab has focused on a composite injury model 
of a segmental bone defect in combination with volumetric muscle loss.  The skeletal 
muscle envelope surrounding bones houses the peripheral nervous system as well as the 
vasculature of the circulatory system, and thus, volumetric muscle loss invokes injury to 
both tissue types in addition to the muscle tissue damaged.  Findings from this model 
confirmed the hypothesis that volumetric muscle loss would impair bone regeneration 
(Willett et al., 2012).  Interactions between skeletal muscle and the bones it envelopes 
extend beyond physiologic biomechanical stimuli.  Initial studies have identified skeletal 
muscle as a source of vascular supply to intact and healing bone, as well as a possible 
reservoir of soluble factors and progenitor cells capable of participating in, and 
influencing the outcome of, bone healing (Fig. 6.1).   
 
 
Figure 6.1.  Mechanisms of interaction between bone and skeletal muscle.  The skeletal 
muscle envelope of bones provides contraction-induced mechanical stimuli due to its 




However, the mechanisms of interaction associated with volumetric muscle loss may also 
be inclusive of those previously discussed for bone-neural and bone-vascular tissues.  
Beyond preclinical mammalian models, additional future insight may be obtained from 
ongoing work in vertebrate species such as salamanders that possess the inherent capacity 
to regenerate entire limbs (Brockes and Kumar, 2005; Nacu and Tanaka, 2011) (Fig. 6.2).   
 
 
Figure 6.2.  Entire limb regeneration demonstrated by salamanders.  Adapted from Nacu 
and Tanaka, 2011.   
 
Moving forward, successful leverage of models of composite tissue limb trauma will 
advance the understanding of tissue repair biology, and ultimately, may produce new 
therapeutic interventions for limb salvage and reconstruction that improve outcomes for 




A.1 Segemental Bone Defect Surgery 
Materials 
Autoclave on Trays 
 surgery drill 
 surgery saw 
 saw hex tool 
 # 65 uncoated drill bits  
 5.5 x 12 x 0.4 mm micro oscillator saw blade 
 scalpel handles 
 curved hemostats 
 needle holders/suture cutters 
 small sharp scissors 
 blunt scissors to cut drapes 
 pickups (brown-adson forceps) 
 small pointed forceps (both curved and straight) 
 russian forceps 
 wound clip applicator 
 retractors 
 fixation plate holding c-clamp 
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 miniature screws, #00-90, ¼” length (JI Morris Part No. P000120CE125) 
 miniature screws, #000-120, 1/8” length (JI Morris Part No. P0090CE250) 
 fixation plate assemblies (1 polysulfone and 2 steel components per assembly) 
 miniature screw drivers (both larger and smaller tips) 
Autoclave separately in pouches 
 sterile bowls  
 hoses for pneumatic drill/saw 
 wound clips 
 surgery lamp handles 
Other Materials 
 4-0 vicryl suture  
 #10 scalpel blades 
 sterile 4x4 gauze 
 small sterile drapes packs 
 sterile half-drapes for surgery table 
 sterile table drape for side table with tools 
 surgical gowns 
 sterile gloves 
 glass bead sterilizer 
 sterile water for rinsing tools  
 sterile water (or saline) for irrigation 
 sterile needles for irrigation 
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 sterile 10 ml syringes for irrigation 
 scaffolds and biologics as necessary 
 sterile bowls  
 hoses for pneumatic drill/saw 
 wound clips 
 surgery lamp handles 
Procedure  
1. All personnel should wear scrubs, masks, head caps, and booties to ensure sterile 
environment. 
2. Surgeons and sterile assistants should scrub in. 
3. After scrubbing in, sterile personnel should assemble surgery tables making care 
to ensure a sterile surgical field.  Non-sterile personnel assist in opening 
packaging.   
4. Position glass bead sterilizer and turn on. 
5. Position the circulating water bed and turn on to pre-warm for surgery.  Cover 
with a sterile drape. 
6. Animal prep can begin when surgeons are adequately close to operating.  Care 
should be taken to minimize the time that animals are anesthetized. 
7. Transfer a properly prepared rat to the surgery table. Insert the rat’s nose into the 
nose cone, and straighten the tail so that it is not in contact with the feet of the 
animal. 
8. Non-sterile personnel should hold each foot/toes with forceps to allow sterile 
personnel to wrap the feet with ioban.  
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9. Cut a hole in a sterile drape and position over the rat such that only the leg and 
surgical site are exposed. 
10. Verify that fixation plate assemblies are constructed prior to beginning operation. 
11. Make a skin incision on the anterior side of the leg.  The incision should be 
roughly 25-30 mm and run approximately from the knee to the lower abdomen 
near the most caudally located nipple.  Retract the skin.  Additional skin retraction 
can be achieved by dissecting the skin away from underlying fascia. 
12. It may be necessary to make an incision in the adipose tissue below the skin as 
well, especially at the more proximal end of the skin incision. 
13. Using blunt dissection with a hemostat, separate the quadriceps muscle on the 
anteriolateral side of the femur.  There should be a visible split in the muscle 
bundles that can serve as a guide.  Be careful to avoid the femoral artery and other 
large blood vessels on the medial side of the quadriceps. 
14. Loosen and retract the soft tissues from around the femur.  Muscle tissue must be 
separated from the defect area to allow for accurate fixation plate placement. 
15. As necessary, make small incisions in the musclulature to extend the opening 
created by blunt dissection and expose the femur for placement of fixation 
hardware.  
16. Place the fixation plate on the anteriolateral side of the femur.  This surface of the 
bone should be relatively flat and accommodate the plate placement well.   
17. Secure the fixation plate in place with the c-clamp.  After verifying correct plate 
placement, tighten the c-clamp prior to drilling.  Be careful not to over-tighten the 
c-clamp, as this can lead to plate failure or bone fracture. 
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18. Drill through the bone using the screw holes on the plate as a guide.  Start on the 
distal end and insert one screw, making sure that it is fully seated.  If desired, the 
plate placement can be re-examined after insertion of the first screw to allow for 
adjustment if necessary.    
19. Drill on the proximal end and drive one screw in the same manner.   
20. Drill holes and drive the remaining two screws and remove the c-clamp. 
21. Squirt a small amount of sterile water or saline onto the bone to serve as cooling 
fluid for making the saw cuts. 
22. Make bone cuts using the oscillating saw at positions indicated by plate notches.  
Cuts should be made perpendicular to the long axis of the femur and parallel to 
each other.   
23. Remove the segment of the femur and flush the defect site to remove any debris 
and residual bone chips. 
24. Implant scaffolds and biologics as necessary. 
25. Close the soft tissues with 4-0 vicryl suture. 
26. Appose the skin incision and apply wound clips for closure. 
27. When surgery is complete, non-sterile personnel can transfer the animal from the 
table and begin post-operative care. 
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A.2 Hind Limb Ischemia Surgery 
Materials 
Autoclave on Trays 
 scalpel handles 
 curved hemostats 
 needle holders/suture cutters 
 small sharp scissors 
 blunt scissors to cut drapes 
 pickups (brown-adson forceps) 
 small pointed forceps (both curved and straight) 
 fine dissecting Dumont forceps 
 russian forceps 
 wound clip applicator 
 retractors 
Autoclave separately in pouches 
 sterile bowls  
 wound clips 
 surgery lamp handles 
Other Materials 
 4-0 vicryl suture  
 6-0 silk suture 
 160 
 #10 scalpel blades 
 sterile 2x2 and 4x4 gauze 
 sterile Q-tips 
 small sterile drapes packs 
 sterile half-drapes for surgery table 
 sterile table drape for side table with tools 
 surgical gowns 
 sterile gloves 
 glass bead sterilizer 
 sterile water for rinsing tools  
 sterile water (or saline) for irrigation 
 sterile needles for irrigation 
 sterile 10 ml syringes for irrigation 
 scaffolds and biologics as necessary 
Procedure  
1. All personnel should wear scrubs, masks, head caps, and booties to ensure sterile 
environment. 
2. Surgeons and sterile assistants should scrub in. 
3. After scrubbing in, sterile personnel should assemble surgery tables making care 
to ensure a sterile surgical field.  Non-sterile personnel assist in opening 
packaging.   
4. Position glass bead sterilizer and turn on. 
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5. Position the circulating water bed and turn on to pre-warm for surgery.  Cover 
with a sterile drape. 
6. Animal prep can begin when surgeons are adequately close to operating.  Care 
should be taken to minimize the time that animals are anesthetized.   
7. Transfer a properly prepared rat to the surgery table. Insert the rat’s nose into the 
nose cone, and straighten the tail so that it is not in contact with the feet of the 
animal. 
8. Non-sterile personnel should hold each foot/toes with forceps to allow sterile 
personnel to wrap the feet with ioban.  
9. Cut a hole in a sterile drape and position over the rat such that only the leg and 
surgical site are exposed. 
10. Make a skin incision on the anterior side of the leg.  The incision should be 
roughly 25-30 mm and run approximately from the knee to the lower abdomen 
near the most caudally located nipple.  Retract the skin.  Additional skin retraction 
can be achieved by dissecting the skin away from underlying fascia. 
11. Locate femoral vessels and dissect away connective tissue. 
12. Using fine Dumont forceps, carefully dissect the femoral artery and vein away 
from the associated nerves.   
13. Ligate the femoral artery and vein at the level of the inguinal ligament using 6-0 
silk suture.  This is the most proximal ligation. 
14. Ligate the femoral artery and vein just proximal to the popliteal bifurcation.  This 
is the most distal ligation. 
15. Two additional ligations are made at major arterial branch points.   
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16. Excise the length of the femoral artery and vein between the proximal and distal 
ligations, taking care to not cut any nerves.  If necessary, the distance between the 
proximal and distal ligations can be measured prior to excision. 
17. Irrigate the surgical field with saline. 
18. If bone defect surgery is not necessary, proceed to wound closure.  
19. Appose the skin incision and apply wound clips for closure. 
20. When surgery is complete, non-sterile personnel can transfer the animal from the 




A.3 Contrast Agent Vascular Perfusion  
Materials 
 0.9% normal saline 
 0.4% (m/v) papaverine hydrochloride (Sigma-Aldrich) in 0.9% saline 
(vasodilator) 
 Microfil MV-122 kit (yellow color lead chromate compound) 
(http://www.flowtech-inc.com) 
 10% neutral buffered formalin  
 properly labeled waste bottles for formalin waste 
 1 pair small surgical scissors, 1 pair large scissors, 2 hemostats, 1 small curved 
pair of forceps, additional instruments by personal preference 
 18 gauge (green) 2” long catheter (Terumo SurFlo) 
 needles 
 1ml slip tip and 30ml luer lock syringes  
 peristaltic pump  
 peristaltic pump tubing (Cole-Parmer Masterflex 96410-16) 
 small tubing for connecting pump tubing to catheter (Cole-Parmer 95802-02) 
 male and female luer lock connectors as needed 
 diaper pads 
 50ml conicals for mixing Microfil and harvesting legs 
 gauze and cotton swabs 
 2-0 needle-less suture 
 Super glue 
Procedure  
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1. Set up the peristaltic pump, check the flow, and bleed all air out of the line using 
the saline solution. You may have to start flow by siphoning the saline through 
the tubing using a syringe. 
2. Induce anesthesia at 5% isoflurane in an induction chamber. 
3. Switch animal over to the face mask at 2% isoflurane. 
4. Check for pedal withdrawal reflex using the toe pinch.  When this reflex is not 
observed, the animal has reached a deep surgical plane and the procedure can 
begin. 
5. Using needles, pin animals hands and feet to styrofoam.  Legs should be as 
straight as possible. 
6. Using scissors, cut transversely through the skin & muscles just below the 
xyphoid process of the rib cage to expose the diaphragm.  
7. Gently cut the diaphragm away from the rib cage, taking care not to puncture the 
heart or underlying vessels.  Administration of isoflurane can be discontinued 
once the diaphragm has been cut.   
8. Cut through the rib cage to allow opening of the chest cavity.  A large hemostat 
can be used to help keep the chest cavity open by clamping to xyphoid and 
positioning the instrument as necessary. 
9. Carefully dissect the heart free of the connective tissue holding it to the rib cage. 
10. Using small blunt tip forceps, pass a piece of 2-0 suture behind the aorta.  
11. While the heart is still pumping, insert the 18g catheter into the left ventricle 
(apex of the heart).  Blood should begin to back out of the catheter.   
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12. After penetrating the wall of the LV, carefully back the needle and advance the 
soft catheter into the ascending aorta.  Note the position of the catheter relative to 
the first branch of the aorta.  During perfusion, the catheter tip should not be in 
this branch.  It should be short of the branch or passed beyond the branch. 
13. Using a single loop with the 2-0 suture, constrict the aorta around the catheter 
within its lumen to prevent back-flow later in the perfusion process.  Optionally, 
place a small amount of super glue at the insertion point at the apex of the heart 
for additional stability. 
14. Attach the connection tubing to the catheter, making sure to minimize any air in 
the tubing. 
15. Cut the inferior vena cava. 
16. Immediately, turn on the pump, pefusing with saline ~25-50 ml  
17. Perfuse with ~100 ml of papaverine solution.  The liver should blanche quite 
quickly.  Skin can carefully be cut away on the leg for “windows” to inspect 
perfusion of the hind limbs.  Kidneys can be inspected to evaluate perfusion, also. 
18. Clear with ~25-50 ml of saline.  It may be necessary to continue to run saline for 
the vessels to clear. 
19. Perfuse with 10% NBF ~150-250 ml. Perfusion volume is an estimate.  The goal 
is to perfuse until the extremities are fully fixed.  Inflation of the lungs is an 
indicator of backflow in the system.  After ~100 ml, one may observe relative 
inflation of the GI system, which is not abnormal.  
20. Clear with Saline ~25-50 ml 
 166 
21. Mix MV-122 with diluent in a 50 ml conical tube.  Then, add catalyst, mix, and 
immediately transfer to a 30 ml syringe for injection.  Exhaust as much air as 
possible from the syringe before attaching to tubing. 
22. Switch luer-lock connector from pump tubing to syringe, being careful to 
minimize induction of air to the system. Slowly perfuse the animal manually, 
taking care not to let the catheter back out. 
23. Store animal in 4C refrigerator overnight to allow the microfil to polymerize. 
24. Remove the hindlimbs and immersion fix (generally only a few days). 
25. MicroCT scan to get composite image of bone and vasculature. 
26. Decalcify hindlimbs in Cal-Ex II for 2 weeks.  Use only gentle agitation, if any.  
Strong agitation will shake polymerized microfil out of the vessels. 
27. MicroCT scan to get vasculature alone. 
 167 
A.4 RNA Sample Purification from Animal Tissue 
This protocol is a modification of the Qiagen protocol for the RNEasy Fibrous Tissue 
Mini Kit.  It is recommended to review their handbook prior to beginning RNA 
purification. 
Determining the Correct Amount of Starting Material 
It is essential to use the correct amount of tissue in order to obtain optimal RNA yield and 
purity. With the RNeasy Fibrous Tissue Mini Kit, a maximum of 30 mg tissue can 
generally be processed. For most tissues, the RNA binding capacity of the RNeasy spin 
column and the lysing capacity of Buffer RLT and proteinase K will not be exceeded by 
this amount. Average RNA yields from various tissues are given in the Qiagen handbook.  
For more homogeneous sampling, starting material in excess of 30 mg tissue can be used 
(with appropriate scale up of RLT buffer), but after lysis step, only 300 μl should be used 
for downstream steps. The remainder of the homogenized tissue lysate can be stored at –
70°C for several months. 
Do not overload the RNeasy spin column, as this will significantly reduce RNA yield and 
quality. 
Weighing tissue is the most accurate way to quantify the amount of starting material. As 
a guide, a 3 mm cube (27 mm3) of most animal tissues weighs 25–35 mg. 
Important Points Before Starting 
 If using RNeasy Fibrous Tissue Kits for the first time, read “Important Notes” 
from Qiagen handbook 
 If working with RNA for the first time, read Appendix A from Qiagen handbook 
 168 
 Since the RNase-inactivating Buffer RLT must be diluted to permit proteinase K 
digestion, this protocol should not be used for tissues rich in RNases, such as 
pancreas or intestine per Qiagen. 
 Fresh, frozen, or RNAlater stabilized tissues can be used. If freezing tissues, 
flashfreeze in liquid nitrogen and immediately transfer to –70°C, where they can 
be stored for several months. Do not allow tissues to thaw during weighing or 
handling prior to disruption in Buffer RLT. Homogenized tissue lysates from step 
4 can also be stored at –70°C for several months. Incubate frozen lysates at 37°C 
in a water bath until completely thawed and salts are dissolved before continuing 
with step 5. Avoid prolonged incubation, which may compromise RNA integrity. 
 Do not vortex reconstituted DNase I. DNase I is especially sensitive to physical 
denaturation. Mixing should only be carried out by gently inverting the tube. 
 Buffer RLT may form a precipitate upon storage. If necessary, redissolve by 
warming, and then place at room temperature (15–25°C). 
 Buffer RLT and Buffer RW1 contain a guanidine salt and are therefore not 
compatible with disinfecting reagents containing bleach. 
 Unless otherwise indicated, perform all steps of the procedure at room 
temperature. During the procedure, work quickly. 
 Perform all centrifugation steps at 20–25°C. Ensure that the centrifuge does not 
cool below 20°C. 
Things to Do Before Starting 
 β-Mercaptoethanol (β-ME) must be added to Buffer RLT before use. Add 10 μl β-
ME per 1 ml Buffer RLT. Dispense in a fume hood and wear appropriate 
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protective clothing. Buffer RLT containing β-ME can be stored at room 
temperature for up to 1 month. 
Alternatively, add 20 μl of 2 M dithiothreitol (DTT) per 1 ml Buffer RLT. The 
stock solution of 2 M DTT in water should be prepared fresh, or frozen in single-
use aliquots. Buffer RLT containing DTT can be stored at room temperature for 
up to 1 month. 
 Rotor stator homogenizer must be cleaned before use if it will be used for 
generating homogenized tissue lysates. It should be thoroughly wiped down with 
RNaseZAP and thoroughly rinsed with ethanol then water. 
 Buffer RPE is supplied as a concentrate. Before using for the first time, add 4 
volumes of ethanol (96–100%) as indicated on the bottle to obtain a working 
solution. 
 If on column DNase digestion will be performed, prepare DNase I stock solution 
before using the RNase-Free DNase Set for the first time. Dissolve the lyophilized 
DNase I (1500 Kunitz units) in 550 μl of the RNasefree water provided in the 
RNase-Free DNase Set box. To avoid loss of DNase I, do not open the vial. Inject 
RNase-free water into the vial using an RNase-free needle and syringe. Mix 
gently by inverting the vial. Do not vortex. 
 For long-term storage of DNase I, remove the stock solution from the glass vial, 
divide it into single-use aliquots, and store at –20°C for up to 9 months. Thawed 
aliquots can be stored at 2–8°C for up to 6 weeks. Do not refreeze the aliquots 
after thawing. 
Procedure  
1. Heat a water bath or heating block to 55°C for proteinase K digestion in step 6. 
2. If working with tissues that are notstabilized in RNAlater RNA Stabilization 
Reagent, place the tubes on dry ice. 
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3. Excise the tissue sample from the animal or remove it from storage. Determine 
theamount of tissue. Do not use more than 30 mg (as noted above, exceptions 
apply for the amount of initial tissue, but more than 30 mg worth of lysed tissue 
should not be used downstream of the lysis step). Proceed immediately to RLT 
buffer addition in step 4. 
Weighing tissue is the most accurate way to determine the amount. 
If the tissue sample was stored in RNAlater RNA Stabilization Reagent, remove it 
from the reagent using forceps and be sure to remove any crystals that may have 
formed. 
RNA in harvested tissues is not protected until the tissues are treated with 
RNAlater RNA Stabilization Reagent, flash-frozen, or disrupted and 
homogenized in step 4. Frozen tissues should not be allowed to thaw during 
handling. The relevant procedures should be carried out as quickly as possible. 
4. Place the tissue in a suitably sized vessel. Add 300 μl Buffer RLT (add additional 
RLT buffer if tissue sample for lysis is in excess of 30 mg). 
Generally, round-bottomed tubes allow more efficient disruption and 
homogenization than conical-bottomed tubes. Qiagen 2 ml collection tubes (PCR 
clean) and BD polystyrene 5 ml tubes (not-PCR clean) have both been 
successfully used. 
5. Disrupt the tissue and homogenize the lysate using the rotor stator homogenizer. 
See “Disrupting and homogenizing starting material” in Qiagen handbook, for 
more details on disruption and homogenization. 
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Note: Ensure that β-ME is added to Buffer RLT before use (see “Things to do 
before starting”). 
Note: Incomplete homogenization leads to significantly reduced RNA yields and 
can cause clogging of the RNeasy spin column. 
Place the tip of the homogenizer into the vessel and operate at 50-75% full speed 
until the lysate is uniformly homogeneous (usually 1 or 2 bouts of ~20 s). 
Note: Between samples, the homogenizer should be cleaned to avoid cross-
contamination. Wipe down with RNaseZAP, followed by rinses of PCR clean 
water, ethanol, and water again. Excess fluid remaining on homogenizer should 
be dabbed away with a KimWipe to avoid dilution of RLT buffer.  
6. Incubate homogenized lysate samples at RT for 5 min. 
7. Add 590 μl RNase-free water to each 300 μl lysate. Then add 10 μl proteinase K 
solution, and mix thoroughly by pipetting. 
8. Incubate on heat block at 55°C for 10 min. 
9. Pipette each sample to two Qiashredder columns (450 μl in each). Centrifuge at 
20–25°C for 5 min at 12,000 x g. 
10. Pipet the supernatant (approximately 900 μl) into a new 1.5 ml or 2 ml 
microcentrifuge tube (not supplied). 
Avoid transferring any of the pellet. If this is unavoidable, a small amount of 
pelleted debris may be carried over without affecting the RNeasy procedure. If 
any film is present on top of supernatant (rare after having used Qiashredder 
column), hold the pipet tip under the thin layer or film on top of the supernatant, if 
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present. This layer will usually adhere to the outside of the pipet tip and should 
not be transferred. 
11. Add 0.5 volumes (450 μl) of ethanol (96–100%) to the cleared lysate. Mix well by 
pipetting. Do not centrifuge. 
Precipitates may be visible after addition of ethanol. This does not affect the 
procedure. 
12. Transfer 700 μl of the sample, including any precipitate that may have formed, to 
an RNeasy Mini spin column placed in a 2 ml collection tube. Close the lid 
gently, and centrifuge at 20–25°C for 15 s at 8000 x g (10,000 rpm). Discard the 
flowthrough in proper recepticle. 
Reuse the collection tube in step 13. 
13. Repeat step 10 using the remainder of the sample. Discard the flow-through. 
Reuse the collection tube in step 14. 
14. Add 350 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and 
centrifuge at 20–25°C for 15 s at 8000 x g (10,000 rpm) to wash the membrane. 
Discard the flow-through. 
Reuse the collection tube in step 15. 
Optional: If on-column DNase digestion is not desired, add 700 μl Buffer RW1 
instead, centrifuge for 15 s at 8000 x g, and discard the flow-through* (but not the 
collection tube). Proceed to step 18. 
15. Add 10 μl DNase I stock solution to 70 μl Buffer RDD. Mix by gently inverting 
the tube, and centrifuge briefly to collect residual liquid from the sides of the tube. 
 173 
Note: DNase I is especially sensitive to physical denaturation. Mixing should only 
be carried out by gently inverting the tube. Do not vortex. 
16. Add the DNase I incubation mix (80 μl) directly to the RNeasy spin column 
membrane, and place on the benchtop (20–30°C) for 15 min. 
Note: Be sure to add the DNase I incubation mix directly to the RNeasy spin 
column membrane. DNase digestion will be incomplete if part of the mix sticks to 
the walls or the O-ring of the spin column. 
17. Add 350 μl Buffer RW1 to the RNeasy spin column. Close the lid gently, and 
centrifuge for 15 s at 8000 x g (10,000 rpm) at 20–25°C. Discard the flowthrough. 
Reuse the collection tube in step 18. 
18. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and 
centrifuge at 20–25°C for 15 s at 8000 x g (10,000 rpm) to wash the membrane. 
Discard the flow-through. 
Reuse the collection tube in step 19. 
Note: Buffer RPE is supplied as a concentrate. Ensure that ethanol is added to 
Buffer RPE before use (see “Things to do before starting”). 
19. Add 500 μl Buffer RPE to the RNeasy spin column. Close the lid gently, and 
centrifuge at 20–25°C for 2 min at 8000 x g (10,000 rpm) to wash the membrane. 
The long centrifugation dries the spin column membrane, ensuring that no ethanol 
is carried over during RNA elution. Residual ethanol may interfere with 
downstream reactions. 
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Note: After centrifugation, carefully remove the RNeasy spin column from the 
collection tube so that the column does not contact the flow-through. Otherwise, 
carryover of ethanol will occur. 
20. Optional: Place the RNeasy spin column in a new 2 ml collection tube, and 
discard the old collection tube with the flow-through. Close the lid gently, and 
centrifuge at full speed for 1 min.  
Perform this step to eliminate any possible carryover of Buffer RPE, or if residual 
flow-through remains on the outside of the RNeasy spin column after step 19. 
21. Place the RNeasy spin column in a new 1.5 ml collection tube (Eppendorf). Add 
30–50 μl RNase-free water directly to the RNeasy spin column membrane. Close 
the lid gently. Allow to rest for 1 min prior to centrifugation. To elute the RNA, 
centrifuge for 1 min at 8000 x g (10,000 rpm) at 20–25°C. 
22. Optional: Repeat step 21 using another 30–50 μl RNase-free water, or using the 
eluate from step 21 (if high RNA concentration is required). Reuse the collection 
tube from step 21. If the expected RNA yield is >30 μg, there is no need to repeat 
step 19.If using the eluate from step 19, the RNA yield will be 15–30% less than 
that obtained using a second volume of RNase-free water, but the final RNA 
concentration will be higher. 
23. Use spectrophotometer to determine RNA sample concentration and purity. 
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